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The gastrointestinal tract  
 
The gastro-intestinal (GI) tract of a chicken starts with the beak, followed by the 
esophagus and crop, proventriculus (glandular stomach), gizzard (muscular 
stomach), duodenum, ileum, a pair of blind elongated caeca, colon and ending in 
the cloaca. The GI-tract consists of a large, single cell layer of epithelial cells 
surface and a complex microflora that symbiotically interacts with the host. The 
surface is enlarged by the folds in the mucosal surface which are covered with villi, 
which in turn are covered by microvilli. For humans the surface of the skin is about 2 
m2, while the gut surface is 150-200m2 (about the size of a tennis court). For 
chickens, these numbers are not available, but the ratio probably is also 100 times 
the skin surface. Villi are present throughout the small and large intestine. They are 
longest in the duodenum, but gradually shorten and thicken towards the colon. In 
the first part of the cloaca they are stumpy and rounded. Villi are present in the 
caeca also, becoming flattened toward the blind end.  
 
Although the GI-tract is inside the body, the epithelial cell layer forms the border 
between inside and outside the body and is thus continuously in contact with the 
external environment. The GI-tract has conflicting functions: active transport of 
nutrients and water while keeping bacteria, viruses, toxins and potentially antigenic 
food molecules outside. Transport is arranged by diffusion, facilitated diffusion and 
active transport. The barrier is formed by the combination of a confluent single 
epithelial cell layer covered with mucus on the lumen side and a supportive 
underlying connective tissue layer. They form the border between the internal and 
external milieu, integrated with specific and non-specific immunological defense 
mechanisms. The gut-associated lymphoid tissue (GALT) comprises all cells and 
tissues along the alimentary tract from beak to cloaca. It includes organized 
structures like cecal tonsils (situated near the ileocolonic junction), Meckel’s 
diverticulum (or diverticulum vitellinum, formed around the connection between yolk 
sac and embryonic intestine, situated at the jejunum), lymphoid aggregates and 
single cells in the lamina propria and epithelium (137). 
 
The epithelial wall of the intestine of the chicken is similar to that of mammals, 
although Peyer’s patches (in organized, clear structures as in mammals) are absent 
(18). Furthermore chickens duodenal glands are absent and the submucosa is 
extremely thin (7). M-cells exist in the chicken, but their phenotype and function are 
less well distinguished from neighbor epithelial cells than observed in mammals 
(138). All epithelial cells are capable of absorption from the lumen (137). The 
running time of food through the GI-tract is 10 times shorter in chickens than in 
humans. In humans the total transit time through the gastrointestinal tract is 
between 55-72 hours (162), while in chickens it is around 6 hours: gizzard 1 hour 6 
min; duodenum 6 min; jejunum 1 hour; ileum 1 hour 20 min; caeca 1 hour 15 min; 
colon + cloaca 42 min (254). 
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Chicken 
 
In the past, chickens have been selected for improved feed conversion and rapid 
growth or for high production of eggs. This has led to two different phenotypes of 
chickens: broiler- and layer type chickens. Because of this selection for 
economically important production traits, these chickens differ in body weight gain 
and maximum life span. Recently data became available that these chicken types 
also differ in immune system because of genetic differences. Growth of broiler type 
chickens has been markedly increased. The modern broiler type chicken weighs 
almost 5 times as much as the random-bred chicken from 45 years ago and this is 
for 85-90% because of genetic selection. Another cause of the increased body 
weight is the improved nutrition, which increased growth performance with 20-30%) 
(109, 110). Modern heavier broiler type chickens and turkeys have a less well 
developed immunocompetence (46, 148, 163, 164), disease resistance (312) and 
exhibit a propensity for skeletal and metabolic disorders (109, 110, 141). Therefore, 
concern has risen with respect to their ability to mount an immune response to the 
whole array of pathogens as encountered in poultry breeding.  
 
More recently, the public opinion is turning around from focusing on cheap broiler 
meat to awareness about the welfare of the animals. This is leading to the 
development of more so called biological, ecological and organic farming systems, 
where the animals are living in an environment where they can behave naturally. 
However, they lack the strict hygienic measurements and antibiotics to prevent 
pathogenic and parasitic infections. Although the welfare of the animals is 
apparently increased in the eyes of the general public and customers, the 
environmental threats outside is an increased risk for the health of the chickens and 
therewith for the consumers. The risk of viruses (e.g. Avian influenza), bacteria (e.g. 
Salmonella and Campylobacter) and parasites (e.g. Eimeria) may be increased 
enormously. The chickens that are used in the intensive farming nowadays are 
especially bred for fast growth or egg production under hygienic circumstances. 
When chickens are held organically, more robust chickens will be necessary. In 
addition, antibiotics as feed additives will be prohibited per January 2006. Fear for 
possible transmission of antibiotic resistance from animals to humans and 
increased awareness of consumer safety have led to this prohibition. Antibiotics will 
be allowed for therapeutical purposes only (77). Increased disease resistance and a 
well-developed immune system will be even more important when antibiotics are 
removed from the feed and/or when chickens will be held organically.  
 
Chicken immune system  
 
The immune system is part of the host’s defense against infection. The chicken 
immune system is similar to the immune system of mammals. Although lymph 
nodes do not occur in the chicken, diffuse lymphatic tissue and lymphatic nodules 
are widespread (8). The immune system can be divided in innate (or natural) 
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immunity and acquired (or adaptive) immunity, each composed of cellular and 
humoral elements. Both forms of immunity are functionally integrated with each 
other. The function of the adaptive immune system is based on specific antigen 
recognition, enabling specific responses, and memory, enabling faster responses 
upon subsequent encounters. The innate response is mainly based on pattern 
recognition (conserved motifs) and receptor recognition and is therefore fast, 
although it does not specifically recognize individual pathogens. The lack of 
specificity is more than compensated for by the speed and level of response, which 
is much faster (minutes rather than days) than that of the adaptive immune 
response (133, 172). Phagocyte recognition and uptake of pathogens involves 
pattern-recognition molecules such as the macrophage mannose receptor, 
scavenger receptors and Toll-like receptors (19, 103, 184). 
 
Table 1  Innate versus acquired immunity (172) 
 
Innate immunity Acquired immunity 
Immune response is antigen independent 
 
Immune response is antigen dependent 
Immediate maximal response 
 
Lag time exposure -> maximal response 
Group specific (sequence, motive, structure) 
 
Antigen-specific 
No immunological memory 
 
Exposure results in immunological memory 
Involves myeloid cells  
(platelets, eosinophils, neutrophils, basophils, mast 
cells ->macrophage, monocytes) 
Involves lymphocytes  
(B cell ->plasma cell, T cell (helper, cytotoxic, 
suppressor) 
 
Innate immunity 
 
The innate immune response is the first line of defense against pathogens. The 
elements of the innate immune system include: 
• anatomical barriers (skin, mucosal epithelia); 
• secretory molecules (antimicrobial substances as lysozyme, complement, 
peroxidase, lactoferrin, defensins); 
• cytokines  
- pro inflammatory: Interleukin-1 (IL-1), tumor necrosis factor (TNF), 
interferon-gamma (IFN-γ), IL-12, IL-18 and granulocyte-macrophage colony 
stimulating factor (GM-CSF);  
- anti-inflammatory : IL-4, IL-10, IFN-α;  
• cellular components (inflammatory reaction as accumulation of macrophages, 
monocytes) 
• resident flora (colonization resistance).  
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Until recently, only a few avian cytokines have been characterized and potential 
applications of cytokine detection and measurements have remained limited to 
mammals. Classic approaches (e.g. producing antibodies) to identify cytokine 
genes in birds proved difficult because the sequence conservation is generally low. 
As new technology and high throughput sequencing became available, this situation 
changed quickly in the last few years. The whole genome of the chicken is just 
identified and will be published soon. Recently the identification of genes for the 
avian homologues of interferon-alpha/beta (IFN- α, β and γ, various interleukins, 
and several chemokines took place. From the initial data on the biochemical 
properties of these molecules, the image is emerging that avian and mammalian 
cytokines may perform similar tasks, although their primary structures in most cases 
are remarkably different (270). Recently in our lab lightcycler RT-PCR assays have 
been set up in chicken to determine relative concentrations of mRNA of IFN-γ, IL-2, 
IL-6 and IL-18 (25). Expanding this technique to more interleukins could be helpful 
for identifying immune responses in tissue of the chicken, e.g. the gut.  
 
Acquired immunity 
 
An acquired immune response is the development or enhancement of antigen-
specific defense mechanisms in response to a stimulus. Immune responses are 
associated with antigen presenting cells and two major subpopulations of 
lymphocytes, namely B lymphocytes and T lymphocytes (172). The main feature of 
the adaptive immune system is to discriminate between self- and non-self antigens.  
The antigen specific adaptive immune system has two important effector 
mechanisms to attack pathogens. One is based on the formation of 
immunoglobulins by B cells and is called humoral immune response. The other, the 
cellular response, is based on a great variety of cells each with their own individual 
effector mechanism. Examples of these cells are cytotoxic T cells that kill infected or 
tumor cells. T cells may produce an enormous variety of soluble molecules that 
function as messengers between cells of the immune system or can directly kill 
pathogens. The communication signals between the cells may be proteins such as 
lymphokines, cytokines and chemokines (126). These bring about a complex 
response, mutual affecting, with cellular dialogues and feedback mechanisms, 
resulting in an enormous response reserve that guarantees an optimal enhancing 
effect of both the humoral and cellular responses (75). 
 
An antigen specific response leaves the host with specific immunological memory, 
enabling it to respond more effectively to re-exposure to the same stimulus. The 
response to a second round of infection is more rapid than to the primary infection 
because of the activation of existing memory B and T cells.  
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Microflora 
Normal chicken gut flora 
 
Chickens are born with a sterile intestinal tract. Under natural conditions, 
immediately after birth bacteria originating from the maternal feces, the environment 
and the diet will colonize the GI-tract. This results in a diverse microbial population 
in the GI-tract that is balanced with the maternal environment. As a result, after the 
first colonization, dependent on the stability of the composition of this initial 
microflora, new bacterial species will have more difficulties to colonize (colonization 
resistance). In the common intensive breeding where chicken generations are 
strictly separated, there is no contact between the newly hatched chicken and the 
adult microflora of the mother hen. Therefore any bacteria from the environment 
might colonize the intestinal tract (290). It is suggested that lack of contact results in 
an imperfect composition and a delayed development of the intestinal microflora. In 
the modern housing situation, enterococci and lactobacilli dominate the crop, 
duodenum and ileum of broiler type chickens in the first week of life while coliforms, 
enterococci and lactobacilli dominate the caeca. Thereafter, a complex microflora 
with mostly obligate anaerobic bacteria starts to dominate the caeca (11, 260, 292) 
while lactobacilli dominate the crop, duodenum and ileum. After two to three weeks 
the microflora is established in the intestine of broiler type chickens (51) while under 
natural conditions this takes only a couple of days. The bacterial contents of 
chickens intestine is an enormous biomass that contains up to 1014 bacterial cells. It 
is estimated that this microflora comprises over 400 bacteria species. In chickens 
the most complex flora exists in the caeca. It contains up to 1011 viable bacteria per 
gram content. This most probably is the result of the low local flow rate (caeca are 
emptied 2-4 times per day and therefore resemble batch culture). Of the cecal 
species 99% are obligatory anaerobic species and about 10% are lactobacilli and 
bifidobacteria (12, 297). Until now, many species could not be grown in culture, but 
can now be detected with new PCR techniques (124, 125, 147, 246, 261, 281).  
 
The normal flora consists of autochthonous flora (or indigenous flora). This 
indigenous flora consists of resident micro-organisms present in all communities of 
a particular animal species, the allochtonous flora, or harmless transient microflora, 
and microorganisms that are transiently present such as pathogens. Hence not all 
species represented in the indigenous flora of the chicken are present in all 
members of a single flock (248). Opportunistic bacteria are also a part of the 
microflora and under specific conditions these can be harmful. Indigenous flora 
bacteria can be harmless, harmful and everything in between.  
 
The bacteria of the microflora and the host have multiple interactions and maintain a 
dynamic balance with each other (figure 1). The flora is quite stable although it 
adapts in overall metabolic activity and relative proportion of microorganism species 
to nutrient changes. This balance can also be modulated by medicines (antibiotics), 
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intruding microorganisms, host related factors (age, immunity, hormones), stress, 
feed (bacteria, growth enhancers) or environmental factors (125). 
 
Function of the microflora  
 
The gut flora has several functions which involve the digestion and health of the 
host. The flora assists in degradation of certain food components such as the 
predigestion of ‘non’-digestible poly- and oligosaccharide fibers, production of 
vitamins B and K (20), stimulation of priming and development of the immune 
system, induction of GI tract peristalsis and intestinal mucosal integrity, conversion 
of dietary (pre)carcinogens to non-carcinogens (100), production of digestive and 
protective enzymes, production of antimicrobial substances, forming a barrier 
against pathogenic and opportunistic micro-organisms. Some of these beneficial 
effects also have a negative counterpart in converting dietary non-carcinogens to 
(pre)carcinogens (100), in ecological disruptions that lead to intestinal overgrowth 
by indigenous bacteria and opportunistic infections that lead to translocation over 
the GI tract wall (22, 122). 
 
 
 
 
 
 
 
 
 
Figure 1. Flora, host and immune system have multiple interactions with each other  
 
Since newly hatched chickens separated from their mother or other older animals 
do not have the chance to pick up a normal healthy adult microflora they are more 
vulnerable to pathogens and infections. Chicken feeding starts with storing food 
temporarily in the crop. The crop is colonized by lactobacilli and during food storing 
lactobacilli from the crop are continuously added to the food (88). Locally, these 
bacteria can create a micromilieu that is not favorable for pathogens and thereby 
lower the infection pressure of a pathogen. After leaving the crop the lactobacilli 
enter the rest of the GI-tract with the food. Probiotic lactobacilli might be able to help 
develop and stabilize the microflora of newly hatched chickens.  
 
 
Interactions of the gut flora  
Microflora interactions with the gut 
 
Although research has focused mainly on intestinal pathogens that may cause local 
and systemic infections, most intestinal microflora bacteria are beneficial to the host 
host 
  immune system flora
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(123, 238). Beneficial functions attributed to intestinal bacteria include positive 
effects on the morphology, physiology, biochemistry and immune system of the 
host. This includes development of the gut wall, intestinal villi and lamina propria 
(20), induction of intestinal angiogenesis (271), nutrient processing (309), 
production of vitamin B complex and vitamin K (20), development of GALT (274), 
induction of oral tolerance (276), mucosal immunity (277)and diversification of the 
pre-immune Antibody repertoire (160, 238). In addition, the microflora seems to play 
a significant role in the generation of immunocompetent cells during development 
and maintenance of the intestinal homeostasis and prevention of inflammation (24, 
31, 48, 121). It is hypothesized, and several recent publications are strengthening 
this hypothesis, that the lack of proper interactions between bacteria and the host 
contributes to the prevalence of allergies and Crohn’s disease in developed 
countries (240, 273). 
 
Host interactions with the microflora 
 
Although the microflora has a considerable influence on the host, the host also 
plays a role in composition and magnitude of the microflora. The major host factors 
influencing the flora (122) are the intestinal pH; secretions such as 
immunoglobulins, bile-salts, enzymes; motility as speed, peristalsis; physiology 
(compartmentalization) and excretions of cells such as mucins and bacteriocidins 
produced by Paneth cells and other tissue exudates. Changes in these factors may 
be related to changes in the physiological conditions of the host (aging, stress, and 
health status), composition of the diet and environmental conditions (e.g. 
contamination with pathogens, use of pharmological products). In this way the 
digestion (e.g. pH, substrate availability, redox potential, transit time, flow of enteric 
fluid, IgA secretion, etc.) may be modulated and thereby the microflora (122). 
 
The immune system is known to regulate the composition of the microflora. During 
pregnancy or in the egg a coating of maternal antibodies is formed along the gut. 
This antibody coating influences the colonization of the gut by bacteria. The 
antibodies bind microorganisms, thereby preventing their adhesion to the gut, so 
that they are selectively washed-out. Because of this selection of microorganisms 
the immune system is exposed to a selection of microorganisms to which tolerance 
is established and the specific immune system (IgA, T- and B cells) is selectively 
triggered by this selection. The repertoire of antibodies provided by the mother is 
therefore first influencing the selection of microorganisms and the presentation of 
the microorganisms to the immune system. After that the microorganisms, to which 
animals are exposed to, seem to determine the balance of the microflora later in life.  
For the Lactobacillus flora the environment is an important factor. This flora is more 
defined by the housing than by host genetics (65). 
 
The process of primary bacterial colonization in the gut is also dependent on the 
nature of the individual’s innate carbohydrate repertoire. If these first bacteria 
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posses glycolytic activities, they will modify the carbohydrate repertoire, thereby 
encouraging new bacteria to establish and others to be lost (162). In conclusion, the 
microflora is influenced by the bacterial flora of the mother and the maternal 
antibodies, the primary bacteria the individual is exposed to, the carbohydrate 
expression in the host (host genetics) and influx of bacteria from the environment. 
 
Interaction of microflora with pathogens  
 
Several mechanisms have been proposed by which the resident microflora inhibits 
the colonization of invading bacteria in the intestine. After passing the protective 
mucus layer, indigenous bacteria adhere to specific glycoprotein receptors on 
intestinal epithelial cells. The resulting barrier of microflora, which is firmly attached 
to the mucosa, together with the mucus layer, prevents contact and colonization by 
pathogenic organisms together with the mucus layer. Mucosal attachment is a 
prerequisite for successful colonization and possible translocation of a pathogen. 
Without adhesion, bacterial multiplication is generally inadequate to compensate for 
the wash out of bacteria with the flow of intestinal content (35). The microflora 
interacts with pathogens and other microorganisms in several ways: 
• synergy (metabolic co-operation, growth factors and vitamin excretion, changes 
to oxidation-reduction potential, pH, O2tension); 
• antagonism/stimulation (short chain fatty acids, lactic acid, amines; changes to 
oxidation-reduction potential, pH, O2tension; antimicrobial components (H2O2, 
bacteriocidins and acids), siderophores; nutritional requirements, etc.) (35, 101, 
115, 122); 
• competition: two or more microbial types in rivalry for a factor in the gut-
ecosystem that is not present in sufficient quantities to satisfy the demands of 
all of the inhabitants. This could be competition for nutrients, space, etc.; 
The prevention of pathogenic colonization by excluding other microbes than the 
resident flora by competition and antagonism (e.g. by lactobacilli) is called 
colonization resistance (20, 201). 
 
Lactobacillus 
 
Lactobacilli are gram positive, rod shaped lactic acid bacteria. Although there are 
some exceptions, most of the Lactobacillus strains are not pathogenic and 
lactobacilli are major constituents of the human and animal gut. Because of the safe 
use in food for centuries, they have the GRAS-status and are frequently used in 
bioprocessing and preservation of food and feed (e.g. yogurt, kefir, milks, cheeses, 
breads, wines, meats, sauerkraut, olives, pickles and silage). Nowadays lactobacilli 
are mainly known for their health stimulating properties. The importance of 
lactobacilli for human health was first recognized by Metchnikoff at the beginning of 
the 20th century (186). He suggested that harmful effects of undesired bacteria 
could be overcome by establishing a new balance between intestinal bacteria, 
through ingestion of lactobacilli or fermented products made using these organisms. 
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He attributed the long, healthy lives of Bulgarian peasants to their consumption of 
fermented milk products containing ‘Bulgarian Bacillus’ (now known as Lactobacillus 
bulgaricus). 
 
Probiotics are live bacterial food supplements, which beneficially affect the host by 
improving its intestinal balance (87). In the seventies of the 20th century probiotics 
were presented as miracle bacteria with all kinds of positive effects on the health of 
the host. These positive effects varied from improvement of feed-conversion rate in 
farm animals (88), overall improvement of well-being (194), shorten viral diarrhea 
(128), positive effect on cancer, prevention of cancer, lowering blood cholesterol 
levels (58), enhancing disease resistance (236), treatment and prevention of 
allergies (129), and improving the immune response (54, 217). As a result of all 
these positive effects probiotic bacteria were expected to be super-bacteria and 
expectations with respect to application ran high. This resulted in many 
investigations. Subsequently, also disappointing results were reported. These were 
in part the result of expectations with respect to beneficial effect on certain functions 
while the probiotics that were subject of research had not been selected for the 
investigated purpose. Therefore, the interest in probiotics declined during the 
seventies and eighties. In the nineties the interest in probiotics revived. New 
techniques and insights renewed the vision on probiotics. It became apparent that a 
single probiotic strain could never meet all these expectations and that the positive 
effects should be adapted to these new insights. In addition, it became apparent 
that a probiotic strain could have a specified positive effect in one host and not in 
another.  
 
Probiotics can have a positive effect on the health of the host, but the effect often is 
small and limited to the combination of Lactobacillus strain and host in the 
investigation that reports the effect. It also became clear that the properties of the 
strains of probiotic bacteria had to be well characterized. The nature of the 
modulating effects of the strains also needed refined description, so as to allow 
attributing certain effects to selected strains. It became apparent that different 
strains exerted different sets of effects (62, 111, 169).  
 
Chicken feed contains relatively low, non-therapeutical concentrations of antibiotics 
because of their growth promoting and antibacterial effect. The long term use of 
antibiotics could lead to resistance to certain groups of antibiotics which could 
possibly end up in the human food chain and there form a danger to humans.  
 
Especially during the last few decades, extensive research on the positive effects of 
Lactobacillus strains has been carried out, in search of health and/or nutritional 
benefits for humans and animals by oral administration (168). Still, the exact role of 
lactobacilli in the enhancement of health is not fully understood. The more recent 
research is carried out for the greater part more precisely with well-defined strains 
and sometimes even with randomized placebo controlled human studies. A list of 
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proposed effects of orally administered probiotics is shown in table 2. Apparently, 
the beneficial effects of probiotic bacteria are strain dependent and largely based on 
the improvement of the intestinal barrier in terms of competitive exclusion, 
production of inhibitory substances, and stimulation of innate and acquired immunity 
(69, 199, 208). For instance, it has been shown that various Lactobacillus strains 
induce the production of certain cytokines in the host that direct particular immune 
responses (167, 169). Despite many studies in which lactobacilli interacted with 
immunocompetent cells in in vitro assays (reviewed by Maassen (168)) the exact 
nature of the physical interaction of lactobacilli with the immune system in vivo is 
still largely unknown. It appears that orally administered lactobacilli are taken up by 
M-cells or dendritic cells (237) in the small intestine or by intestinal epithelial cells 
and there interact with the immune system. 
 
Table 2  Short overview of various probiotic microorganisms and the suggested 
health effects of probiotics in animals and humans 
Described probiotic bacteria 
species 
Suggested health-promoting effects of probiotics.  
(Reviews: 69, 168, 199, 208, 209, 255) 
L. acidophilus (58, 247, 313) 
L. casei (16, 63) 
L. rhamnosus (94, 98, 224, 253) 
L. plantarum (41, 192) 
L. johnsonii (66, 288) 
L. reuteri (48, 197, 241, 282) 
L. paracasei (150, 169) 
B. breve (6, 111, 310) 
B. longum (97, 111) 
B. bifidum (228) 
B. lactis (47, 98) 
Reduced diarrhea (128, 170) 
Enhanced protection against intestinal infections (31, 91, 
236, 278) 
Colonization prevention (6, 71) 
Prevention of cancer (233) 
Anti-allergy activity (129, 194) 
Anti-auto-immune activity (99, 146, 179) 
Improvement of immune responses (54, 62, 166, 217-
219) 
Improved lactose digestion (4, 38, 81) 
Modulation of intestinal flora (37, 140) 
Improved gut physiology (81) 
 
Recent progress in molecular microbiology opens the possibilities to identify strains 
precisely as well as microorganisms in the microflora, which until now can not be 
cultured. New techniques as microchips and -arrays (genomics, proteomics) provide 
opportunities to reveal the host interactions by which probiotics modulate the 
immune system.  
 
Probiotics and the immune system 
 
Most exogenous microorganisms used as probiotics are taken up orally and arrive 
via the stomach in the gut. There, the probiotics interact with other bacteria of the 
microflora and the intestinal epithelium. Interactions with the epithelial cells of the 
gut wall may lead to various bioactive effects. Ideally, the normal, undamaged gut 
forms a barrier through which particles such as living bacteria, viruses and living 
parasites cannot pass. The gut wall with its layer of mucus is thereby preventing 
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systemic infection and disease. From numerous studies, it has become clear that 
most particulate matter such as bacteria is taken up rapidly by M- cells or antigen 
presenting cells as dendritic cells (DCs) (154, 196, 237). These cells are covered 
with small microvilli. Although M-cells are actually a highly specialized version of gut 
epithelial cells they may behave like macrophages. Within a few hours after uptake 
of particles from the gut, M-cells have transferred and presented their contents to 
specialized immunologically active cells (145, 154). DCs can sample through the 
intestinal barrier without disrupting it (237). 
 
The particulate matter that is taken up by M-cells is probably recognized by antigen-
presenting cells and presented to both B and T cells. These cells become 
stimulated and start expressing surface molecules on their cell wall indicating their 
activated state. In mammals this triggers these cells to migrate and leave the 
Peyer’s patches with the efferent lymph towards the nearest draining mesenteric 
lymph node (53, 145, 196). In chickens, which lack lymph nodes or similar 
structures, activated cells migrate via the blood towards the spleen. Upon arrival in 
the draining lymph node and spleen, the T- and B cells together with the antigen 
presenting cell establish themselves as ‘ménage a trois’ in and around the germinal 
centers. Germinal centers are follicles engaged in an immune response. The 
ensuing immune response is indicated by the cognate physical interaction between 
antibody producing B cells and cytokine producing T cells. The activated T cells 
leave the lymph node or spleen, enter the bloodstream, and migrate back to the villi 
where they take up residence in the lamina propria and between the epithelial cells 
(as intra-epithelial lymphocytes) at the mucosal surface lining the gut towards the 
lumen. The cells producing cytokines and antibodies are mainly located inside the 
villi in the lamina propria.  
 
The T cells in the lamina propria are mainly producing B cell stimulating cytokines 
whereas the B cells are producing vast amounts of IgA that is secreted in such a 
form and way that it can cover the entire inner surface of the gut. This secretory IgA 
coating with its multiple binding sites is a formidable defense against pathogens due 
to its high binding (although low affinity) and agglutinating capacity. The repertoire 
of IgA is broad and allows a rather promiscuous interaction with microflora and 
pathogens. Natural antibodies, i.e. IgA that binds to pathogens non-specifically, are 
produced independent on the specific immune response. But specific IgA, 
generated in response to an infection/immune encounter, is even more effective in 
clearing pathogens from the gut (39, 53, 145, 196). 
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Abstract 
 
In the current intensive live stock industry the gut flora can be disturbed as a result 
of several stressors that affect the intestinal tract. New food safety regulations 
demand to replace antimicrobial additives in poultry feed and still produce healthy 
poultry. Probiotic micro-organisms like lactic acid bacteria administered with the 
feed may contribute to a strategy to comply with these demands. Lactobacilli have 
been shown to stimulate immunity, increase colonization resistance and increase 
competitive exclusion. This review highlights some effects of probiotics and their 
working mechanisms. It is concluded that still more effort should be directed 
towards the mechanisms behind immune stimulating properties, their contribution to 
resistance against enteric infections, and the selection of probiotic strains. 
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Intestinal flora and probiotics 
 
The bacterial contents of the animals intestine is estimated to contain over 400 
bacteria species; 99% of these species are obligatory anaerobic species and about 
10% are lactobacilli and bifidobacteria (12, 297). These bacteria and their host have 
multiple interactions and maintain a dynamic balance with each other. The flora is 
quite stable and it adapts in overall metabolic activity and relative proportion of 
micro-organism species to nutrient changes. However, this balance can be 
modulated by antibiotics, intruding micro-organisms, host related factors, feed or 
environmental factors.  
 
In the current intensive live stock industry this microbial intestinal balance is 
affected by stressors, such as composition of feed, hygienic conditions, infection 
pressure, and fast growth and high production yields achieved by genetic selection. 
In order to realize increased growth rates and to suppress pathogenic bacteria, 
antibiotic feed additives are commonly added in animal husbandry. The continuous 
use of relatively high amounts of antibiotics in animal feed may lead to 
contamination of the food chain with residues of antibiotics and antibiotic resistant 
micro-organisms, including pathogens. In addition, the possible transmission of 
antibiotic resistance from animal to humans together with increased awareness of 
consumer safety has lead to prohibiting these feed additives and antibiotics will be 
allowed for therapeutical purposes only (77). 
 
The working mechanism of the antibiotic feed supplements is not exactly known. 
Part of its actions includes the bacteriostatic influence on specific constituents of the 
microflora. Probiotic feed supplementation can repair deficiencies in the 
composition and/or activity of the gut flora and to provide the type of microflora 
which contributes to the host disease resistance (89). 
The most frequently used definition of a probiotic is: a live microbial feed 
supplement that beneficially affects the host by improving its intestinal microbial 
balance (87). 
 
In humans and mice probiotics have been shown to have several beneficial 
properties. They contribute to resistance against pathogens, modulate the immune 
system, strengthen the gut mucosal barrier, regulate gut motility, control intestinal 
infections, reduce inflammatory reactions, reduce allergic effects, reduce mutagenic 
and tumorogenic activity, have nutritional advantages, control serum cholesterol 
levels and modulate effects on allergy and autoimmune disease (61, 180, 214, 243, 
300). Examples of these probiotics are L. casei, L. casei Shirota, L. acidophilus, L. 
rhamnosus GG, Bifidobacterium bifidum. 
 
For probiotics for farm animals (already on the market), claims have been made 
including increased animal growth rate, improved feed conversion, better absorption 
of nutrients, provision of essential nutrients, increased egg production, improved 
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milk production in dairy cows and improved health (88, 89). As a result of the 
reduced rate of bacterial infections, improved quality of eggs and meat is claimed in 
addition. There is much variation between these features and therefore it is 
important to realize that not all properties are represented in one probiotic micro-
organism. For farm animals these probiotic properties of lactobacilli have both 
health and welfare aspects and as a consequence economic aspects.  
 
When antibiotic additives are removed from the feed, probiotic micro-organisms can 
be applied to guide the balance into a host favorable condition. These bacteria can 
stimulate innate and acquired immune functions (299), prevent pathogens from 
colonization, enhance defense by antagonistic interactions (e.g. production of anti-
microbial factors (70)) and improve the health status of the animal. Through these 
properties probiotics can, at least in part, replace antibiotic feed supplements.  
 
Functional criteria to select probiotic micro-organisms 
 
For proper selection, the capabilities of the specific probiotics should be known. 
Probiotics should at least have one or more of the following properties (78, 80, 104, 
174, 207, 208, 280):  
- adapted to survive local conditions in the digestive system, such as acidic 
conditions in the stomach, digestive enzymes, bile salts and other bacterial 
interactions 
- demonstrate non-pathogenic behavior;  
- be able to influence metabolic activities of microflora components;  
- modulate immune responses; 
- adhere (might be temporarily) to the intestinal mucosa;  
- produce anti-microbial substances. 
 
According to Berg and Salminen and our own experience each potential probiotic 
strain should be assessed independently, as extrapolation from data of closely 
related strains or hosts is not acceptable. These strains can show large variations in 
properties, e.g. health-stimulating properties, strength of the effect obtained and 
fermentation pathways (21, 243, 245).  
 
Probiotic lactobacilli 
 
Lactobacilli have the longest history as probiotics and are still among the most 
common ingredients used in animal feed for notably calves, pigs, and poultry. In 
addition, lactobacilli are presently known for their health stimulating properties. 
Lactobacilli form a substantial proportion of the gastro-intestinal (GI)-tract microflora 
when pigs and poultry are maintained under optimal animal husbandry conditions 
(297). The choice for lactobacilli as probiotics seems obvious, especially when 
animals are confronted with non-optimal conditions as in young animals which have 
to grow rapidly or the early weaning as in piglets (279). Because of their harmless 
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character lactobacilli have the GRAS-status, which indicates that they are generally 
regarded as safe. Lactobacilli are already frequently used in classic and modern 
preservation of food and feed and biotechnology.  
 
The importance of lactobacilli for human health was first recognized by Metchnikoff 
at the beginning of the last century (186). He suggested that harmful effects of 
undesired GI-tract bacteria could be overcome by establishing a shift in the balance 
between intestinal bacteria, through ingestion of fermented milk products containing 
high amounts of lactic acid bacteria.  
 
Some of the positive effects of lactobacilli are mediated by non-immune 
components such as modulation of vitamin production, enzymes, and antibiotics. 
Other positive effects are immune system related, especially modulation of the 
mucosal immune system seems to play an important role (122). Enhancing 
protection against infections could be induced by activation of local innate immune 
defense effector functions (e.g. macrophages) and/or to support of the specific local 
response against infectious micro-organisms by upregulation of IgA production. 
 
Lactobacilli in chicken 
 
In chickens the passage of feed and other ingested material through the GI-tract is 
relatively fast (2-5 hours (40)). This is not only of importance for the digestion and 
absorption, but it is also of importance with respect to the administration of 
lactobacilli with probiotic characteristics. Because of this short passage time 
probiotics in chicken have a short time to exert their actions and therefore good 
adhesion or even colonization characteristics play an important role. Probiotic 
strains that are poorly adhering or colonizing may be added to feed, e.g. fermented 
feed, and guarantee in such a way that the strain is continuously present. 
 
An important site for colonization of lactobacilli is the crop. Within 24 hours after the 
newly hatched chick starts eating, a layer of lactobacilli (1 to 3 cells thick) is formed 
in the crop (85). After feeding, the pH in the crop decreases and the concentration 
of lactobacilli is high (108-109 cfu/g wet weight) (86). This indicates that the feed in 
the crop will be inoculated by lactobacilli. Lactobacilli hardly multiply in the small 
intestine therefore the inoculation via the crop is important to maintain the level of 
lactobacilli in the jejunum (86). In the caeca the number of lactobacilli is 108 cfu per 
gram, but the total number of obligatory anaerobe bacteria is at least 10 times 
higher (11). This localization is probably the result of the slow flow rate, caeca are 
emptied 2-4 times per day and probably enough bacteria stay in the caeca to 
inoculate new caecum contents, and the complexity of the cecal flora. Many 
bacterial species including pathogens like Salmonella spp. can frequently be 
cultured from the cecal content (12). Therefore this preferential localization seems 
to be non-specific (15).  
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Immune stimulation by probiotics in chicken 
 
Probiotics can stimulate both the humoral and the cellular immune system. In an 
animal experiment groups of 10 layer type chickens were administered orally for 5 
days with 109 cfu/day of a Lactobacillus strain and the control group received buffer 
instead of lactobacilli. On day 5 all animals were immunized with a suboptimal 
amount of a model antigen, TNP-KLH, and after 10 days blood samples were 
collected for serum. These samples were analyzed or specific IgM and IgG anti 
TNP titer. The results are presented in figure 1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Specific IgM (white bars) and IgG (black bars) anti TNP antibody titers (+ 
S.E.M.) in layer type chickens (n=10) orally fed with 4 different Lactobacillus strains 
or buffer (blanc) at 10 days after priming with TNP-KLH. * indicates statistically 
significant higher than blanc (p<0.05). 
 
The group, which was fed with L. reuteri, had a higher specific antibody titer than 
the blanc group (p<0.05). L. murinus also gives higher specific antibody titers, but  
not significantly. Both L. buchneri strains don't have an effect on the specific 
antibody titer. This experiment is demonstrated that Lactobacilli can have an 
adjuvant effect on the humoral immune response in chickens. 
 
We developed an in vitro test to screen lactobacilli on probiotic activity in layer type 
chickens. The test is based on a lymphocyte proliferation assay. A single cell 
suspension of chicken spleen is enriched over Ficoll and lymphocytes are incubated 
for 68 hours at 41°C with a suboptimal concentration Concanavalin A (ConA) and 
lactobacilli in 3 different percentages compared to the number of cells in the test. 
The last 4 hours of incubation 3[H]-thymidine is added and the built in radioactivity is 
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measured in a beta-counter. The proliferation index is calculated by the following 
formula: 
 
[# cpm cells + suboptimal conc. ConA + lactobacilli] – [# cpm lactobacilli]   * 100% 
[# cpm cells + suboptimal conc. ConA]  
 
The 3 L. reuteri strains, one L. buchneri, L. murinus and one L. casei strain have a 
positive effect on the proliferation of spleen lymphocytes in vitro. L. buchneri 2, L. 
plantarum and L. casei 2 have no effect on the proliferation of the spleen 
lymphocytes. From this in vitro experiment it is clear that different strains of 
lactobacilli give different proliferation indexes. In vitro pre-screening of lactobacilli in 
this way is feasible. It is also clear that strains from the same species do not have 
the same effect on the proliferation and thus it is necessary to evaluate every strain 
on probiotic properties in order to know if a particular strain has these properties. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Nine different Lactobacillus strains in three concentrations (in percentage 
bacteria to spleen cells: black 10%, grey 1% and white 0.1%) were evaluated in 
vitro on chicken spleen lymphocytes. The extra proliferation by lactobacilli is shown 
in the proliferation index. 
 
 
Protection against intestinal colonization 
 
Probiotics, which have a protective effect against the colonization by pathogenic 
bacteria, can be divided into cecal flora and other complex flora's, anaerobes, and 
lactobacilli. In commercial conditions for breeding the hygienic measures and the 
separation of the young from the adult bird prevent the chick from uptake and 
ingestion of the adult intestinal flora. As the adult flora is thought to contribute to 
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resistance of chicks to colonization with Salmonella, Nurmi and Rantala were the 
first who treated chickens with cecal flora (204, 234). By such treatments the 
colonization level of Campylobacter (265), E. coli (264, 304), and Clostridium was 
reduced (76).  
 
Goren et al. suggested that in protective bacterial mixtures anaerobes are essential 
for protection (102). Lactobacilli are facultative but not strict anaerobes and thus it is 
questionable whether lactobacilli alone can protect chickens from colonization with 
pathogens. This may explain why studies on Salmonella prevention with lactobacilli 
are not consistent. Several authors found that a single strain of Lactobacillus or a 
simple mixture of lactobacilli was unable to protect chickens against Salmonella 
colonization (3, 205, 263, 305). Others have found suppressive effects of lactic acid 
bacteria on the colonization level of enterococci (231, 232, 285), 
Enterobacteriaceae (86, 190, 231), Salmonella spp. (302, 303), and Campylobacter 
(195).  
 
At least four mechanisms are postulated to explain the working mechanism of lactic 
acid bacteria in prevention of colonization by opportunistic pathogens like E. coli, 
enterococci and Salmonellae. 
First, competition for nutrients. The probiotic consumes the available and necessary 
nutrients so it competes for nutrients with pathogens (82, 202). 
 
Second, adhesion to the mucosa. The ability to adhere to the intestinal epithelium is 
generally considered to be the most important property to prevent e.g. Salmonella 
colonization (80, 183, 272). Adhesion of lactobacilli can prevent colonization of 
pathogens by competition for adhesion receptors with the pathogens (304); forming 
a bacterial mat that prevents pathogens to adhere to epithelial receptors or 
preventing the specific binding to cell receptors by steric hindrance or by masking 
the cell receptor (43, 83, 262, 264, 268). Moreover, adhesion is considered to be a 
prerequisite for successful colonization of the probiotic strain(80). However, Rada et 
al. used a Lactobacillus strain that had good colonization characteristics, which was 
however poorly adhering (232). For lowering the level of colonization of 
Campylobacter, microaerophilic or obligatory anaerobic bacteria with a preference 
of the mucus layer of the epithelial surface in the caecum might be essential (3, 38), 
because this is the niche colonized by Campylobacter (17). 
 
Third, coaggregation. By binding of the Lactobacillus to the pathogen, the pathogen 
can subsequently not bind to epithelial receptors (139, 268). Coaggregating bacteria 
can facilitate colonization of other probiotic lactobacilli (105). 
 
Fourth, bactericidal substances. Lactobacilli can produce substances like hydrogen 
peroxide (H2O2(96)), and lactic acids or other volatile fatty acids that are toxic for 
e.g. Salmonella (2, 252). The anti-microbial activity of lactic acid may be the result 
of decreased pH in and the specific toxic effects of the un-dissociated molecule (2). 
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Following dissociation of short chain organic acids, the un-dissociated acid 
molecules enter cells, dissociate into anions and protons, and causes the pH of the 
cytoplasm to decrease. Some lactobacilli, L. reuteri, L. acidophilus and L. 
plantarum, produce antibacterial substances or even bacteriocidins like reuterin, 
acidophilin, lactocidin, and lactolin (267). This is a heterogeneous group of 
substances produced by many bacteria, as reviewed extensively elsewhere (235, 
269). 
 
Future research of probiotics 
 
Although different specific mechanisms have been postulated, it is still not 
elucidated how lactic acid bacteria influence the dynamic ecosystem of the gut. 
Because multiple factors contribute to the diversity of the ecosystem when in 
optimal balance, multiple factors, and also multiple organisms of the microbiota will 
be responsible for pathogen exclusion (161).  
 
It has been established in rodents that lactic acid bacteria given per os can 
significantly affect both the systemic and mucosa associated immune response (78, 
222). However, thus far specific enhancement of immune-reactivity has only been 
demonstrated for vaccines and model antigens. Though the stimulation of immunity 
may be significantly improved, it will only be protective if the levels of specific 
immunity that are reached are sufficiently high to counteract bacterial or viral 
infections. Although promising results exist in rodents, this has not been confirmed 
in farm animals yet (89). Lactobacilli still may be of importance in animal husbandry. 
Probiotics stimulate the individual resistance against e.g. Salmonella colonization. 
Although this resistance may be insufficient to totally protect a chicken against 
colonization, the sum of all decreased susceptibilities of individual chickens can 
lead to sufficient resistance of the total flock.  
 
Continued progress in probiotic research will require improved understanding of 
host intestinal physiology, its relationship with intestinal microbes and the 
mechanism by which these bacteria influence the immune system. For example, 
identification of host cell-surface molecules that serve as receptors for microbial 
colonization may allow screening for desirable probiotic organisms (182).  
 
A serious limitation in studying the gut flora composition is that the majority of the 
intestinal micro-organisms cannot be cultured by traditional in vitro methods. 
Several in vitro models can help to predict the fate of ingested strains: these 
systems consist of simple models to test sensitivity to acid or bile (122). Dynamic 
models of the stomach and small intestine, which simulate the in vivo 
gastrointestinal environment, have been developed and validated and these may 
become excellent accessory tools to conventional in vitro methods. These models 
simulate the dynamics of the transit and secretions in the gastrointestinal tract. The 
applications of these dynamic models include following the survival and interaction 
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of the indigenous microflora, probiotic, pathogenic, and genetically modified micro-
organisms (173, 175).  
 
As probiotics are living micro-organisms, they may in theory be responsible for side-
effects, e.g. systemic infections (in single case studies in catheterized severely 
immunocompromised patients only). In over-dose situations the risk exists of 
deleterious metabolic activities such as induction of diarrhea and intestinal lesions. 
The adjuvant side-effects may be based on enhanced unwanted responses such as 
fever or arthritis induced by peptidoglycans. Another type of risk could be gene 
transfer. However, genetically modified probiotics are not available for feed use and 
therefore their theoretical adverse effects need no consideration.  
 
Lactic acid bacteria display a wide range both of natural and antibiotic sensitivity 
and resistance. In most cases antibiotic resistance is not transmissible, but 
represents an intrinsic species or genus specific characteristic of the organisms. 
Although plasmid-linked antibiotic resistances are not common among lactic acid 
bacteria, they cannot be excluded and safety implications should be taken into 
consideration. Strains harboring resistance plasmids should not be used either as 
human or animal probiotics. Checking the ability of a proposed probiotic strain to act 
as a donor of antibiotic resistance genes may be a precaution, in particular in the 
case of animal feeding, where use of antibiotics as growth promoters apparently 
creates a selective advantage for resistance factors (244). 
 
The features claimed for lactic acid bacteria overweigh their possible risks. The 
immune-stimulation and colonization resistance features may be useful in poultry 
husbandry. Food safety demands urge to replace antimicrobial feed additives and to 
produce healthy and Salmonella- and Campylobacter- free poultry. Lactic acid 
bacteria added with the feed may be a good strategy to comply with present and 
future regulations.  
 
During the last decades a lot of research has been done on the effect of probiotics 
in rodents, humans, and also farm animals. However, still more effort must be 
invested to elucidate the immune stimulating properties, find the mechanisms 
causing resistance against enteric infections, and to select probiotic strains. 
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Introduction to the experimental work 
The aim of our study was to find Lactobacillus strains with probiotic 
immunomodulating properties. To select strains with these capabilities we optimized 
a model in which immunomodulation by lactobacilli could be tested in chickens 
(chapter 4), and a screening method to find immunoprobiotic strains within the 
existing pool of Lactobacillus strains (chapter 5). The selected strains were tested 
on their immunomodulating capacities in vivo (chapter 6). The two most capable 
strains were tested in a relevant infection model, Salmonella infection (chapter 7).  
 
The quest for immunomodulating probiotics in chicken started with testing the 
models that could be used for selecting bacteria with probiotic properties. In order to 
detect immunoprobiotic lactobacilli an in vivo immunomodulation model was a 
necessary tool. In chapter 4, the TNP-KLH immunization model was modified in 
order to detect immunomodulation. Intravenous immunization was selected from the 
different routes tested (intravenous, intramuscular, ocular, subcutaneous) to be 
used in the subsequent experiments. Stimulation of the immune response should be 
detectable in the model. Therefore the baseline immune response to the antigen 
should be way below maximal. When the chickens were immunized with a 
suboptimal amount of TNP-KLH, immune stimulating probiotic lactobacilli could 
notably enhance the cellular and humoral anti-TNP-KLH response. In the 
experiments, it became clear that although broilers and layers have developed 
differently with regard to their physiology. This did not only affect meat or egg 
production, but also the immune response to TNP-KLH. The broilers seem to be 
specialized in IgM response only, while layers responded broader, resulting in 
higher IgG and cellular responses to TNP-KLH, while the IgM response was not low 
either. 
 
In order to find immunomodulating probiotics an in vitro assay was set up for 
lymphocyte proliferation (chapter 5). In this assay, the cells are not only stimulated 
by mitogens or antigens, but also by mitogen (ConA) in combination with 
lactobacilli. The assay was validated by two in vivo experiments. In the in vitro 
assay spleen cells from 6-week old layer type chickens were stimulated with a 
suboptimal concentration of ConA (in order to be able to measure stimulation of 
proliferation) and the lactic acid bacterium strain to be tested. The stimulating effect 
of a strain was measured by extra proliferation by the strain compared to the 
proliferation by the suboptimal ConA concentration alone. The inter-chicken-
variation made it necessary to incorporate a reference strain to which all results 
could be compared. With these referenced values, comparing of data obtained with 
spleen cells from different animals and performed on different days became 
possible. The in vitro proliferation enhancement and the in vivo humoral immune 
response enhancement were found to be related to antigen presenting cells like 
macrophages and dendritic cells. The lactobacilli activated these cells to produce 
interleukins, which stimulated the T cells to proliferate. These activated T cells 
supported more B cells to produce immunoglobulins. With this assay, only five 
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strains out of almost 100 seemed to have a potential immunomodulating effect in 
the chicken type tested. 
 
In chapter 6 immunomodulation by probiotic bacteria, selected by the in vivo model 
and the in vitro assay is described. Immunomodulation was found as enhancement 
of the humoral (in serum) and cellular immune responses (proliferation of spleen 
cells and uptake and killing of Salmonella by monocytes of spleen, caecum and 
ileum). The immunomodulation was shown to be dependent on the Lactobacillus 
strain used, its interaction with the host immune system, the dosage and 
administration schedule of the lactobacilli and the age of the host. 
 
L. paracasei and L. brevis seemed to be the most promising immunomodulating 
strains in chickens. Therefore these strains were tested in an infection model 
employing Salmonella enteritidis infection (chapter 7). The effects of the probiotic 
lactobacilli on the Salmonella infection and the physiological effects in the gut and 
the immune response were monitored. Our hypothesis was that the selected 
probiotics could have a positive effect on disease resistance because of the 
combination of competitive exclusion and immunomodulation. The infection was 
reduced by the Lactobacillus strains tested (faster clearance of the systemic 
infection), as was the immune response. The latter was found both locally 
(interleukins in the gut) and systemically (humoral and cellular immune responses). 
Infection was less severe due to the use of the probiotic lactobacilli, the strains did 
not stop the shedding of Salmonella from the infected chickens or prevented 
colonization of the chickens. 
 
In chapter 8, the background of immunomodulating probiotics in chickens is 
discussed in relation to the data presented in the chapters 4 to 7. 
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Abstract 
 
In commercial poultry husbandry alternatives for the use of antibiotics and vaccines 
are under investigation, which preferably have to be applicable for both layer- and 
broiler-type chickens. There are indications that the defense mechanisms vary 
between layer- and broiler-type chickens. Therefore, the difference in immune 
response between layer- and broiler-type chickens of the same age was 
investigated, using TNP-KLH (trinitrophenyl-conjugated keyhole limpet hemocyanin) 
as antigen without adjuvant. First different routes of immunization (intravenously, 
intramuscular, subcutaneous and ocular) were examined to find out which 
immunization route gives the highest antibody titers. The intravenous immunization 
route resulted in higher TNP-specific antibody responses than the other 
immunization routes tested and therefore this immunization route was used in both 
following experiments. In order to investigate the optimal dose of antigen needed for 
immunization, a dose-response curve in broiler- and layer-type chickens was 
completed. The humoral immune response was measured in serum by a TNP-
specific ELISA and the in vitro cellular immune response by an antigen-specific 
lymphocyte proliferation assay. 
 
The antibody response of layer- and broiler-type chickens appeared to differ, not 
only in optimal dose and response, but also in kinetics of the response itself. Broiler 
chickens generated higher IgM anti-TNP titers whereas layer-type chickens 
generated higher IgG anti-TNP titers. This specific antibody response in broiler-type 
chickens did not last as long as in layer-type chickens. The TNP-specific cellular 
immune response was detectable in layer-type chickens, but not in broilers. Both 
types generate a non-specific cellular immune response, although this response in 
broilers is lower than in layer-type chickens.  
 
From these results we conclude that broilers primarily respond to TNP-KLH with a 
high IgM antibody response whereas layer-type chickens respond with a high IgG 
response. In addition, the cellular response of layer-type chickens is much higher 
than the response of broilers. The results suggest that broilers are specialized in the 
production of a strong short-term humoral response and layer-type chickens in a 
long-term humoral response in combination with a strong cellular response, which is 
in conformity with their life expectancy. 
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Introduction 
 
In the past, chickens have genetically been selected for improved feed conversion 
and rapid growth or production of eggs. This has led to two different types of 
chickens: broilers and layer-type chickens. As a consequence of this selection for 
economically important production traits, these chickens differ in body weight gain, 
duration of life and, recently data are becoming available, also in immune system 
caused by genetic differences. Therefore concern has risen with respect to their 
ability to mount an immune response to the whole array of pathogens as 
encountered in poultry breeding. In organic animal husbandry the animals are kept 
in a more natural environment without the strict hygienic measurements and 
antibiotics to prevent pathogenic and parasitic infections. When antibiotics are 
removed from the feed or if chickens will be held organically the capacity to mount 
immune responses will be even more important. 
 
Several publications are available on the relation between performance traits and 
immunological responses (32, 159, 206, 226, 230, 258, 293). A negative correlation 
was found between weight and antibody response (total antibody response and 
specific anti-sheep red blood cell (SRBC)) in broilers. It was concluded that the 
genetic and possibly nutritional changes in broiler chickens have put faster growing 
broilers in a disadvantageous situation in terms of humoral immune function. This 
correlation was also demonstrated in layer chickens: a layer-type chicken line 
selected for low antibody responses to SRBC had significantly higher 4-week body 
weights than either the unselected control or the high antibody response line (259). 
In addition, broiler-type chickens of a relatively low body weight line were reported 
to have high and long-lasting anti-SRBC titers after primary immunization as 
compared to those of a heavy body weight line (191). Although layer-type chickens 
have also undergone selective breeding, it seems that this selection has less 
influenced their immune system, although only few data are available about the 
effect of the selection for egg production on this type of chicken (258).  
 
From literature data it is quite impossible to compare the immunological 
competence of layer- and broiler-type chickens, as the conditions in most reports 
differ with respect to type and dose of antigen, route of immunization, age of the 
chickens, etc. So far, broiler- and layer-type chickens have never been compared 
for their immune responsiveness under identical circumstances. Therefore, we 
investigated whether the immune system of layer-type chickens differs from that of 
broiler chickens under similar circumstances at similar age. As prototype for layer 
chickens we have chosen White Leghorn and as a typical broiler type Ross 508. For 
immunization, we used an artificial antigen that chickens have never been exposed 
to before, trinitrophenyl-conjugated KLH (TNP-KLH). TNP-KLH is a non-replicating, 
thymus-dependent antigen, which is used without an adjuvant. Interaction with 
maternal antibodies against this antigen is not possible, which ensures that no 
differences exist between broilers and layer-type chickens concerning responses to 
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TNP-KLH. Because the immunization route for non-replicating or dead antigens 
influences the humoral and cellular immune response significantly in chickens (200, 
294) and mice (284), we first investigated which immunization route (intravenous, 
ocular, intramuscular or subcutaneous) resulted in the optimal antibody responses. 
Subsequently we compared the humoral response to different concentrations of 
TNP-KLH (administered intravenously) in broiler- (Ross) and layer- (White Leghorn) 
type chickens. Finally we compared the specific (TNP-KLH) and non-specific 
(ConA) cellular response of the two types of chickens after intravenous 
immunization with TNP-KLH. 
 
 
Materials and methods 
Animals and husbandry 
 
Eggs of broiler (Ross, Pronk B.V. Meppel, the Netherlands and Praktijkonderzoek 
pluimvee, Beekbergen, the Netherlands) and layer-type (White Leghorn, Charles 
River) chickens were bred and kept under routine specific pathogen free (SPF) 
conditions. Feed (‘Opfokkruimel 2775’, Hope Farms B.V., Woerden, the 
Netherlands) and water were available ad libitum and the boxes had wood chips on 
the ground. The conditions in the boxes were as follows: temperature 25 °C, 
lightcycle 16 hours light and 8 hours dark and humidity 55%. The animals were 
numbered individually and held together in groups. Layers and broilers were held in 
the same room but in different pens. 
 
Immunization and experimental design 
Antigen 
 
2,4,6-Trinitrophenyl (TNP; Eastman Kodak, Rochester NY, USA) was conjugated to 
KLH (Sigma, St. Louis, USA) as described previously (49). 
 
Influence of immunization route 
 
At 4 weeks of age, four groups of 10 SPF layer-type chickens (White Leghorn) were 
immunized with 20 µg TNP-KLH in 0.2 ml 0.9% NaCl by different routes: 
intravenous (in the wing vein), intramuscular (in the thigh muscles), subcutaneous 
(in the neck) or ocular (eye drop). The relatively low dose of 20 µg was chosen to 
better evaluate the efficacy of the four routes of administration. On day 7 and 10 
after first immunization (day 7 and 10 p.p.) blood samples were collected for serum. 
At 21 days after first immunization, the chickens were immunized again with the 
same dose and via the same route as the first immunization. On days 7 and 10 after 
second immunization (day 7 and 10 p.b.) blood samples were collected for serum.  
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Background titers and proliferation 
 
At four weeks of age, one group of 17 layer-type chickens was intravenously 
immunized with 20 µg TNP-KLH in 0.2 ml 0.9% NaCl. Four weeks after first 
immunization the chickens were immunized again with 20 µg TNP-KLH via the 
same route. Another group of 15 layer-type chickens was not immunized. On day 5, 
7 and 10 after first immunization and day 5, 7, 10 and 14 after secondary 
immunization serum samples were taken from all chickens. One week after primary 
immunization LPA was performed on spleen cells of six chickens.  
 
Comparative studies 
Antigen dose and response kinetics 
 
At 4 weeks of age, groups of six chickens of broiler- or layer-type were 
intravenously immunized with 10, 33, 100, 333 or 1000 µg TNP-KLH in 0.5 ml 0.9% 
NaCl. At 6, 10 and 14 days after first immunization two chickens of each group were 
used to obtain serum for detection of TNP-specific antibodies. 
 
Specific T cell proliferation 
 
Broiler chickens (n=15) and layer-type chickens (n=15) were divided in six groups 
(group A-B-C broilers and group D-E-F layer-type chickens) of five animals each. 
On day 14 after hatch groups A, B, D and E were primed by intravenous 
immunization with 500 µg TNP-KLH in 0.2 ml 0.9% NaCl. On day 35 after hatch 
group A and D were immunized again (iv) with 500 µg TNP-KLH in 0.2 ml 0.9% 
NaCl and group C and F were primed with 500 µg TNP-KLH in 0.2 ml 0.9% NaCl. At 
this same day chickens of groups B and E were used for lymphocyte proliferation 
assays (LPA) on peripheral blood and spleen. On day 42 and 49 after hatch (= 7 
and 14 days after the last immunization) LPA were performed on peripheral blood 
and spleen of chickens of group A, D, C and F. 
 
Determination of TNP-specific humoral and cellular response 
Antibody determination by ELISA 
 
Serum antibodies to TNP were determined by means of a direct ELISA as 
described previously (136). Briefly, TNP-bovine serum albumin (BSA, Sigma, St. 
Louis USA) was coated overnight in 96-well high binding ELISA plates (Greiner, 
Nürtingen, Germany). Titrated sera were incubated for 1 hour at room temperature 
in a twofold dilution. The isotype specific responses were determined with mouse 
monoclonal antibodies CVI-ChIgM-59.7, specific for chicken IgM, and CVI-ChIgG-
47.3, specific for chicken IgG (23, 135). Detection was performed with rabbit-anti-
mouse-HRPO (DAKO A/S, Glostrup, Denmark) and the substrate 
tetramethylbenzidine (0.1 mg/ml) and H2O2 (0.005 % v/v). Extinction was measured 
at 450 nm. Antibody titers were calculated as the dilution of the sample giving an 
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extinction value of 1 above the background. Geometric mean titers (GMT) of 
individual 2-log titers, S.E.M. and antilog (2GMT) values were calculated.  
 
Lymphocyte proliferation assay 
 
Spleens were removed aseptically and homogenized directly. Single cell 
suspensions of splenocytes were prepared by crushing individual spleens through 
70 µm nylon cell strainers (Becton Dickinson, Franklin Lakes, NJ USA). Heparinized 
blood was diluted two times in PBS. The mononuclear cells of spleen and blood 
were enriched over a Ficoll-Paque gradient (Amersham Pharmacia Biotech, 
Uppsala Sweden) and washed three times in PBS. 106 viable cells per well were 
incubated 68 hours in a humidified incubator at 41°C with 5% CO2 in 200 µl RPMI 
1640 (Gibco, Life Technologies) containing 1% normal chicken serum (Gibco, Life 
Technologies) and antibiotics in flat bottom 96-well plates (Costar, Corning Inc., 
Corning NY, USA). The cells are incubated with different concentrations of ConA 
(40 and 80 µg/ml) or TNP-KLH (1.5, 5, 15 and 50 µg/ml) in order to measure 
(re)stimulation in vitro. For ConA after 68 hours and for TNP-KLH after 92 hours 0.4 
µCi/well 3[H]-thymidine (Amersham Pharmacia Biotech, United Kingdom) was 
added and 4 hours later the plates are harvested onto fiberglass filters and counted 
by liquid scintillation spectroscopy (Betaplate, Wallac Oy, Turku, Finland). 
 
Statistical analysis 
 
All statistical analyses were carried out with Student’s t-test and are shown 
wherever appropriate. Differences between groups with P-values > 0.05 were 
considered not to be significant. 
 
Results 
Influence of immunization route 
 
We investigated four immunization routes to find out which of these resulted in 
optimal antibody responses after immunization with TNP-KLH. Table 1 shows TNP-
specific IgM and IgG antibody titers in sera of layer-type chickens on day 7 and 10 
after first immunization and day 7 and 10 after second immunization. 
 
After first immunization the IgM responses were not high and therefore the 
differences between the routes were not pronounced. The immunizations via ocular 
and intravenous routes resulted in significant higher IgM titers than the 
intramuscular immunization route on day 7. At this day the subcutaneous route is 
not significantly different from the other routes. On day 10 the serum IgM responses 
following intramuscular and subcutaneous routes were still as high as on day 7, 
while IgM titers after intravenous and ocular immunization started to decrease. After 
second immunization the intravenous immunization route resulted in the 
significantly highest IgM and IgG titers at both 7 and 10 days. 
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Table 1 IgM and IgG anti-TNP titers in layer-type chickens after immunization via 
different immunization routesa,b.  
 
a Means (S.E.M.) from serum samples taken on days 7 and 10 after first and second 
immunization. 
b Different subscripts in the same column are significantly different (at least P < 
0.05). 
 
The IgG titers were low after first immunization. The intravenous route results in a 
significant higher IgG response on day 7 after first immunization. On day 10 after 
first immunization the intravenous route is significantly higher than the intramuscular 
and ocular routes.  
 
The highest IgG titers were generated on day 10 after second immunization and the 
IgM titer peaked depending on the route: on day 7 the intravenous route and on day 
10 the intramuscular route generated the highest titer. IgM titers generated after 
ocular and subcutaneous immunization did not result in a peak. These titers stayed 
at the same level on day 7 and day 10. 
 
Comparative studies 
Background titers and proliferation  
 
The background titer against TNP-KLH in chickens was compared to the titers in 
chickens that were immunized with this antigen. In tables 2 and 3 it is shown that 
the chickens that were not immunized with TNP-KLH, neither had a specific 
antibody-response nor a specific cellular response against TNP-KLH. 
 
 
 
Immunization 
route 
7 days after 
first 
immunization 
10 days after 
first 
immunization 
7 days after 
second 
immunization 
10 days after 
second 
immunization 
IgM     
Intravenous   289 (51)a   146 (21)b 15040 (3340)a  5706 (1252)a 
Intramuscular   161 (17)b   165 (39)b    377 (119)b  1619 (807)b 
Subcutaneous   285 (84)   319 (91)a    566 (261)b    519 (321)b 
Ocular   343 (62)a   254 (38)a    205 (31)b    178 (31)b 
     
IgG     
Intravenous   119 (31)a   11 (3)a  3716 (1155)a  30901 (13443)a 
Intramuscular     45 (9)b     5 (1)b    180 (63)b    1556 (628)b 
Subcutaneous     60 (16)b     7 (2)a    125 (30)b      234 (97)c 
Ocular     60 (38)b     5 (3)b      37 (15)c        28 (13)d 
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Table 2 IgM and IgG anti-TNP titers in layer-type chickens after first and second 
immunization with TNP-KLHa.  
 
  IgM IgG 
  Control Immunized Control Immunized 
 Day 0 18 (4) 30 (5) 3 (11) 4 (2) 
      
First immunization Day 5 44 (3) 2114 (730) 1 (1) 372 (165) 
 Day 7 65 (8) 1492 (408) 6 (1) 425 (143) 
 Day 10 41 (3) 295 (77) 7 (2)     397 (94) 
      
Second immunization Day 5 53 (4) 12388 (3114) 9 (3) 6639 (1651) 
 Day 7 45 (5)   5407 (1458) 10 (5) 4697 (1055) 
 Day 10 42 (5)    882  (452)   45 (15)   1652 (355) 
 Day 14 38 (1)      446  (208)   29 (21)   1205 (273) 
a Mean titers (S.E.M.) from serum samples taken on days 5, 7 and 10 after first 
immunization (iv) and days 5, 7, 10 and 14 after second immunization (iv).  
 
Table 3 Proliferation (cpm) of spleen T cells of layer-type chickens after 
restimulation with TNP-KLH or ConAa.  
 
 Medium TNP-KLH ConA 
Immunized  388 (246) 2844 (1380) 5469 (8630) 
Control        162 (38)  516 (215)  54120 (10012) 
a Proliferation assays were performed 1 week after second immunization with TNP-
KLH (iv) and the control group was not immunized. 
 
Antigen dose and response kinetics 
 
The humoral immune response was tested after intravenous immunization with 
several doses of TNP-KLH in broiler- and layer-type chickens. Responses were 
measured on day 6, 10 and 14 after immunization. Figures 1a-d show the specific 
IgM and IgG antibody titers of layer- and broiler-type chickens after first 
immunization (iv) with different doses (3, 10, 33, 100, 333 and 1000 µg) TNP-KLH.  
 
Broilers generated higher IgM titers than the layer-type chickens. Both chicken 
types had the highest IgM antibody titer on day 6 after immunization with 333 µg  
TNP-KLH (figures 1a and b). For broilers the IgM titer after the highest TNP-KLH 
immunization declined over a few days while for layer-type chickens the IgM titer 
seemed to disappear earlier. 
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Figure 1. a) IgM anti-TNP titer in layer-type chickens; b) IgM anti-TNP titer in 
broilers; c) IgG anti-TNP titer in layer-type chickens; d) IgG anti-TNP titer in broilers  
 
Layer-type chickens generated higher IgG titers than broilers on day 14 after first 
immunization with most doses of TNP-KLH (figure 1c). The IgG titer in layer-type 
chickens increased with higher concentrations of TNP-KLH (figure 1d). Broilers 
especially responded with IgG on day 10 after immunization with the highest 
concentration TNP-KLH used (1000 µg). This response level was comparable to the 
IgG response on day 10 to the same concentration of TNP-KLH in layer-type 
chickens. The IgG titer in layer-type chickens was increasing on days 10 and day 
14, while the IgG titer decreased from day 10 towards day 14 in broiler-type 
chickens.  
 
Antigen-specific and non-specific cellular response 
 
From the results on the influence of antigen dose it appeared that the optimal 
response in both broiler- and layer-type chickens was found after immunization with 
doses between 333 and 1000 µg TNP-KLH. Therefore 500 µg TNP-KLH was used 
in the experiment to examine the lymphocyte proliferation in PBL and spleen.  
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Using PBL from TNP-KLH immunized chickens, no proliferation was induced by in 
vitro TNP-KLH restimulation as compared to the background (cells in medium). This 
was independent of the type of chicken or the concentration TNP-KLH used in this 
assay (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. a) Proliferation (+S.E.M.) of peripheral blood lymphocytes from layer-type 
chickens and b) of broilers after stimulation with ConA. c) Proliferation (+S.E.M.) of 
spleen lymphocytes from layer-type chickens and d) of broilers after restimulation 
with TNP-KLH. e) Proliferation (+S.E.M.) of spleen lymphocytes from layer-type 
chickens and f) of broilers after stimulation with ConA. White bars: after first 
immunization; black bars: after second immunization with TNP-KLH. 
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The PBL did respond to ConA (figures 2a and b). Responses of PBL of layer-type 
chickens increased with a higher concentration of ConA. These lymphocytes 
proliferated after stimulation with 40 and 80 µg/ml ConA (respectively 1.2-4.8*103 
and 44-54*103 net cpm). With 40 µg/ml ConA the broiler PBL could not be induced 
to proliferate above background, even after stimulation with 80 µg/ml ConA the 
lymphocytes of broilers did slightly proliferate. At this dose the proliferation of broiler 
PBL was low (200-1500 net cpm) as compared to the response of PBL of the layer-
type chicken.  
 
The specific proliferation induced by restimulation with TNP-KLH in spleen cells of 
layer-type chickens gave a dose-response curve with optimal restimulation 
concentration 15 µg/ml (figure 2 c). In addition, a clear first and second 
immunization effect was visible after restimulation with 15 and 50 µg/ml TNP-KLH, 
of which 15 µg/ml TNP-KLH induced the highest proliferation. In broilers, none of 
the concentrations used for in vitro restimulation induced proliferation after first 
immunization. After second immunization only in vitro restimulation with 50 µg/ml 
TNP-KLH induced proliferation in broilers (figure 2d). 
 
Spleen lymphocytes of both types of chickens proliferated after stimulation with 40 
and 80 µg/ml ConA (figures 2 e and f), although a big difference in response was 
observed. The spleen lymphocytes of layer-type chickens proliferated more than 
three times as much as the broiler lymphocytes after stimulation with ConA.  
 
Discussion 
 
The differences between layer- and broiler-type chickens with respect to 
immunological capacity were under identical circumstances investigated on B and T 
cell level using the artificial antigen TNP-KLH. For the model antigen TNP-KLH the 
intravenous immunization route induced the highest antibody titers in layer-type 
chickens. For this experiment applies what others previously found: the height of the 
antibody titer is influenced by the immunization route (284, 294). After first 
immunization all routes induced low titers whereas only the ocular route induced 
relatively high IgM titers. This route did not induce an IgG or second immunization 
response, though. This might be caused by the using the dose of 20 µg, perhaps 
being too low for this immunization route. We chose for this low dose of antigen for 
immunization in order to be able to determine modulation of the immune responses 
by for example probiotics or adjuvants. For the intramuscular and subcutaneous 
routes the dose of antigen used might be too low as well in order to get a proper 
antibody titer. The results of the subcutaneous immunization showed more 
variability in the response, which led to a higher standard deviation. The kinetics of 
the response after subcutaneous immunization showed a response that was higher 
on day 10 than on day 7, for all the other routes the reverse was observed. This 
route probably is less efficient for the antigen to be presented to the immune system 
than the other routes. The antibody response is decreasing rapidly after first 
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immunization, which is plausible to be caused by using the antigen without 
adjuvant. Without adjuvant the antigen can be immunized via the intravenous route, 
whereas antigen with adjuvant, as in commercially available vaccines, could be 
toxic when immunized in the veins. In conclusion, intravenous immunization with 
TNP-KLH induced the highest IgM and IgG titers after second immunization. The 
intravenous immunization route was therefore used in the following experiments. 
 
Subsequently, the optimal dose of antigen was determined for the broiler- and layer-
type chicken. The dose of TNP-KLH influenced the antibody response in both 
broilers and layer-type chickens. For IgM the optimum concentration was 333 µg 
TNP-KLH. The concentration of 1000 µg TNP-KLH had a negative influence on the 
antibody titer and is therefore too high. For IgG we found a linear dose-response 
curve in both type of chickens: the higher the dose, the higher the antibody 
response and 1000 µg inducing the highest titer. The optimum dose for intravenous 
immunization with TNP-KLH inducing both high IgM and IgG antibody titers is 
therefore between 333 and 1000 µg. 
 
The kinetics of the specific IgM anti-TNP responses in layer- and broiler-type 
chicken was similar. The peak was on day 6 after immunization. The specific IgG 
anti-TNP response for layer-type chickens peaked between day 10 and 14. In 
contrast, broilers did not seem to generate a proper specific IgG response, because 
this response was only appreciable with the highest immunization dose on day 10 
after immunization. In summary, broilers seemed to generate a good IgM response, 
but a poor IgG response. The layer-type chickens generated an IgM response, 
which was a bit lower than the response of the broilers, but these chickens 
generated an IgG response, which was higher and lasted longer than the response 
in broilers. Other research groups also found a correlation between lower body 
weight and higher antibody titers to non-replicating antigen in chickens, although 
they only investigated different boiler lines (191, 259). In a recent study in our 
laboratory comparing different broiler lines, it was also found that old-fashioned 
chicken lines (old Dutch breeds with high body weights, the ancestors of the present 
broiler lines) had higher antibody titers than the heavier genetically improved broiler 
lines (Kramer et al., personal communication). These differences between broilers 
and layers may be caused by differences in the structure and function of lymphoid 
organs, such as the spleen, due to genetic selection. After selection of layer-type 
chickens for high and low responders to SRBC, the spleen of the high responders 
contained larger B cell areas (159). 
  
Obviously layer-type and broiler chickens differ enormously in body weight at 6 
weeks of age. Our data indicate, although we only compared one type of layer-type 
chickens (White Leghorn) and broilers (Ross), that the observations concerning a 
negative relationship between bodyweight and antibody titer also seem to be 
relevant for chickens of these different types. Although in our experiments the IgG 
response in layer-type chickens was higher than in broilers, the IgM responses were 
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similar in both types. From an evolutionary point of view the primary IgM response 
may be more important than the more sophisticated secondary response, and 
therefore has not been a major factor in genetic selection.  
 
It was found that broilers and layer-type chickens differ considerably in the humoral 
response after immunization. Subsequently, we have investigated whether these 
types of chickens also differ in cellular responses. T cells from broiler- and layer-
type chickens, isolated from blood and spleen, proliferated after stimulation with 
ConA. The height of this proliferation is much lower in broilers than in layer-type 
chickens. Since ConA is used to measure the maximum functional capacity of the T 
cells, this means that the overall T cell immune response in broilers is lower than in 
layer-type chickens.  
 
The specific T cell response against TNP-KLH is detectable in spleen, but not in 
peripheral blood. This is surprising, because peripheral blood is supposed to reflect 
the events occurring in lymphoid organs, such as the spleen. The difference in 
proliferation may therefore, at least to a large extent, be related to the proportions of 
responding lymphocytes in spleen and blood. Otherwise differences may exist in the 
functional status of the antigen-presenting cells present in the two organs that are 
necessary during in vitro restimulation. In view of the results after ConA stimulation, 
the last explanation seems more relevant. In spleen, both specific and non-specific 
T cell responses were detectable: the cellular response in layer-type chickens is 
considerably higher than the response in broilers. The in vitro restimulation showed 
an optimum at a TNP-KLH concentration of 15 µg/ml in layer-type chickens. In 
contrast, restimulation of spleen cells of broilers was only detectable at the highest 
concentration TNP-KLH. In conclusion, the cellular reaction in broilers occurred at a 
lower level and a higher concentration of antigen or mitogen is needed in order to 
detect this (re)stimulation.  
 
In summary, we found that layer-type chickens show two types of immune 
responses: antigen-specific IgM and IgG humoral responses and antigen-specific 
cellular response. In broilers, part of the immune responses seems to dysfunction 
due to the genetic selection on bodyweight and feed conversion. Nevertheless, 
broilers seem to be able to survive with this immune response in the present 
husbandry systems. However, the moment that the pressure on the immune system 
will be higher, for example by withdrawal of antibiotics from the feed, health 
problems may occur. The fact that broilers have some remaining IgG response and 
T cell response, however, indicates that application of immunomodulating 
substances, like probiotics, may be feasible in poultry husbandry.  
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Abstract 
 
Oral administration of immunoprobiotic bacteria may support animal health. Species 
specificity of such microorganisms required appropriate selection. An in vitro assay 
for the selection of immunoprobiotic lactic acid bacteria (LAB) was developed in 
chicken. The assay allowed testing of large numbers of individual strains. Immune 
stimulation in vitro correlated well with the in vivo situation in two experiments and 
no false negative results occurred. Therefore this assay is an appropriate selection 
tool for immunomodulating properties of LAB in chicken. 
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Introduction 
 
Probiotics were defined as ‘a live microbial food supplement that beneficially affects 
the host by improving its intestinal balance’ (87). Numerous studies reported a wide 
variety of health-promoting properties influencing the host intestinal balance, 
competitive exclusion, lactose intolerance, diarrhea, mucosal immune response, 
blood cholesterol and cancer. Since in vivo evaluations of probiotic properties are 
time-consuming, labor-intensive and require large numbers of animals for selecting 
candidate probiotic LAB strains many in vitro assays have been developed (193, 
287). These included selection for gut and stomach conditions such as acid- and 
bile tolerance and adhesion to gut mucus or intestinal cell lines (Caco-2 and HT-29) 
(30, 52). Also selection methods were described for probiotics that express 
antimicrobial activity (1, 29, 181), growth inhibition of unwanted flora elements (132) 
and competitive exclusion (288). Also an in vitro gut model (171, 291) has been 
described to evaluate gut microbial ecology.  
 
After oral or parenteral administration of LAB in humans and mice T cells and 
macrophages may be stimulated (55, 59, 178). Based on such properties we 
developed an in vitro system for rapid pre-selection of LAB with immunomodulating 
properties. For T cell proliferation following mitogenic stimulation the activation of 
accessory cells is required. The pre-selection assay was based on a Concanavalin 
A (ConA) mitogen induced lymphocyte proliferation assay in which enhancement or 
inhibition of the response was the result of the immunomodulating properties of LAB 
for which either T cells or accessory cells may be sensitive. Since chickens do not 
have lymph nodes, spleen cell suspensions were used that include all relevant cell 
types. Spleen cells were incubated with LAB and a suboptimal concentration of Con 
A to allow positive or negative modulation of the responses. To validate this assay 
typical LAB strains selected in the in vitro assay were evaluated in two in vivo 
experiments.  
 
Materials and Methods 
Chickens 
 
Eggs of layer type (LSL White Leghorn, Charles River) chickens were bred and 
raised under routine specific pathogen free (SPF) conditions (no vaccinations, 
antibiotics or coccidiostatics). For all experiments chickens were fed a starter diet 
for pullets (Arkervaart, Leusden, the Netherlands) and water ad libitum. Stable 
conditions: temperature 25 °C, lightcycle 16 hours light and 8 hours dark and 
humidity 55%. Young chicks had extra heating in order to prevent cold stress. At the 
start of the in vivo experiments animals were equally divided over the groups with 
respect to weight and gender. The animals were numbered individually and housed 
per group receiving the same treatment. The pens were closed with plates at the 
sides and between two pens in use one pen was kept empty to avoid contact and 
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prevent cross-contamination. All animal experiments were in compliance with Dutch 
regulations on animal experimentation. 
 
Bacteria 
 
LAB strains used in in vivo experiments were identified using fatty acid and sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis analyses and 3 strains by 16S-
rDNA-sequence analysis (BCCM/LMS, Gent, Belgium) The LAB were cultured 
overnight (18 hours) in MRS broth (de Man, Rogosa and Sharpe, Oxoid Ltd.) after 
inoculation with 1% of a fresh full-grown culture. The LAB were cultured at 30°C or 
37°C dependent on the optimal culture temperature of the strain. To accurately 
count the bacteria, appropriate dilutions were plated in double-layered MRS agar 
plates and incubated 2 days at 30°C or 37°C.  
 
Antibody determination by ELISA 
 
Serum antibodies to TNP were determined by a direct enzyme-linked 
immunosorbent assay (ELISA) as described previously (148). Briefly, TNP-bovine 
serum albumin (BSA, Sigma, St. Louis USA) was coated and sera were serially 
diluted in twofold. Responses were determined with mouse monoclonal antibodies 
CVI-ChIgM-59.7 and CVI-ChIgG-47.3, specific for chicken IgM and IgG (23, 135). 
Detection was performed with rabbit-anti-mouse-HRPO (DAKO A/S, Glostrup, 
Denmark) and the substrate tetramethylbenzidine (0.1 mg/ml) and H2O2 (0.005 % 
v/v). Extinction was measured at 450 nm. Antibody titers were calculated as the 
dilution of the sample giving an extinction value of 1 above the background. 
Geometric mean titers (GMT) of individual 2-log titers, S.E.M. and antilog (2GMT) 
values were calculated. 
 
Lymphocyte proliferation assay (LPA) for selection of immunoprobiotics  
 
Spleens of 6-week-old chicks were removed aseptically. Single cell suspensions 
were prepared and mononuclear cells were enriched over a Ficoll-Paque gradient 
(Amersham Pharmacia Biotech, Uppsala Sweden). Cells were washed three times 
in phosphate-buffered saline (PBS, Gibco, Life Technologies) and diluted in culture 
medium: RPMI 1640 Dutch modification (Gibco, Life Technologies) containing 1% 
normal chicken serum (Gibco, Life Technologies), 5×10-5 M ß-mercapto-ethanol, 2 
mM L-glutamin and a mix of antibiotics 5% for sterility and to prevent overgrowth by 
LAB (penicillin 106U/l, streptomycin 1.0 g/l, amphotericin B 60 mg/l, polymyxin B 
0.50 g/l and kanamycin 20x con). Triplicate cultures with 106 viable cells in 200 µl 
per well were incubated in flat bottom 96-well plates (Costar, Corning Inc., Corning 
NY, USA) in a humidified incubator at 41°C with 5% CO2. Tests included cultures 
with medium + cells and medium + cells + LAB. Cultures with medium alone, 
medium + LAB served as controls. The proportion of LAB amounted to 10% of the 
number of cells. The cultures were incubated without and with 1, 4, or 10 µg/ml  
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ConA. After 68 h of incubation 0.4 µCi per well 3[H]-thymidine (Amersham 
Pharmacia Biotech, United Kingdom) was added. Four hours later the plates were 
harvested onto fiberglass filters and counted (cpm: counts per minute) in a liquid 
scintillation counter (Betaplate, Wallac Oy, Turku, Finland). The stimulation index 
(SI) was calculated by dividing the proliferation induced by ConA plus the bacteria 
corrected for 3[H]-thymidine built in by LAB, by the proliferation induced by ConA 
only and multiplied by 100.  
              
   cpm [cells + ConA + LAB] – cpm [cells + LAB] 
SI =   ———————————————————————  * 100 
                  cpm [cells + ConA] 
 
SI = 100 means no stimulation with the bacterial strain tested. To allow comparison 
between chickens and between experiments, an internal reference strain (L. 
paracasei LW122) was included in every assay. For inter- an intra-assay 
comparison the SI of this strain was set to 100 and the SI induced by the other 
strains tested with cells from the same spleen in the same assay was normalized to 
the SI of the reference strain. This normalized SI is indicated as NSI. 
 
Antigen-specific responses in cell proliferation and serology  
 
For immunization and antigen-specific proliferation 2,4,6-trinitrophenyl (Eastman 
Kodak, Rochester NY, USA) conjugated to keyhole limpet hemocyanin (KLH; 
Sigma) was used as described previously (49). 
 
In vivo experiment 1: The effect of feeding of LAB on the humoral immune 
response after priming 
 
To induce immunomodulation LAB were orally administered daily to 6 groups of 13 
chickens aged 3 weeks. Groups 1-6 daily received respectively 109 L. paracasei 
LW122 (group 1), L. murinus-animalis LW121 (group 2), L. buchneri LW 50 (group 
3), L. buchneri LW 83 (group 4), S. alactolyticus LW 89 (group 5) in PBS or PBS 
alone (group 6) for five consecutive days. The fifth day all chickens were 
intravenously immunized with a suboptimal amount of antigen: 20 µg TNP-KLH in 
0.2 ml 0.9% NaCl. On days 7, 10 and 14 after immunization serum samples were 
taken.  
 
Statistical analysis was performed in the statistical package GenStat (90). To 
exclude confounding plate effects, a random plate effect was included in the 
analysis of variance (ANOVA) model. Linear mixed models for the peak IgM and 
IgG responses (day 10 after immunization) were analyzed by residual maximum 
likelihood methods (REML). 
 
Chapter 5 
 52 
In vivo experiment 2: the effect of feeding of LAB on the specific humoral and 
cellular responses after priming and booster 
 
The set up was similar as for experiment 1. Now 11 groups of 17 layer type 
chickens orally received 109 LAB for 5 consecutive days: L. paracasei LW122 
(group 1), L. reuteri LW 81 (group 2), L. brevis LW5 (group 3), L. brevis LW 40 
(group 4), L. brevis LW 167 (group 5), L. plantarum LW 143 (group 6), L. paracasei 
LW120 (group 7), L. murinus-animalis LW121 (group 8), L. buchneri LW 50 (group 
9), L. paracasei LW 122 (group 10) in PBS or PBS alone (group 11). Four weeks 
after priming LAB administration was repeated. Serum samples were taken on days 
5, 7 and 10 after priming and days 5, 7, 10 and 14 after booster. One week after 
primary and secondary immunization we performed LPA on spleen cells of six 
chickens per group. These spleen cells were incubated with medium, (re)stimulated 
with 15 µg/ml TNP-KLH, 1, 4 and 10 µg/ml ConA, L. plantarum LW 143 and L. 
paracasei LW122 (LAB strains made up 10% of the number of cells in a well 
together with suboptimal ConA concentrations). 
 
Statistical analyses were performed in GenStat. Treatments were assigned 
differently to test plates than in experiment I to avoid confounding. ANOVA 
comprised treatments as the only experimental factor. Treatments were grouped 
into 3 clusters according to the results in the in vitro test. The differences between 
the clusters and the homogeneity within the clusters were analyzed with respect to 
the peak of the serological responses; that is, the IgM peaked on day 5 after 
booster immunization but for the IgG responses, the kinetics were different 
dependent on the strain of LAB that was used (day 5-7 after booster immunization).  
 
Results 
Set up of the in vitro assay for selection of immunomodulating LAB 
 
The modulation of in vitro lymphocyte proliferation was used to pre-select 
immunomodulating LAB. Assay conditions were developed in various stages.  
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Figure 1. Dose-response curves for ConA induced chicken spleen cell proliferation 
for selection of the true suboptimal ConA concentration for threshold stimulation. 
Indicated is the mean dose-response curve with standard deviation (n= 33). To 
indicate individual variation width the dotted line indicates the dose-response for the 
individual with the lowest response, the dashed line indicates the highest responder. 
A useful common suboptimal dose could not be selected. Solid line=average of 33 
chicken spleens + S.D. 
 
Antibiotics were added to the culture medium to prevent the LAB strains from 
growing and thereby interfering with the proliferation in the assay. All strains tested 
died within 24-36 hours after incubation, which ensured that differences in 
sensitivity to antibiotics between LAB strains were excluded. LAB alone did not 
induce lymphocyte proliferation in vitro to such extent that it could be used for 
selection (not shown). Therefore we developed a co-stimulation assay for LAB with 
suboptimal mitogen (ConA) concentrations to allow the selection for enhancement 
of the ConA induced response. The proliferative spleen cell response in control 
chickens showed an almost linear relation between the ConA concentration and 
incorporation of 3[H]-thymidine (figure 1). However, individual dose-response curves 
showed large variation. This may be concluded from the lowest and highest dose-
responses that were observed (figure 1). The proliferation of cells with medium only 
was constantly low for all chickens (30 - 500 cpm; figure 1). Proliferation following 
incubation with 10 µg/ml ConA varied from 40 000 – 180 000 cpm. The steepness 
of the dose-response curve also showed large individual variation. Therefore we 
decided to use both 1 and 4 µg/ml ConA for suboptimal stimulation in all further 
assays and used the results of a true suboptimal concentration for the calculations 
(table 1).  
 
Table 1. Selection of true suboptimal ConA concentration in spleen cell proliferation 
assaya,b  
 
Spleen ConA Concentration (µg/ml) 
 0 1 4 10 
1 120 138 5991 51375 
2 146 256 11641 61318 
3 921 63058 93108 103028 
4 158 141 12425 68796 
5 101 1368 60754 81428 
a Cultures were incubated with three concentrations of ConA and a medium control 
was included. 
b Data were expressed as cpm for each spleen. For calculation of SI/NSI the results 
in bold were used. 
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Table 2. In vitro selection of LAB based on immunomodulation of sub-optimal 
stimulated chicken spleen cellsa.  
 
Exp. LAB Strain Spleen/Animal  NSI Select Responder  
  1 2 3 4 5 Mean S.D.  Chickens 
1 L. paracasei LW 122 100 
(232)
100 
(299)
100 
(117)
100 
(229)
100 
(705)
100 0 + 5/5 
 
 L. buchneri LW 50 37 
(85) 
39 
(117)
90 
(105)
77 
(177)
55 
(399)
60 23 - 1/5 
 L. buchneri LW 83 32 
(74) 
41 
(124)
78 
(92) 
56 
(129)
34 
(237)
48 19 - 0/5 
 L. plantarum LW 143 34 
(78) 
34 
(100)
85 
(100)
45 
(103)
12 
(86) 
42 27 - 0/5 
 L. murinus-animalis LW 121 100 
(232)
65 
(196)
107 
(125)
78 
(179)
42 
(295)
78 26 + 3/5 
 L. paracasei LW 120 92 
(214)
81 
(242)
98 
(115)
62 
(141)
37 
(262)
74 25 + 3/5 
 S. alactolyticus LW 89 5 
(12) 
8 
(23) 
16 
(19) 
8 
(18) 
26 
(184)
13 9 - 0/5 
2 L. paracasei LW 122 100 100 100 100 100 100 0 + 5/5 
 L. buchneri LW 50 67 71 37 48 22 49 20 - 0/5 
 L. buchneri LW 83 72 70 34 64 56 59 15 - 0/5 
 L. plantarum LW 143 38 45 N.D. 66 31 45 15 - 0/4 
 L. murinus-animalis LW 121 64 65 111 74 52 73 23 + 2/5 
 L. paracasei LW 120 60 53 103 99 87 80 23 + 3/5 
 S. alactolyticus LW 89 1 2 6 0 4 3 2 - 0/5 
3 L. paracasei LW 122 100 100 100 100 100 100 0 + 5/5 
 L. brevis LW 5 305 96 129 114 496 228 172 + 5/5 
 L. brevis LW 7 511 112 90 85 945 349 379 + 4/5 
4 L. paracasei LW 122 100 100 100 100 100 100 0 + 5/5 
 L. brevis LW 5 210 115 183 320 269 219 79 + 5/5 
 L. brevis LW 7 316 191 252 323 229 262 57 + 5/5 
5 L. paracasei LW 122 100 100 100 100 100 100 0 + 5/5 
 L. brevis LW 40 49 20 33 103 170 75 62 + 2/5 
 L. reuteri LW 81 133 173 198 131 128 152 31 + 5/5 
6 L. paracasei LW 122 100 * 100 100 100 100 0 + 4/4 
 L. brevis LW 40 96 * 47 92 65 75 23 + 2/4 
 L. reuteri LW 81 77 * 378 100 277 208 144 + 3 /4   
7 L. paracasei LW 122 * 100 100 100 100 100 0 + 4/4 
 L. brevis LW 167 * 47 26 78 36 47 22 - 0/4 
8 L. paracasei LW 122 100 * 100 100 100 100 0 + 4/4 
 L. brevis LW 167 18 * 78 27 77 50 32 - 0/4 
9 L. paracasei LW 122 100 100 100 100 100 100 0 + 5/5 
 L. brevis LW 5 121 210 142 92 66 126 55 + 4/5 
 L. brevis LW 7 189 212 323 77 70 174 105 + 3/5 
 L. reuteri LW 81 138 278 253 34 94 159 104 + 4/5 
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 a Nine experiments are shown that were normalized for the results obtained with an 
internal reference strain. This illustrates reproducibility, sensitivity of individuals and 
the result of application of selection criteria  
NSIs were calculated with reference to strain L. paracasei LW122 set to 100. The 
average of NSI > 70% was used as cut-off value for positive selection (+/-).  
* No correct/useful suboptimal ConA concentration observed.  
For experiment 1 also non-normalized SIs are shown between brackets. 
 
In cultures with ConA only the response varied between 10% and 60% of the 
positive control (cells with 10 µg/ml ConA). Enhancement of the responses induced 
by LAB was calculated from the set of cultures with true suboptimal responses to 
ConA alone and those with suboptimal ConA + LAB. The SI was calculated as the 
ratio of the proliferation induced by the LAB + ConA and by ConA only (SI range 
10–900). For experiment 1 these SIs are shown in parentheses in table 2. The 
results were normalized with respect to the reference strain (L. paracasei LW122) 
set to 100. For normalized SI (NSI) > 70 the strain was considered to have an 
immuno-enhancing effect. This cut-off value was calculated in retrospect from the  
relation between the in vivo and in vitro experiments and builds-in a safety-margin 
to prevent exclusion of valuable strains.  
 
A typical experiment (experiment 1, table 2) shows that a broad range in response 
was observed. The results of 9 different in vitro experiments were presented in table 
2. The normalization with respect to an internal reference (L. paracasei LW122) 
allowed comparing different experiments based on the use of NSI values. For 
experiment 1 also the non-normalized SI values are given between brackets. This 
table illustrated that a LAB strain did not have exactly the same value in every 
chicken, but that its positive or negative effect is reproducibly detected. Apart from 
L. paracasei LW 122 (the reference strain), also L. reuteri LW81 and L. brevis LW5 
and LW7 were found to have a positive stimulating effect in vitro. As is clear from 
table 2 not all chickens within a breeding line react in the same way to stimulation 
with immunoprobiotics. Therefore the frequency of chickens reactive in a positive 
manner was included as a selection criterion. LAB strains showing the highest 
induction potential also had the broadest working pattern (table 2). 
 
Correlation of in vitro immunomodulating probiotic activity with in vivo 
experiments 
 
Several in vitro selected strains (positive, intermediate and negative) were tested in 
vivo for validation of the assay and to establish the predictive value for immune 
stimulation of LAB in vivo. In experiment 1 five strains were tested. Immune 
stimulation was evaluated as enhancement of serological responses to priming with 
KLH-TNP in vivo. L. paracasei LW122 had a significant enhancing effect on the 
specific humoral immune response (P<0.001). L. murinus-animalis LW121 showed 
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an enhancing effect that was not significant (P <0.20). The other strains evaluated 
did not have a response enhancing effect (figure 2).  
 
These results showed that significant immune stimulation could be induced in a 
strain dependent manner. The LAB strains that enhanced ConA-induced cell 
proliferation in vitro also induced immune stimulation after oral application of these 
LAB in vivo. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Specific IgM and IgG anti-TNP titers (+S.E.M.) in layer type chickens 10 
days after primary intravenous immunization with TNP-KLH in chickens that were 
fed LAB for 5 consecutive days preceding the antigen injection. L. paracasei LW122 
had a positive effect on the specific IgM anti TNP-KLH response (P<0.05). 
Grey bars: specific IgM anti TNP titer; black bars: specific IgG anti-TNP titer. 
 
Nine LAB strains were tested for their effect on the secondary immune response in 
in vivo experiment 2. As expected, oral administration of L. paracasei LW 122 did 
not generate an IgM or IgG antibody titer to the antigen in the group that was not 
immunized with TNP-KLH. Three clusters of serological response patterns were 
observed. The group that was immunized but did not receive LAB (cluster I) 
generated the lowest IgM response (figure 3a). The groups that received LAB 
strains that were not enhancing the in vitro proliferative response generated a 
similar low IgM titer as the group that did not receive LAB (cluster II: L. buchneri LW 
50, L. plantarum LW 143, L. brevis 167; p = 0.695). No false negatives were 
observed. Cluster III strains had an intermediate or positive effect on the ConA-
induced proliferation in vitro and also enhanced the IgM titers in vivo. Responses of 
LAB in cluster III: L. paracasei LW122, L. paracasei LW120, L. brevis LW40, L. 
murinus-animalis LW121, L. reuteri LW81, L. brevis LW5) were statistically different 
from responses induced by LAB from cluster I (P = 0.004). Also individual strains 
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i.e. L. paracasei LW122 (P = 0.019), L. murinus-animalis LW121 (P = 0.033) and L. 
paracasei LW120 (P = 0.024) responses differed significantly from the response of 
the group without lactobacilli. For IgG the picture was not as clear (figure 3b). All 
strains except L. reuteri LW81 strains did not have an effect on the IgG response on 
day 5 after secondary immunization. However, it appeared that the IgG titer of the 
groups receiving the LAB strains L. murinus-animalis LW 121, L. paracasei LW120, 
L. plantarum LW143, L. brevis LW40 and LW 167 and L. buchneri LW50 showed a 
slower decline than was observed for the titers in the chickens that did not receive 
LAB. The responses of clusters 2 and 3 were significantly different (P = 0.031).  
Experiment 2 demonstrated that the results of the in vitro assay correlated well with 
the immunostimulation during primary and secondary IgM response but less well 
with the IgG response.  
 
Discussion 
 
Selected LAB have been shown in various systems to express immune-enhancing 
properties (33, 130, 185, 215, 223). In order to select in a relatively simple manner 
LAB that express immune stimulating properties in vivo in chickens an in vitro assay 
was set up. The assay was based on enhancing proliferation of suboptimally 
stimulated lymphocytes by probiotic bacteria. To verify whether selected LAB 
inducing immune stimulation in vivo could be selected in simple procedures in vitro, 
the enhancement of proliferation in response to suboptimal ConA was thought to 
provide a suitable model. ConA proliferation of T cells is dependent on the presence 
and activation of accessory cells. It was hypothesized that those LAB that were able 
to enhance T cell proliferation in vitro by activation of either accessory cells or T 
cells might do the same in vivo. This assumption was based on observation of 
enhanced secretion of IFN-γ, phagocytosis and expression of complement 
receptors on phagocytes (28, 165, 214, 308). But in the in vitro assay LAB and 
spleen cells were co-cultured, which is quite different from the potential interactions 
that at first sight can be expected after oral administration of LAB in vivo. However, 
LAB may induce expression of various cytokines at the level of GI-tract-associated 
lymphoid cells (169). In addition, gut dendritic cells (DCs) may penetrate the 
epithelial cell layer without disrupting the barrier function and directly sample gut-
associated bacteria (237). Via this route also LAB may differentially affect DC 
maturation (48) and stimulate the local T cells. Subsequently, the circulating pool of 
mucosa-homing T-lymphocytes may exert an immune outcome at distant (mucosal) 
sites (50). Such an effect might be measured as immune stimulation or adjuvant 
activity since activated T-helper cells could also move to the spleen and stimulate 
the Th2 cells in e.g. antibody production.  
 
For selection in the in vitro assay the definition of suboptimal stimulation was 
critical. Chickens are produced in breeding-lines and even though the number of 
breeding fathers was limited, chicken cells in the in vitro assay showed wide 
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variation in ConA induced proliferation. Suboptimal rather than optimal ConA 
concentrations induced relatively large standard deviations. However, using multiple  
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Figure 3. Specific anti-TNP titers (+S.E.M.; panel a represents IgM and panel b 
represents IgG) in layer type chickens on days 5, 7, 10 and 14 after secondary 
intravenous immunization with TNP-KLH.  
For clarity only the highest and the lowest line have S.E.M. bars. S.E.M. for other 
data were of similar proportions. The dashed lines represent the separation in 
clusters: Cluster I received no oral LAB; Cluster II received oral administration of 
LAB that had no effect in vitro and Cluster III that included evaluation of LAB strains 
that showed intermediate/positive effects in vitro.  
L. paracasei LW122 (closed circle); L. paracasei LW 120 (closed square); L. brevis 
LW 40 (triangle); L. reuteri LW 81(closed diamond); L. brevis LW 5(star); L. 
plantarum LW 143 (open circle); L. buchneri LW 50 (open square); L. murinus-
animalis LW121 (open triangle); L. plantarum LW 167 (open diamond); no LAB 
(striped); L. paracasei LW 122, in non immunized chicks (cross). 
 
suboptimal concentrations allowed to reproducibly determine the relative stimulation 
at one selected ConA concentration and to compare that value to the control 
situation (shown in table 1). This, however, reduced the number of strains that could 
be evaluated using one chicken spleen. 
 
L. paracasei LW 122 in the preliminary experiment had a positive effect upon oral 
administration on the in vivo humoral responses and ex vivo in vitro proliferation. 
This confirmed results obtained with this strain in the mouse system (169). 
Therefore, L. paracasei LW 122 was used as an internal reference in each chicken 
which allowed intra- and inter-assay comparison. A strain was considered positive 
when the proliferation in the spleen cells of the same chicken was > 70% of NSI 
induced by L. paracasei LW122. Some LAB strains induced proliferation in spleen 
cells of every chicken in vitro (5/5, see table 2), other strains only in a few chickens. 
This effect was also seen in vivo both in humoral and in proliferative responses. 
This broad variation in immunomodulation by lactobacilli in different individuals has 
also been observed in mice and man (166, 225). Strain selection should therefore 
not only be based on the strength of the effect but also on the proportion of 
positively reactive chickens. 
 
Results from LAB strains tested both in vitro and in vivo correlated well between 
results of in vitro proliferation assays and modulation of the induction of an antigen-
specific IgM titer in vivo. The LAB strains that had a positive effect in vivo and in 
vitro were: L. paracasei LW 122 and LW 120, L. brevis LW 5 and LW 40, L. reuteri 
LW 81 and L. murinus-animalis LW 121. The strains S. alactolyticus, L. plantarum 
LW143, L. brevis 167, L. buchneri LW 50 and LW 83 had no effect in vitro or in vivo. 
This indicates that false negatives were not observed. In this experiment LAB were 
fed for only 5 days prior to immunization. This might explain why the IgM titers 
showed a better correlation to the in vitro proliferation results than was observed for 
the IgG titers that in general increase later than IgM. The delay between LAB 
feeding and IgG switching may have been too long to induce a significant effect. For 
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modulating the IgG titers it might be necessary to feed LAB for a longer period or in 
higher doses. 
 
The strains that were investigated were chosen for the purpose of validating the 
selection system. Not all strains were expected to be strong immune modulators. 
The strains differed in origin/source and fermentation pattern (obligate or facultative 
anaerobe, sugar fermentation). Some strains were known for other purposes or 
properties in other animals. L. buchneri was used as bacterial inoculant for silage 
(67), L. plantarum was selected for production of fermented liquid feed (pH effect) 
(289) and S. alactolyticus, being the most abundant commensal in the pig GI tract 
(36), was therefore not likely to be a strong immunomodulator.  
 
In in vivo experiment 2 different strains from the same species (e.g. the three 
different L. brevis strains) did not have the same effect on the humoral response. 
This indicated individual strains had different probiotic properties, independent on 
the effect of their closely related family members, and therefore every individual 
strain needs to be analyzed. 
 
The in vitro assay discriminated between various degrees of immunomodulation. 
There was no quantitative relation between NSI in vitro and in vivo immune 
stimulation. In this in vitro assay the LAB and the effector cells (lymphocytes and 
macrophages) were brought together in direct contact and optimal proportions. In 
the in vivo situation after oral administration the contact situation and proportions 
will probably be quite different. Moreover, other LAB properties or host related 
factors such as survival in the GI-tract, acid and bile tolerance, growth rate, and  
adhesion to the gut will play an important role in in vivo health stimulation. This 
could explain why some strains were promising in vitro, but showed little effect in 
vivo.  
 
For this in vitro assay spleens were used from SPF chickens not treated with LAB. 
When LAB strains were administered to chickens in vivo, the SI of these strains in 
the in vitro assay remained unchanged for spleen lymphocytes (data not shown). 
Oral administration did not lead to proliferative anti-LAB responses and the effect of 
probiotic LAB strains in the in vitro assay was not influenced by the lactobacilli 
present in the gut of the animal. The proliferation to the antigen with which the 
animals were immunized was altered minimally by previous oral application of 
lactobacilli. This could be negatively influenced because of the relatively long period 
after feeding before the proliferation was tested. 
 
The present assay significantly reduced experimental animal use. This in vitro 
assay only uses 10 chickens to test 10-15 strains. In vivo testing takes at least 15 
animals per LAB strain. In addition, evaluating 10-15 LAB strains in vitro takes less 
than a week whereas an in vivo experiment lasts 4-6 weeks. An advantage of this in 
vitro test is that simultaneous analysis of the cytokine profile induced by the by LAB 
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in spleen cells is possible. This adds to further understanding and selection based 
on the mechanism of action of immunomodulation by LAB. Differences in cytokine 
profiles that are induced might explain the major differences in immunomodulation 
even for closely related LAB strains. 
 
In conclusion, this in vitro assay is suitable for pre-selection of LAB on 
immunomodulating properties in vivo in chickens. The pre-selection assay thus far 
showed no false negative results. Strains that have a positive effect on in vitro 
proliferation of spleen lymphocytes also have a positive influence on specific 
humoral immune responses in vivo. Although this assay was developed for chicken, 
it possibly applies to other species as well, though it remains to be demonstrated 
whether the responses to model antigens can be reproduced in modulation of 
chicken response to pathogens.  
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Abstract 
 
The aim of the experiments was to evaluate whether selected probiotic 
Lactobacillus strains have different immunomodulating effects in layer- and broiler-
type chickens. Humoral and cellular specific and non-specific immune responses 
were studied by experiments in cellular proliferation, entry and survival of 
Salmonella bacteria in gut and spleen leukocytes, immunoglobulin isotypes and 
specific immunoglobulin titers. The effect of two different feeding regimes (short and 
continuous feeding) and doses for application of lactobacilli was studied. The 
Lactobacillus strains that were evaluated showed modulating effects on the immune 
system of layer- and broiler-type chickens. In broiler type chickens the lactobacilli 
had a stimulating effect when the chickens were young (up to 3 weeks) and the 
dose was relatively high, whereas in layer type chickens a lower effective dose and 
discontinuous administration was also effective. Immunoprobiotic lactobacilli can 
have a positive effect on humoral and cellular immune responses in layer- and 
broiler-type chickens, but the Lactobacillus strain to be used, the age of the animals 
and effective dose of lactobacilli to be administered need to be optimized.
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Introduction 
 
Lactobacilli are normal components of the healthy intestinal microflora. Selected 
Lactobacillus strains are used as probiotics with supposed health-promoting 
activities. These probiotic properties come in various categories and include 
beneficial influence on: intestinal balance (242), gut mucosal barrier (243) and 
mucosal immune response (214). Some probiotics have competitive exclusion 
effect for specific pathogens (79)and help reduce duration of diarrhea (176). In 
addition, beneficial effects have been observed on lactose intolerance (95), blood 
cholesterol concentrations (58) and cancer (177).  
 
Probiotics are used to develop and maintain a healthy intestinal microflora in young 
animals, like newly hatched chicks (203). In regular poultry housing chickens are 
raised under hygienic conditions in absence of the mother hen. As a consequence, 
the young chicks do not acquire a maternal microflora that matches with the natural 
antibodies transfused with the yolk, thereby leaving them vulnerable to colonization 
by pathogenic bacteria.  
 
Chickens have genetically been selected either for improved feed conversion and 
rapid growth or for production of eggs. This selection for economically important 
production traits has led to two physiologically quite different types of chickens: 
broiler- and layer-type chickens. As a consequence these chicken types differ in 
body weight gain, maximum lifespan and in a negative relation between 
performance traits of chickens and immunological responses (32, 158, 206, 226, 
311). Layer- and broiler-type chickens differ in their immune response to infectious 
disease and to model antigens such as TNP-KLH (trinitrophenyl-conjugated keyhole 
limpet hemocyanin) and sheep red blood cell (SRBC) (148, 158). Also in turkeys a 
direct relation between a lower mitogenic leukocyte response to Concanavalin A 
and higher antibody response to sheep red blood cells was observed in turkeys 
selected for high body weight (163, 164). These results indicate that selection for 
high body weight (as in broiler type chickens) can affect immunological parameters 
for disease resistance like antibody production or mitogenic responses. 
 
Various effects of probiotic lactic acid bacteria have been described in specific 
animals or man. These effects are depending on strain, host, dose, timing and 
viability of the strain (63, 131, 169, 221, 222). Some probiotic strains were selected 
in rodents or pigs for application in humans (71, 153, 213). This indicates that it is 
not excluded that probiotics act over various species. Although broiler- and layer-
type chickens belong to the same species there are considerable phenotypic 
differences between these chickens. Next to the enormous difference in growth and 
life expectancy the development of the immune system is possibly also quite 
different. Since antibody responses (IgG) and non-specific proliferative responses in 
broiler type chickens were reduced as compared to that in a layer type chickens 
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under the same conditions (148) especially broiler type chickens might need 
stimulation to reach immune responses comparable to layer type chickens.  
 
Therefore, we hypothesized that the interaction of lactobacilli with the chicken gut 
and immune system and therefore their immunomodulating effect might differ 
qualitatively and/or quantitatively between chicken types. Recently we selected 
immunoprobiotics in LSL chickens (149). L. paracasei LW 122 had a positive effect 
on the specific antibody titer and non-specific cell proliferation. L. plantarum LW 143 
did not have an effect on the antibody titer, but contributed to resistance to 
Salmonella Enteritidis (118). Layer type chickens were used since their life span 
better accommodated the duration of the experiments necessary for evaluation of 
immunoprobiotic effects modulating responses to priming and booster 
immunization. 
  
We investigated whether the immunoprobiotic properties of lactobacilli that were 
observed in layer type chickens expressed similar effects in broiler type chickens. 
The immunoprobiotic effect may be dependent on the amount of lactobacilli 
administered (9, 92, 213) therefore we studied two different lactobacilli feeding 
regimes. High doses were administered for a long period with fermented liquid feed 
(118). In other experiments the chickens received lactobacilli only during five days 
before an immunological challenge. As prototype for layer type chicken we have 
chosen LSL White Leghorn and as broiler type chicken Ross 208. 
 
Materials and methods 
Chickens  
 
Eggs of layer type chicken (LSL White Leghorn, Charles River) were bred and 
raised under routine specific pathogen free (SPF) conditions (no preventive 
vaccinations, no antibiotics and no coccidiostatics). One-day old Ross 208 broiler 
type chickens were obtained from a parent flock with a Salmonella-free history. Fluff 
and paper pads from the hatching cabin were examined on the presence of 
Salmonella. When all samples were negative for Salmonella, the chickens were 
used in the experiments.  
 
Housing 
 
At the start of the in vivo experiments the animals were divided equally over the 
groups for weight and gender (experiment II, in experiment I only female chicks 
were used). The animals were numbered individually and housed in groups that 
received the same treatment. The pens were closed with plates at the sides and 
between two pens a space as big as one pen was kept empty to avoid unwanted 
spreading of the bacteria. The pens were placed on a concrete floor with about five 
cm of sawdust bedding. Stable conditions were as follows: temperature 33 °C 
gradually declining to 18°C and the humidity was 55% throughout the experiments. 
Immunomodulation by probiotic lactobacilli in chicken 
 67 
In experiment I the light: dark scheme was 23 hours: 1 hour and in experiment II 16 
hours: 8 hours. 
 
Experimental design 
 
All animal experiments were in compliance with Dutch regulations on animal 
experimentation. 
 
Experiment I: Continuous feeding of L. paracasei LW 122 in fermented liquid 
feed (Fermented liquid feed): The effects of immunoprobiotics selected in 
layer type chickens on broiler type chickens 
 
One-day old chickens were divided into three groups of 20 animals each. Group 1 
received fermented liquid feed fermented with L. plantarum, group 2 received 
fermented liquid feed fermented with L. plantarum and L. paracasei, and group 3 
received dry control feed. The chickens received the feed from day one. On days 5 
and 33 the animals were immunized with TNP-KLH (trinitrophenyl-conjugated 
keyhole limpet hemocyanin). On days 6 and 7 after second immunizations chickens 
were sacrificed for lymphocyte proliferation assay (LPA) on spleen cells. On days 7, 
10 and 14 after both immunizations serum samples were taken from all chickens for 
total and specific IgM and IgG anti-TNP-titer analysis in ELISA.  
 
Experiment II: Temporary oral administration of L. paracasei LW 122: 
Comparison of response to immunoprobiotics in layer- and broiler-type 
chickens 
 
Two groups of 15 LSL chickens (groups 1 and 2) and two groups of 15 Ross 
chickens (groups 3 and 4) aged three weeks were administered either L. paracasei 
(groups 1 and 3) or buffer (groups 2 and 4). The chickens received lactobacilli for 
five consecutive days one week before immunization (days 8 to 12). On days 15, 17 
and 19, five animals of each group were immunized with TNP-KLH. Seven days 
after immunization animals were sacrificed and blood, spleen and samples from 
caecum and ileum were collected.  
 
Lactic acid bacteria 
 
Lactic acid bacteria strains were identified by BCCM/LMS (Ghent, Belgium) using 
fatty acid and SDS-PAGE analysis and L. paracasei LW 122 was also identified by 
16S rDNA sequence analysis. The lactic acid bacteria were cultured overnight (18 
hours) in MRS broth (de Man, Rogosa and Sharpe, Oxoid Ltd.) after inoculation of 
MRS with 1% of a fresh full-grown culture. Lactic acid bacteria were cultured at the 
optimal growth temperature for each strain, 30°C (L. plantarum) and 37°C (L. 
paracasei). To accurately count the bacteria, cultures were diluted in Pepton 
Physiological Salt solution (BioTrading, Mijdrecht the Netherlands) and plated out in 
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double layered pour-plates with MRS agar. The plates were incubated two days at 
the same temperature as the growing conditions of the culture (30°C or 37°C).  
 
Feed preparation and administration of lactobacilli to the chickens 
 
In experiment I fermented liquid feed was used. The fermented liquid feed was 
prepared as described by Heres (118). 200 g dry feed (pelleted feed, sterilized by 
gamma radiation (0.9 Mrad) (starter diet for pullets, Arkervaart, Leusden the 
Netherlands) was mixed with 280 g water and 1 ml of a fresh overnight culture of L. 
plantarum LW143 (289)or 1 ml L. plantarum + 1 ml L. paracasei LW122 (149, 169). 
The mixes were incubated for two days at 30°C. After fermentation the pH was 
about 4 (4.0 when fermented with L. plantarum 4.0 only and 4.2 with both strains). 
The fermented liquid feed contained 109-1010 colony forming units (cfu) L. plantarum 
per gram or about 4*109 cfu L. plantarum and about 2*109 L. paracasei per gram 
mixed fermented liquid feed and was stored at 4°C until use (max. two days). Seeds 
(corn, peeled barley and wheat, all coarsely ground) were added to make the feed 
more crumbly during the first days (fermented liquid feed: seeds = 3:2). On days 5 
and 6 the seeds were added to a level of 10% (w/w) and after day 6 no seeds were 
added. The same quantities of seeds were added to the dry feed of the control 
group. Water and feed were available ad libitum in both experiments.  
 
In experiment II the lactobacilli were orally administrated using a syringe mounted 
with a gavage. This allowed administering the lactobacilli in the upper part of the 
throat. During five consecutive days the groups received 109 cfu freshly cultured L. 
paracasei in 0.2 ml Na2CO3 buffer and the control group 0.2 ml Na2CO3 buffer. 
 
Gut content analysis 
 
On days 3, 7, 14 and 35 five chickens per group were randomly selected for 
necropsy. The intestines were removed aseptically. The contents of the crop, ileum 
and caecum were emptied in separate sterile stomacher bags and immediately 
diluted with cold Buffered Peptone Water (BPW, Oxoid, Haarlem the Netherlands). 
These samples were macerated during 2 minutes and serial diluted in saline. 
Enterococci were enumerated on Kanamycine Aesculine Azide (KAA) agar, 
Enterobacteriaceae on Violet Red Bile Glucose (VRBG) agar and lactobacilli on 
Rogosa-agar (all three agars from Oxoid). The plates and counted after 20-24 hours 
incubation at 37°C (KAA and VRBG) and after 3 days at 30°C (Rogosa). The pH 
was measured immediately after gathering of the contents by inserting an electrode 
(Ingold electrode, Mettler Toledo) into the lumen of crop, ileum and caecum.  
 
Antigen 
 
2,4,6-trinitrophenyl (TNP; Eastman Kodak, Rochester NY, USA) was conjugated to 
KLH (Sigma, St. Louis, USA) as described previously (49). In animal experiment I 
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chickens were intravenously immunized with 200 µg TNP-KLH in 0.2 ml 0.9% NaCl 
and in experiment II intravenously with 50 µg TNP-KLH in 0.5 ml 0.9%NaCl. The 
lower concentration of TNP-KLH was selected in experiment II because we had 
found earlier (148) that layer type chickens needed a lower concentration of TNP-
KLH than broiler type chickens in order to produce a suboptimal specific IgM 
response. In experiment II we did not want to immunize with two different antigen 
concentrations within one experiment and therefore selected a concentration which 
induces a response in both types of chickens. 
 
ELISA 
 
Total antibody concentrations IgM and IgG were measured in serum using a double 
antibody sandwich ELISA as previously described (155). An external standard (ITK 
diagnostics B.V., Uithoorn the Netherlands) with known IgM and IgG concentrations 
was used to indicate total antibody concentrations of the samples (IgG titer 1000 = 
5.6 mg/ml and IgM titer 1000 = 0.1 mg/ml).  
 
Anti-TNP antibody titers were determined by means of a direct ELISA as described 
previously (148). Briefly, TNP-bovine serum albumin (BSA, Sigma, St. Louis USA) 
was coated and sera were serially diluted in twofold. Responses were determined 
using mouse monoclonal antibodies CVI-ChIgM-59.7 and CVI-ChIgG-47.3, specific 
for chicken IgM and IgG (23, 135). In both ELISAs detection was performed with 
horseradish-peroxidase conjugated rabbit-anti-mouse (DAKO A/S, Glostrup 
Denmark) and the substrate tetramethylbenzidine (0.1 mg/ml) and H2O2 (0.005 % 
v/v). Extinction was measured at 450 nm. 
 
Antibody titers were calculated as the dilution of the sample giving an extinction 
value of 1 above the background. Geometric mean titers of individual 2-log titers, 
S.E.M. and antilog (2GMT) values were calculated. 
 
Antigen specific restimulation assay in vitro 
 
Cellular responses were determined by LPA as described previously (148). In short, 
spleens were removed aseptically and single cell suspensions were prepared. The 
mononuclear cells of the spleen were enriched over a Ficoll-Paque gradient 
(Amersham Pharmacia Biotech, Uppsala Sweden) and washed in phosphate 
buffered saline (PBS). 106 viable cells per well were incubated in 0.2 ml RPMI 1640 
Dutch modification containing 1% normal chicken serum, glutamine, ß-
mercaptoethanol and antibiotics) for 68 hours in a humidified incubator at 41°C with 
5% CO2. Spleen cells were incubated with the antigen to be tested (10 µg/ml ConA 
or 15 µg/ml TNP-KLH). After 92 hours 0.4 µCi per well 3[H]-thymidine (Amersham 
Pharmacia Biotech, United Kingdom) was added and 4 hours later the plates are 
harvested onto fiberglass filters and counted by liquid scintillation spectroscopy 
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(Betaplate, Wallac Oy, Turku Finland). All assays were performed in triplicate 
cultures.  
 
Entry and survival assay 
 
The assay to determine entry and survival of naladixic acid resistant strain of 
Salmonella enterica serotype Enteritidis PT4 (296) in leukocytes was used to 
measure the probiotic effect on the leukocytes and was slightly modified from the 
method previously described by Kramer et al. (155, 157).  
 
Briefly, the intestine (ileum and caecum) was isolated, opened longitudinally, rinsed 
thoroughly with PBS, and cut in 0.5–1 cm pieces. All tissue pieces were incubated 
for 10-15 min in PBS containing 0.145 mg/ml dithiotreithol (DTT) and 0.37 mg/ml 
EDTA in a shaking water bath (110 strokes/min, 37°C). The pieces of small intestine 
were rinsed once with RPMI 1640 Dutch modification containing 5% FCS and 
incubated in RPMI 1640 Dutch modification supplemented with 5% FCS, 
0.15 mg/ml collagenase, and 0.1 mg/ml DNase in a shaking water bath 
(200 strokes/min, 37°C) during 75–90 min. The supernatant and the pieces of 
intestine were subsequently squeezed through 70 µm nylon gauze (Cell strainer 
Falcon 2350, Becton Dickinson, Leiden, The Netherlands) using RPMI 1640 Dutch 
modification containing 5% FCS and 0.1 mg/ml DNase. The spleen was cut in small 
pieces, incubated in RPMI 1640 Dutch modification with 1 mg/ml collagenase for 
10 min at 37°C, and squeezed through a 70 µm nylon gauze.  
 
The single cell suspensions of ileum, caecum or spleen leukocytes were incubated 
in triplicates with 100 µl of a S. Enteritidis suspension. Adding gentamicin 30 
minutes later (200 µg/ml in order to the kill extracellular bacteria) finished the entry 
phase in all cultures. The number of bacteria that entered the cells during 30 
minutes was determined by washing the cells and one of the three identical cultures 
was resuspended in PBS with 1% saponin to lyse the cells. Appropriate dilutions of 
the Salmonellas released from the cells were plated onto Brilliant Green Agar plates 
enriched with naladixic acid (100 ppm). To determine the survival of S. Enteritidis 
after entering the leukocytes two remaining cell suspensions were washed and 
resuspended in RPMI 1640 with FCS and gentamicin (20µg/ml). These cultures 
were incubated for another 14 h or 24 h in a humidified incubator at 37 °C with 5% 
CO2. Thereafter the chicken cells were lysed and the frequency of surviving bacteria 
in leukocytes was determined by plating on Brilliant Green Agar. 
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Statistics/data analysis 
 
The significance of differences between groups at the same timepoint were 
analyzed with Student’s T-test (two-tailed and two sample with unequal variance).  
 
Results 
 
Two Lactobacillus strains have been tested in layer- and broiler-type chickens in 
two different application regimes, a temporary and a continuous application model 
and different doses. The effect of the administration of lactic acid bacteria on pH 
and microflora in the GI-tract of chickens as well as the effect on non-specific and 
specific humoral and cellular responses were evaluated. 
 
Effects on pH 
 
After feeding fermented liquid feed (experiment I) the pH in the crop was lower pH 
than was observed in the control group (P<0.05, table 1). This difference was 
probably due to the fermentation products like lactic and acetic acid. Unexpectedly, 
feeding fermented liquid feed led to a slightly, non significant, increase of the pH in 
caecum and jejunum as compared to the pH in the same gut sections as in the 
chickens that received control feed. 
 
Effects on Microflora 
 
Following fermented liquid feed feeding (experiment I) the number of Enterococci 
was higher in crop, jejunum and caecum of the control group than was determined 
for chickens in the fermented liquid feed groups, especially in the first week of 
feeding (P=0.001). The control group showed larger day-to-day variation in 
frequency of lactobacilli in crop, caecum and jejunum. The frequency of lactobacilli 
was about 10 fold lower in the control group than in the fermented liquid feed 
groups (P=0.05) in all segments of the GI-tract tested. To estimate the relative 
frequency of the strains of lactobacilli that were fed to the chickens, gut samples 
were investigated. Some (n = 10) typical colonies were analyzed with the API-
CH50-test (BioMérieux) to verify the identity of the colony. All colonies tested had 
exactly the same API-pattern as the strains in the starter culture. It was concluded 
that the majority of the lactobacilli in caecum of the fermented liquid feed fed groups 
consisted of L. plantarum or L. plantarum + L. paracasei from the starter cultures. 
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Effect of feeding putative immunoprobiotic bacteria on the humoral immune 
response  
Non-specific immunoglobulin levels (experiment I) 
 
After primary immunization the chickens that received fermented liquid feed 
fermented with L. paracasei + L. plantarum had higher total IgM titer than the control 
group (P= 0.02). The group fed with L. plantarum fermented liquid feed showed a 
similar trend after priming. After secondary immunization the group that received 
with L. paracasei + L. plantarum had a higher total IgG titer in serum than the 
control group (P= 0.05) and the group that received fermented liquid feed fermented 
with L. plantarum only (P= 0.009). This L. plantarum group also had a higher total 
IgM titer than the control group (P= 0.005, table 2).  
 
Table 2  Effect of continuous feeding of lactobacilli with fermented liquid feed on 
total serum IgM and IgG titers in broiler type chickens (n=15)a,b. 
  
    IgM titer IgG titer 
  Standard sample 5698.2 (69.2) 1079.8 (15.9) 
Priming Control  2320.7 (36.9)a  1303.7 (29.4)a 
 L. paracasei + L. plantarum  3671.2 (59.2)c   2261.7 (71.3)b 
  L. plantarum     3692.1 (102.2)b/c 1789.7 (63.0) 
Boost Control 3924.3 (62.6)a  4394.0 (67.2)a 
 L. paracasei + L. plantarum 5378.2 (83.8)b      6800.5 (127.9)c/d 
  L. plantarum     7899.3 (169.3)d/b   3863.0 (34.0)a 
a Mean titers (S.E.M.) from serum samples on day 7 after priming and booster 
immunization.  
b Different subscripts in the same column indicate significant differences (n a,b,c : 
P<0.05). 
 
TNP-specific immunoglobulin levels (experiments I en II) 
 
After priming fermented liquid feed prepared with L. plantarum and fermented liquid 
feed prepared with L. plantarum + L. paracasei both had a positive effect on the IgM 
titer (both P= 0.07) in the broiler type chickens, but after boost no stimulation of the 
TNP-specific IgM response was detected (table 3). 
 
The serum IgM response to TNP-KLH in layer type chickens was slightly lower than 
was observed in broiler type chickens. In contrast, the IgG response of broiler type 
chickens was lower than was observed for layers (not significant). In experiment II 
temporary administration of L. paracasei for 5 days prior to immunization with TNP-
KLH enhanced the serum IgM and IgG titers in layer type chickens after priming, but 
not in broiler type chickens under the same conditions (table 4). However, 
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stimulated IgM titers in layer type chickens reached similar levels as were observed 
in broiler type chicken controls. For IgG stimulated levels in layer type chickens 
surpassed IgG level that was observed in broiler type chickens.  
 
Table 3. Effect of continuous feeding with fermented liquid feed on specific serum 
IgM and IgG anti-TNP titers in broiler type chickens (n=15)a,b. 
  
    IgM titer IgG titer 
Priming No TNP-KLH 113.8 (5.3) 7.6 (2.1) 
 Control 270.6 (16.3)a 13.6 (1.1) 
 L. paracasei + L. plantarum 694.6 (37.5)b 17.1 (1.3) 
  L. plantarum 781.4 (51.4)b 16.1 (2.2) 
Boost Control 6793.8 (361.2) 117.8 (4.6)a 
 L. paracasei + L. plantarum 4299.6 (224.2) 88.6 (7.3) 
  L. plantarum 6427.3 (321.3) 55.3 (3.8)c 
a Mean titers (S.E.M.) from serum samples on day 7 after priming and booster 
immunization. 
b Different subscripts in the same column indicate significant differences (n a,b,c : 
P<0.05). 
 
Table 4. The effect of feeding of 109 L. paracasei LW122 for 5 days prior to 
immunization with TNP-KLH in layer- and broiler-type chickens (n=15) on the 
specific serum IgM and IgG anti-TNP titersa. 
 
  IgM titer IgG titer 
Layer 1351.9 (245.1)   716.5 (136.6) 
Layer + L. paracasei 2227.2 (255.3) 1243.7 (186.8) 
Broiler 2019.3 (419.3)  329.6 (112.4) 
Broiler + L. paracasei 2188.7 (400.4)            242.7 (66.4) 
No TNP-KLH 29.7 (0.7)              37.7 (1.3) 
a Titers (± S.E.M.) are shown for day 7 after primary immunization. 
 
Modulation of the cellular immune response  
Lymphocyte proliferation (experiment II) 
 
Under identical test conditions the non-specific proliferative response to ConA was 
higher in spleen cells of layer type chickens than was observed in spleen cells of 
broiler type chickens, but temporary feeding L. paracasei did not have an effect on 
this response in both types of chickens (table 5). The specific proliferative response 
to TNP-KLH was enhanced in spleen cells of both layer- and broiler-type chickens 
that orally received L. paracasei as compared to the control groups that did not 
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receive the lactobacilli. However, the immune enhancing effect was more 
pronounced in spleen cells of broiler type chickens (P= 0.023) than was observed in 
spleen cells of layer type chickens (not significant).  
 
Table 5. The effect of temporary feeding of L. paracasei LW 122 to layer- and 
broiler-type chickens (n=15) on the proliferative responses of spleen cells to ConA 
and TNP-KLH in vitroa,b.  
 
  KLH-TNP ConA 
Layer 62157 (7048) 27489 (7322) 
Layer + L. paracasei 73083 (7837) 21828 (6426) 
Broiler   56690 (9183)a   9069 (4709) 
Broiler + L. paracasei     93214 (12004)c 12423 (4967) 
a cpm (± S.E.M.) are shown for assays performed on day 7 after primary 
immunization with TNP-KLH. 
b Different subscripts in the same column indicate significant differences (n a,b,c : 
P<0.05). 
 
Modulation of the innate immune response: Entry and survival (experiment II) 
 
The effect of temporary feeding of L. paracasei was measured as the effect on 
entry, survival and replication of S. Enteritidis in leukocytes of spleen, ileum and 
caecum one week after the last feeding of L. paracasei. 
Both entry (measured after 30 minutes) and survival/replication (measured after 14 
and 24 hours) of S. Enteritidis in spleen and caecum cells was similar in cells of 
layer- and broiler-type chickens. However, entry and survival of S. Enteritidis were 
significantly higher in ileum derived cells from broiler type chickens than observed in 
layer type chickens (figure 1). 
 
Feeding of L. paracasei LW 122 had an enhancing effect on the entry of S. 
Enteritidis in isolated leukocytes of the caecum of layer type chickens. With L. 
paracasei the entry was 1890 cfu/gram and without 633 cfu/gram (P= 0.002). In 
ileum- and spleen cells of these chickens no effect of feeding probiotic bacteria on 
uptake of S. Enteritidis was observed. Feeding L. paracasei did not have any effect 
on the bacterial entry in the gut and spleen cells of broiler type chickens. 
In caecum cells of broiler type chickens fed with L. paracasei LW 122 the survival 
and intracellular replication of S. Enteritidis after 14 h incubation was significantly 
reduced as compared to caecum cells of chickens that did not receive lactic acid 
bacteria (P=0.04). But in caecum cells from layer type chickens the reverse was 
observed (P=0.05). Feeding of L. paracasei LW 122 enhanced survival and 
replication of S. Enteritidis in spleen cells of broiler type chickens, but in layer type 
chickens no effect was observed.  
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Figure 1. The effect of feeding of L. paracasei LW 122 on the innate immune 
response. Entry and survival of S. Enteritidis (S.E.) are shown in isolated leukocytes 
from caecum (a), ileum (b) and ileum (c) of layer- and broiler-type chickens 
(±S.E.M.) after in vitro exposure at one week after the last feeding of the lactobacilli 
(n=15) in experiment 2. In order to keep the figures clear the statistical significance 
is described below: 
(a) In caecum L. paracasei had a significant enhancing effect on the entry of S.E. 
(P=0.002) in the layer type chicken. In broiler type chickens which had L. paracasei 
the survival of S.E. after 14h was significantly reduced as compared to cells of 
chickens that did not receive lactic acid bacteria (P=0.04). In caecum cells of layer 
type chickens the reverse was observed (P=0.05).  
(b) For ileal cells the survival and replication of S.E. after 14 h was higher in cells of 
broiler- than in cells of layer type chickens (P=0.04). 
(c) No statistical differences. 
 
After 24 h of incubation of isolated cells with S. Enteritidis no differences were found 
between the two chicken lines with respect to survival in spleen or GI-tract cells with 
or without prior application of L. paracasei to the chickens. 
 
Discussion 
 
This study clearly showed that feeding or temporary oral administration of 
lactobacilli could modulate physiological aspects of the GI-tract and various aspects 
of the chicken immune response.  
 
Microflora and fermented liquid feed 
 
Obviously the feeding of fermented liquid feed in broiler type chickens modulated 
the composition of the microflora in the crop, jejunum and caecum. The frequency 
of lactobacilli was about 10-fold higher in all three parts of the GI-tract studied. 
Especially in the first week of fermented liquid feed feeding the frequency of 
enterococci was reduced. This might be explained by competition for nutrition, 
space or adherence between lactobacilli and enterococci (249, 250). Lactobacilli are 
important components for a balanced microflora. The reduced day-to-day variation 
in frequencies of lactobacilli in crop, ileum and caecum that was observed during 
fermented liquid feed feeding was an indication for a stabilizing effect of lactobacilli 
on the intestinal microbiota and was in agreement with earlier findings of Heres et 
al. (117). This stabilizing effect as well as the increased frequency of lactobacilli 
together with a reduced frequency of Enterobacteriaceae was also observed in pig 
(295). From this we conclude that the selected lactobacilli expressed beneficial 
effects on the host flora composition. 
 
Daily administration of fermented liquid feed proved to be an effective vehicle to 
increase levels of live lactobacilli in the GI-tract. However, in contrast to fermented 
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liquid feed feeding in pigs, a disadvantage of using fermented liquid feed in chicken 
was the relatively low food intake (117) and therefore a variable intake of lactobacilli 
(1 gram fermented liquid feed ~ 109 cfu lactobacilli). Therefore in the present 
experiment the number of lactobacilli per day was probably not constant and this 
might have influenced some of the results. Therefore in the second experiment the 
chickens were inoculated individually with a fixed number of lactobacilli. 
 
Immune function analysis 
 
The entry of phagocytosis of S. Enteritidis in caecum derived cells was enhanced by 
L. paracasei LW122 in layer type chickens. Similarly probiotic lactic acid bacteria 
enhanced phagocytosis in mice (26, 27, 213, 215, 256). These probiotic properties 
were dose dependent (92, 213, 215, 256). Though in these latter experiments 
phagocytosis was studied with inert/passive materials, the observed dose-effect 
probably did play a role in our experiments with live S. Enteritidis. Although the 
same number of lactobacilli was administered to broiler- and layer-type chickens, 
the gut of broiler type chickens was relatively heavier and longer and therefore the 
number of lactobacilli may have differed between the chicken types with respect to 
the gut surface and volume. Apart from intrinsic differences in immunity this might 
therefore explain part of the observed differences.  
 
Our results indicated that feeding L. paracasei to broiler type chickens enhanced 
the phagocytic and bacterial activity of the gut cells (caecum, ileum). But in spleen 
cells the survival of S. Enteritidis was slightly enhanced as compared to the control 
group. In contrast, feeding of L. paracasei did not influence the phagocytic and 
bacterial activity in ileum and spleen cells of layer type chickens, although in the 
caecum of layer type chickens survival of S. Enteritidis was enhanced. These 
observations may be better explained by intrinsic differences in the quality of the 
innate immune system of layer- and broiler-type chickens than by differences in 
relative doses of lactobacilli only. The enhanced activity at the level of the gut in 
broiler type chickens may provide an advantage in resistance and control of S. 
Enteritidis or other infections in broiler type chickens. 
 
Simultaneous feeding of L. paracasei and L. plantarum with fermented liquid feed 
enhanced total IgM and IgG titers (figure 1). It appeared that both Lactobacillus 
chickens contributed differentially to the a-specific enhancement of antibody titers. 
Following priming IgM titers were enhanced both with the mixed fermented liquid 
feed and with L. plantarum only. Especially following booster immunization L. 
plantarum alone had a stronger stimulating effect on the IgM titer than mixed 
fermented liquid feed. This indicated that no fading of the stimulation of a-specific or 
polyclonal stimulation was observed. The total IgG level in broiler type chickens was 
enhanced by mixed fermented liquid feed feeding only following booster 
immunization which included a longer duration of administration. Fermented liquid 
feed with L. plantarum alone did not enhance polyclonal IgG. However, in 
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experiment II following a feeding period of only 5 days prior to immunization such an 
a-specific enhancement was not observed at the timepoint investigated. Not only 
the difference in doses of lactobacilli but also the delay between the last feeding of 
lactobacilli and the actual measurement of the response may have biased these 
results. 
 
Temporary feeding of L. paracasei LW 122 (previously called L. reuteri-1 on 
functional characteristics) preceding immunization had an adjuvant-like effect on the 
specific humoral responses to TNP-KLH in layer type chickens (149, 150). When 
fermented liquid feed was fed to broiler type chickens (experiment I) an adjuvant-
like effect was observed, but only for antigen specific IgM response after priming 
(figure 2). However, in experiment II, where layer- and broiler-type chickens were 
compared under the same conditions of temporary feeding with lactobacilli an 
adjuvant-like effect was not observed in broiler type chickens and only a weak 
adjuvant effect (IgM and IgG) was measured in layer type chickens (figure 3). The 
differences in experimental conditions such as doses of lactobacilli and the feeding 
regimen (continuous or discontinued at the time of immunization) may have resulted 
in different kinetics for the immunomodulation effects. Also an age effect may play a 
role. The maximum life-span of broiler type chickens is about 5-6 weeks. In 
experiment I (fermented liquid feed) the broiler type chickens were 5 weeks old at 
priming, but in the second experiment they were only 5 days old, creating sufficient 
time for a secondary immunization. A host-dependent effectiveness of lactobacilli in 
the gut associated immune system of layer type chickens was observed by Balevi et 
al. (9) based on competitive exclusion. It tentatively might be concluded that in 
young broiler type chickens the adjuvant effect is absent due to a lower state of 
immune maturation that rendered the cells less susceptible to the effect of 
immunoprobiotics. However, this still does not explain the levels of specific anti-TNP 
Ig production in broiler type chickens in experiment II even without stimulation by 
lactobacilli was as high as was observed in layer type chickens following such a 
stimulation. Although both layer- and broiler-type chickens were 5 weeks old in 
experiment II their immune system still may differ in maturity. As a consequence of 
the short maximum life span of broiler type chickens the maturation of (part of) their 
immune system may develop in an accelerated way as compared to the 
development in layer type chickens. Quantitative data on B cell development may 
support this hypothesis (J. B. Cornelissen, personal communication). 
 
In broiler type chickens lactobacilli did not influence the non-specific proliferative 
response of isolated spleen cells, but the specific response to (re)stimulation with 
antigen in vitro was enhanced by L. paracasei even following temporary 
administration prior to the application of the immune stimulus. This indicated that for 
specific antigens such as e.g. vaccine antigens, immunoprobiotic lactobacilli might 
enhance disease resistance especially in broiler type chickens. 
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Interaction strain/gut/immune system 
 
The interaction of gut, immune system and microflora forms a complex interface for 
mutual interactions between these systems that may be influenced by various 
management factors. As broiler- and layer-type chickens differ enormously in 
growth and maximum life span it may be assumed that they also differ in their 
interactions with the actual bacterial microflora. Administration of L. paracasei 
enhanced T cell proliferation more in broiler- than in layer-type chickens (figure 4). 
This could be caused by intrinsic differences in the regulation of cellular responses 
between the chickens. Present experiments confirm our observation, that showed 
the proliferative responses layer type spleen cells could indeed only become 
enhanced to a limited extend by lactobacilli (150). The enhancement that was 
observed in broiler type chickens, but not in layer type chickens of the same age 
might be caused by differential sensitivity to lactobacilli between the chicken lines 
due to intrinsic differences in development of the immune system. 
 
As was described by Kramer et al. (156) lighter weight broiler type chickens reacted 
to Salmonella bacteria preferably by innate immune mechanisms while a heavier 
weight chicken fought these bacteria especially via the adaptive immune system. 
For comparison between layer- and broiler- these differences might even be more 
extreme since their weight differences are more pronounced than between heavy 
and light broiler type lines. 
 
Recently Clancy (50) described a putative mechanism for immunomodulation by 
probiotic bacteria. According to this model probiotic bacteria activate dendritic cells 
in Peyers’ patches which in turn stimulate the mucosa homing circulating pool of T-
lymphocytes generated from within the Peyers’ patch. In this way these T cells 
might also exert their immune modulation at distant mucosal sites. A higher number 
of lactobacilli that reached the Peyers’ patches could activate more DC’s and 
indirectly increase the immune response. The present experiments demonstrated 
that Lactobacillus strains could have differential effects on the microflora and the 
immune system.  
 
Feeding large amounts of lactobacilli positively influenced the microflora 
composition of young chickens. The frequency of unwanted bacteria was lower and 
the frequency of lactobacilli was higher in treated animals. The microflora was 
stabilized sooner in the treated than in the untreated animals. The age of the 
chickens and the amount of lactobacilli were important variables in the experiments. 
These seemed to be responsible for differences in stimulating the proliferation, the 
entry in leukocytes and humoral responses. The interplay of the Lactobacillus strain, 
dose of lactobacilli age of the chicken and the interaction of the bacteria with the 
host gut and immune system and maybe even more make this a subtle but complex 
way of immunomodulation. This implies that in order to obtain a desired effect, 
these variables should be investigated and balanced in an optimal way.  
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The present experiments showed that Lactobacillus strains had different effects on 
the GI-tract and immune system depending on the type, genetic make-up and age 
of the chicken. Though the magnitude of the effects per animal is limited, non-
specific enhancement of the immune system may support animal health of a flock in 
an inexpensive way.  
 
Under the chosen conditions both humoral and proliferative responses were 
enhanced (adjuvant-like effect) and to draw firm conclusions about the modulation 
of innate responses further investigation is needed. Furthermore the Lactobacillus 
strain, dose, and duration of application played a role in modulation effects. This 
implied that in order to obtain a desired effect these variables should be further 
investigated, optimized and balanced. 
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Abstract 
 
Recently selected probiotics i.e. immunomodulating lactobacilli, were orally 
administered to young chickens prior, during and following Salmonella infection. 
Resistance to the infection was not changed by the lactobacilli. As compared to 
controls, in chickens treated with probiotic lactobacilli the clearance of the systemic 
infection from spleen and liver was enhanced. However, cytokine levels in the gut, 
Salmonella specific IgM titers and Salmonella specific proliferation of splenic 
lymphocytes all were decreased as compared to controls. We hypothesize that the 
probiotic lactobacilli reduced shedding and enhanced clearance of Salmonella, 
thereby reducing the antigenic load, which led to lowered cytokine production, 
reduced specific IgM titers and in vitro proliferation.  
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Introduction 
 
Chickens harbor a complex gastro-intestinal microflora in which lactobacilli are 
considered to confer beneficial influences to the host. From probiotic studies with 
humans and animals it has become clear that health related effects of lactobacilli 
are strain-dependent (112, 152, 169) and assert a set of vital roles regarding to host 
resistance (16, 62, 118). E.g., some Lactobacillus strains prevented colonization of 
pathogens in the GI-tract by competing for epithelial adhesion sites and essential 
nutrients and/or by production of inhibitory compounds. 
 
In newly hatched chickens, the gut is sterile and both the hygienic measures in 
commercial breeding and the separation of the young from the adult bird prevent 
the chick from uptake and ingestion of the adult intestinal microflora. The 
importance of such a flora was firstly demonstrated by Nurmi and Rantala (204, 
234) who treated chickens with cecal flora of adult chickens, which than showed 
resistance to colonization with Salmonella. Lactobacilli also enhanced resistance 
against Salmonella colonization (116, 227). In chickens fed liquid feed fermented 
with L. plantarum the susceptibility for Salmonella was decreased (118). However, 
this effect of fermented liquid feed could not be mimicked with artificially acidified 
feed. This implied that the lactic acid bacteria played an important role in reducing 
Salmonella colonization apart from their acid production (116). Next to competitive 
exclusion and acid production, disease resistance could be increased by microbial 
anti-pathogen substances secreted by probiotics (e.g. bacteriocidins as reuterin, 
acidophilin, nisin, hydrogen peroxide, etc.) or by immunomodulation of the host by 
probiotics.  
 
Recently, immunomodulation by specific Lactobacillus strains was described in 
chicken (150, 152). This immunomodulation was characterized as enhanced 
specific antibody responses and proliferation of splenocytes. Such 
immunomodulation might enhance resistance to a pathogenic infection. 
Augmentation of resistance to Salmonella by lactobacilli due to anti-Salmonellae 
protective immunity mediated by the mucosal tissue (antibody titers to Salmonella in 
serum and GI-tract were increased) was described in rodents by (220). Enhanced 
cell-mediated immunity against pathogenic bacteria mediated by lactic acid bacteria 
(LAB) contributes to increased protection and host resistance in mice and rat (60, 
64, 94, 257). 
 
Therefore, the combination of competitive exclusion and immunomodulation 
conferred by properly selected probiotic lactobacilli was expected to have a positive 
effect on the Salmonella infection in chicken as well. This was experimentally 
verified in layer type chickens that were fed with L. paracasei or L. brevis plus L. 
paracasei prior to and during a Salmonella infection. We used Salmonella Enteritidis 
(S.E.) phage type 4 infection because this is an important pathogen in food safety 
and phage type 4 is the most prevalent phage type in the Netherlands (239). The 
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experiment showed that the probiotics enhanced clearing of liver and spleen from 
Salmonella, however simultaneously local cytokine production, IgM titers and 
proliferation to S.E. were suppressed. 
 
Materials and Methods 
Animal experiments 
 
The animal experiments were in compliance with the institutional animal experiment 
committee and in accordance with the Dutch regulations of animal experimentation.  
 
Chickens 
 
Eggs of layer type chickens (LSL White Leghorn, Charles River), obtained from a 
parent flock with a Salmonella-free history were hatched in our animal facilities. Fluff 
and paper pads from hatching cabin and transport boxes were examined for 
presence of Salmonella. Before inoculation with S.E. the animals were checked on 
the presence of Salmonella (cloaca swabs). Chickens were used in the experiments 
only if all samples were Salmonella-negative. Chickens were raised under routine 
SPF (specific pathogen free) conditions: no preventive vaccinations, no antibiotics, 
and no coccidiostatics. Feed (starter diet for pullets, Arkervaart, Leusden, the 
Netherlands) and water were available ad libitum.  
 
Housing 
 
After inoculation with Salmonella chickens were housed individually in pens with 
wire floors with sawdust bedding to collect droppings. The pens were placed with an 
interspace of at least 20 cm. Sides, back and roof of each pen were closed with 
plastic sheets outside. Direct contact between the chickens was prevented. Front 
sides of the cages were wired and open. To prevent spreading of bacteria between 
pens and chickens, feed and water equipment were handled with 70% alcohol 
disinfected gloves.  
 
Animal experiment 
 
During the experiment lactobacilli and Salmonella suspensions were orally 
administrated using a syringe mounted with a gavage, allowing administration of 
lactobacilli and Salmonella in the upper part of the throat. From day 1 of age, 4 
groups of 40 layer type chickens daily received orally 109 lactic acid bacteria or 
buffer. On the seventh day of LAB (or buffer) administration, groups 1-3 were orally 
infected with 103 cfu Salmonella enteritidis in PBS and group 4 received PBS. This 
dose was established to infect 90% of 7 day old layer type chickens in a preceding 
titration experiment (data not shown). From day 7 on the chickens received 
lactobacilli or buffer for 5 days a week during the rest of the experiment. Group 1 
received Salmonella Enteritidis only; group 2 received Salmonella Enteritidis and L. 
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paracasei LW122; group 3 received Salmonella Enteritidis and a mix of L. paracasei 
LW122 and L. brevis LW5 and group 4 received buffer only. At the day of 
Salmonella inoculation blood samples were taken from 5 animals per group and 
during the experiment on days 4, 7, 14 and 21 after S.E. inoculation blood samples 
were taken from al animals. Ten animals per group were sacrificed on day 4, 7, 14 
and 21 after S.E. inoculation. From these animals spleen and liver and caecum 
content were removed aseptically and kept on ice. Pieces of jejunum, ileum and 
caecum were removed of which one half was directly frozen in liquid nitrogen for 
RNA isolation and the other half was collected in buffered 4% formaldehyde for 
histological purposes. Caecum, liver, and spleen were used for bacteriological 
examination and on day 21 after infection half of the spleen was used for 
immunological research. From day 1 to 11 and on days 14 and 16 after inoculation 
cloaca swabs were taken to monitor shedding of S.E. 
 
Bacterial strains, growth conditions and microbiological determinations 
Lactic acid bacteria 
 
LAB strains were identified (BCCM/LMS Ghent Belgium) using fatty acid and SDS-
PAGE analysis and 16S rDNA sequence analysis. LAB were cultured overnight (18 
hours) in MRS broth (de Man, Rogosa and Sharpe, Oxoid Ltd.) at 37°C, after 
inoculation of MRS with 1% of a fresh full-grown culture. Cultures were diluted in 
Pepton Physiological Salt (PPS) solution (BioTrading, Mijdrecht the Netherlands) 
and plated in double layered pour-plates with MRS agar to count the bacteria. The 
plates were incubated 2 days at 37°C.  
 
Salmonella Enteritidis 
 
A naladixic acid resistant strain of Salmonella enterica serotype Enteritidis PT4 
isolated from chicken was used (296). This strain is pathogenic for humans and it 
may cause clinical disease especially in young or weak chickens. For inoculation a 
fresh overnight culture of S. E. were prepared by growing the bacteria in buffered 
peptone water (BPW, BioTrading, The Netherlands). The bacterial culture was 
incubated at 37ºC under vigorous shaking (100 shakes per minute). The viable 
counts in the inoculum suspensions were determined by diluting and plating on 
Brilliant Green Agar (with 100µg/ml naladixic acid, BGA-Nal+) for 24 hours at 37 °C.  
 
For detection of Salmonella in chickens prior to inoculation with S.E., cloaca swabs 
were incubated in BPW at 37°C for 24 hours. Enriched cultures were plated on 
Modified Semi-Solid Rappaport Vassiliadis broth (MSRV, BioTrading, the 
Netherlands) and incubated during 24 hours at 42°C. Suspected cultures were 
subcultured on BGA-NaI+ for Salmonella determination for 24 hours at 37°C.  
Cloacaswabs of the chickens were enriched in BPW (24 h at 37 °C) before plating 
on BGA-Nal+ plates. Positive diagnosis depended on the presence of one or more 
typical colonies.  
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To detect Salmonella in caecumcontent or liver, 1 g of cecal content or liver was 
homogenized in 9 ml BPW and serial diluted in BPW. Caecum content was plated 
onto square BGA-Nal+ plates according to the track dilution method described by 
Jett (134) and liver on round plates, one dilution per plate. Since the spleens were 
too small to collect 1g tissue, the whole spleen was weighed, ground in 2 ml BPW, 
and followed the same procedure as for liver. 
 
Immunological determinations 
Specific humoral response 
 
Anti-Salmonella antibody titers were determined in a direct ELISA as described 
previously (296). Briefly, S.E. LPS was coated overnight in 96-wells high binding 
ELISA plates (Greiner, Nürtingen, Germany). Sera were serially diluted in twofold 
and incubated for one hour at 37°C. The isotype specific responses were 
determined using mouse monoclonal antibodies CVI-ChIgM-59.7 and CVI-ChIgG-
47.3, specific for chicken IgM and IgG (23, 135). Detection was performed with 
rabbit-anti-mouse-HRPO (DAKO A/S, Glostrup Denmark) and the substrate 
tetramethylbenzidine (0.1 mg/ml) and H2O2 (0.005 % v/v). Extinction was measured 
at 450 nm. Antibody titers were calculated as the dilution of the sample giving an 
extinction value of 1 above the background. Geometric mean titers (GMT) of 
individual 2-log titers, S.E.M. and antilog (2GMT) values were calculated. 
 
Lymphocyte proliferation assay (LPA) 
 
Cellular responses were determined by lymphocyte proliferation assay (LPA) as 
described previously (148). In short, spleens were removed aseptically and single 
cell suspensions were prepared. 106 viable cells per well were incubated in 0.2 ml 
RPMI 1640 Dutch modification (containing 1% normal chicken serum, glutamine, ß-
mercaptoethanol and antibiotics) for 68 hours in a humidified incubator at 41°C with 
5% CO2. Spleen cells were incubated with the antigen to be tested, 10 µg/ml ConA 
or 10 µg/ml S.E. antigen (prepared by culture of S.E. in BPW, concentrated by 
centrifugation, washed with PBS and inactivated by sonification (four times 30 
seconds on ice) and freeze-thawing for four times). For ConA after 68 hours and for 
S.E. antigen after 92 hours 0.4 µCi per well 3[H]-thymidine (Amersham Pharmacia 
Biotech, United Kingdom) was added and 4 hours later the plates are harvested 
onto fiberglass filters and counted by liquid scintillation spectroscopy (Betaplate, 
Wallac, Turku Finland). All assays were performed in triplicate.  
 
Quantitative measurement of cytokine mRNA in jejunum 
RNA extraction and cDNA preparation 
 
Total RNA was extracted from 50-100 mg tissue of jejunum of five animals per 
group (not pooled) and homogenized with liquid nitrogen using mortar and pestle. 
The homogenized tissue samples were dissolved in 1 ml of TRizol Reagent 
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(Invitrogen, Breda, The Netherlands) per 50-100 mg of tissue using a syringe and 
21-G needle passing the lysate for 10 times. The cleared homogenate was used for 
phase separation with chloroform as described by the manufacturer. The isolated 
RNA was quantified by E260 nm. RNA (200 ng) was incubated at 70°C for 10 
minutes with random hexamers (0.5µg, Promega Benelux BV, Leiden, The 
Netherlands), then reverse transcribed in a final reaction volume of 20 µl containing 
Superscript RNase H-reverse transcriptase (200 Units, Invitrogen, Breda, The 
Netherlands), RNAsin (40 U, Promega Benelux BV, Leiden, The Netherlands), 
dNTP (2 mM Promega Benelux BV, Leiden, The Netherlands), 5x First Strand 
Buffer (Invitrogen, Breda, The Netherlands) and 0.1M DTT (Invitrogen, Breda, The 
Netherlands), for 50 minutes at 42°C. The reaction was inactivated by heating at 
70°C for 10 minutes. cDNA was stored at -20°C until use. 
 
Real time quantitative PCR 
 
Real-time PCR was performed with online detection of the PCR reaction based on 
fluorescence monitoring (LightCycler, Roche Diagnostics, Mannheim, Germany). 
Primer and probe sequence were selected with MolBiol software (Berlin, Germany). 
Primers or probe combinations were designed such that the sequence of interest of 
the relevant genes was located across an exon-intron boundary (table 1).  
 
Hybridization probes (TIB MolBiol, Berlin, Germany) were used to monitor the 
amount of specific target sequence product. Quantitative results were determined 
from the cycle threshold value (signal rises above background level). For 
quantification standard curves of the cytokine and 28S product were used. 
Products for PCR optimization and the standard curve were prepared with a 
plasmid construct containing the region of interest. PCR reactions were performed 
according to the LightCycler kit instructions (FastStart DNA Master Hybridization 
Probes, Roche Diagnostics, Mannheim, Germany). Real-time PCR was performed 
in 20 µl containing 1µM of each primer, 0.2 µM of each probe, MgCl2, 2 µl template 
and 2 µl Fast Start mix. The reaction mix and samples were loaded into glass 
capillary tubes. Pre-incubation and denaturation of the template DNA occurred for 
10 minutes at 95°C, whereas the PCR cycling was done 10 sec at 95°C, 10 sec ± 
56°C (table 1) and 25 sec at 72°C for 45 cycles. Temperature transition rates were 
set at 20°C/s. A LightCycler instrument (Roche Diagnostics) was used for 
amplification and detection. To avoid contamination, filter pipette tips were used and 
reagents were mixed in rooms separate from rooms where DNA was present. A 
negative control, containing reagents only, and standard 10-fold dilution series were 
included in each run. A standard curve was generated from the threshold cycles 
(Ct) of the standard dilution series by LightCycler software version 3.5. The slope of 
the standard curve was around -2.97, meaning that the overall reaction efficiency 
for the standard curve was 1.0 - 1.3.  
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Calculation of mRNA concentration 
The PCR reaction can be described as Nn=No*En (198), where N is the 
concentration of a sample (identified by a given cycle number), No is the starting 
concentration of the sample, E is the overall reaction efficiency and n is the baseline 
crossing point in number of cycles. To calculate the concentration cytokine mRNA 
the concentration of cytokine mRNA of each individual chicken was divided by the 
concentration of the 28S mRNA of the same chicken. At each time point the mean 
of the cytokine [mRNA]/28S [mRNA] of five chickens was taken. 
 
Crypt/villi ratios in jejunum, ileum and caecum 
 
Intestinal tissue sections, 5 µm thick, were cut and stained with haematoxylin and 
eosin. Five chickens per group were examined at each time point. The crypt-depth 
and villus-length were measured from the sections using morphometric software 
(Image Pro Plus 4.1, Media cybernetics). 
 
Statistics/data analysis 
 
Statistics were performed on the data of the chickens that were excreting 
Salmonella Enteritidis in groups 1, 2 and 3 (80-90% of the chickens) and all 
chickens of the control group. Student’s t-test was performed at every time point 
between all groups. The significance of differences between groups at the same 
time point were analyzed with Student’s t-test (two-tailed and two sample with 
unequal variance). 
  
Results 
Microbiological determinations 
 
S.E. was detected in cloaca swabs from day 2 after inoculation and on day 4 after 
inoculation in spleen, liver and caecum content of the S.E. infected groups. The 
highest frequency of S.E. cfu’s in the liver was detected on day 14 in the group with 
S.E. only, while the groups that received had this peak earlier: the group with L. 
paracasei on day 7 and the group with L. paracasei + L. brevis on day 4. On day 7, 
where the group with L. paracasei and S.E. had the peak frequency of cfu’s in the 
liver and the group with L. paracasei and L. brevis had started clearance already, 
the difference in enhancement rate between the two groups with lactobacilli was 
significant (P=0.07). In spleen the Lactobacillus strains had a decreasing effect on 
the frequency of S.E. cfu’s on day 7 in both groups with lactobacilli (both P=0.04). In 
caecum no effect of the Lactobacillus strains was found. The number of S.E. was 
3*107 cfu per gram caecum content on day 4 after infection and remained at this 
level during the experiment (table 2). 
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Table 2  Salmonella Enteritidis cfu (10log) per g liver, per spleen and per g 
caecum content on days 4, 7, 14 and 21 after infection (average of 5 animals 
(S.E.M.)a,b,c. 
 
Sample 
  
Treatment Days after infection 
 Lactobacillus strain S.E. 4 7 14 21 
Liver - + 2.9(0.4)a 3.1(0.3)a 3.2(0.4)a nd 
 L. paracasei + 3.0(0.3)a 3.6(0.1)a 3.1(0.5)a 2.2(0.2) 
 L. paracasei + L. brevis + 3.4(0.4)a 2.8(0.4)a/b 2.0(0.3)a/c 1.9(0.2) 
 - - ndb ndc ndb nd 
Spleen - + 3.1(0.4)a 4.3(0.1)a 3.5(0.4)a nd 
 L. paracasei + 3.4(0.2)a 3.7(0.2)b 3.0(0.4)a 2.2(0.3) 
 L. paracasei + L. brevis + 3.7(0.3)a 3.2(0.4)b 2.8(0.5)a/b nd 
 - - ndb ndc ndb nd 
Caecum - + 7.7(7.3)a 7.7(7.3)a 7.4(6.6)a 7.7(7.1)a 
Content L. paracasei + 7.0(6.7)a 7.8(7.7)a 7.4(7.0)a 8.0(7.6)a 
 L. paracasei + L. brevis + 7.4(7.1)a 7.1(6.7)a 7.9(7.6)a 8.0(7.6)a 
 - - ndb ndb ndb ndb 
a nd = not detectable, below detection limit.  
b For spleen and liver the highest concentration measured was dilution 10-2, and the 
estimated value was 1.7 (<50 colonies in spleen or 1g liver and 10log of 50 = 1.7). 
For caecum content the highest concentration tested was dilution 10-3. Only the 
samples from the non-infected group were below the detection limit.  
c Different subscripts in the same column indicate significant differences (na,b,c : 
P<0.05). 
 
Immunological determinations 
Specific humoral response 
 
The S.E. specific antibody responses increased after infection. From day 7 the anti 
S.E. titers were significantly higher than in the group without S.E. for both IgM and 
IgG. On day 21 the highest antibody titers were found. The IgM-anti S.E. titer in the 
L. paracasei group was decreased compared to the group with S.E. only (P=0.02, 
figure 1). This effect was not found in the group with the combination of 
Lactobacillus strains. On day 21 after infection the IgG titers were still low. 
 
Lymphocyte proliferation assay 
 
On day 21 spleen leukocytes of the group with S.E. only proliferated strong to the 
S.E. antigen (figure 2). The proliferation of the spleen leukocytes in the  
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groups with S.E. and lactobacilli was significantly reduced compared to the group 
with S.E. only (P=0.01 L. paracasei and P=0.003 L. paracasei + L. brevis).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Effect of probiotics on the S.E. specific IgM and IgG titer in serum.  
Serum anti Salmonella titers IgM (a) and IgG (b) on day 21 after SE inoculation. 
Following probiotic treatment with L. paracasei the IgM-anti-S.E. titers were 
decreased (P=0.02). Bars: Black = S.E. infection and no lactobacilli; light grey = 
S.E. infection and L. paracasei; dark grey = S.E. infection and L. paracasei + L. 
brevis; white = no S.E. infection and no lactobacilli. 
 
Morphometeric measurements: crypt/villi ratios in caecum, jejunum and ileum 
 
Crypt depth and villus-length were measured on day 4 (early reaction) and day 14 
(late reaction) to Salmonella infection and application of lactobacilli. No differences 
were found in crypt depth. In caecum the crypt/villus ratio was reduced after S.E. 
infection. Feeding of Lactobacillus strains seemed to decrease this reduction. The 
cecal crypt/villus ratio increased with L. paracasei (P=0.05 compared to the group 
with S.E. only). In jejunum the villus length in chickens of the three S.E. infected 
groups was statistically longer than in the non-infected group (P<0.001, not shown).  
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The crypt/villus ratio in jejunum was not changed by the lactobacilli. In ileum the 
lactobacilli had a similar effect as was observed in caecum. Feeding of the 
combination of L. paracasei and L. brevis protected from a decrease of the 
crypt/villus ratio (P=0.01 compared to the S.E. infected group). Statistically the 
crypt/villus ratio in the group with both lactobacilli was not different from the ratio in 
the group without S.E. infection (P=0.931). The early and late reaction were 
comparable for the proportions between the groups, although on day 4 the 
differences between the groups were more pronounced, therefore these results are 
shown in figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Effect of probiotics on the S.E. specific proliferation of spleen leukocytes. 
The proliferation of spleen leukocytes to Salmonella antigen on day 21 after 
inoculation as compared to controls was significantly reduced in the chickens with 
S.E. + L. paracasei (P=0.01) and for chickens that received S.E. + L. paracasei + L. 
brevis (P=0.003). For legend to bars, see figure 1. 
 
Discussion 
 
Our hypothesis was that that properly selected probiotics might have a positive 
effect on disease resistance, e.g. colonization resistance to the pathogen, 
prevention from/reduced systemic infection, faster recovery from the infection 
and/or clearance of the infection, and stay in the gut. In our experiment, the effect of 
feeding the Lactobacillus strains L. paracasei LW 122 and L. brevis LW 5 on a mild 
Salmonella enterica Enteritidis phage type 4 infection in young layer type chickens 
was analyzed. The time needed for clearance of the infection was reduced by the 
Lactobacillus strains, but unexpectedly also a reduction of the anti-Salmonella 
immune response was observed both locally, at level of interleukins in the gut, and 
systemically at the humoral as well as at the cellular level. 
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Figure 3. Effect of probiotics on crypt depth and villus-length during S.E. infection. 
Crypt/villus ratios in caecum (a), ileum (b) and jejunum (c) on day 4 after S.E. 
infection. As compared to the S.E.-only infected group in caecum the crypt/villus 
ratio was increased following treatment with L. paracasei (P=0.05). Also in ileum of 
chickens that received L. paracasei + L. brevis the crypt/villus ratio was increased 
(P=0.01), but was not statistically different from the group without S.E. infection 
(P=0.931)). For legend to bars, see figure 1. 
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Feeding lactobacilli did not prevent the infection from becoming systemic. Since all 
groups started to shed S.E. from day 2 after inoculation, we concluded that 
susceptibility for Salmonella was not altered. The effect of lactobacilli seemed to be 
restricted to differences in infection-kinetics. Livers and spleens of chickens 
receiving lactobacilli were cleared sooner from S.E. than occurred in chicks that 
were inoculated with S.E. only. Feeding lactobacilli accelerated the S.E. infection 
and clearance but reduced the maximum level of infection in liver and spleen. The 
combination of two strains of lactobacilli had a stronger effect on the clearance than 
the L. paracasei only. This could be an additive dosis effect because of the 
administration of two strains, or the supplementary result of two different 
interactions.  
 
However, both lactobacilli strains were selected for the same immunostimulating 
properties (150).Feeding lactobacilli did not have an effect on the frequency of S.E. 
in the caecum or the shedding of Salmonella in feces. This might be explained by 
enhanced phagocytosis of Salmonella by the lactobacilli (93, 216, 253). By this 
enhanced phagocytosis the frequency of Salmonella bacteria could reach the 
reduced maximum level sooner after infection (up to 10 days earlier in liver) and 
enhanced clearance by activated phagocytic cells. 
 
After clearing the infection the S.E. bacteria remained present in the gut and the 
frequency of bacteria in caecum remained stable during the whole experiment. We 
concluded that Salmonella bacteria after a while had become part of the commensal 
chicken flora. This was confirmed by the fact that the chickens did not show signs of 
pathology and inoculated chickens kept shedding the bacteria up to 12 weeks (34, 
68). Since S.E. became part of the commensal flora this is an indication that the 
immunological elimination of Salmonella from the chicken gut probably is not 
feasible and even probiotic immunomodulating bacteria cannot alter this host-
bacteria relationship.  
 
Heres (118) showed that susceptibility of chickens for Salmonella was decreased by 
liquid feed, fermented with L. plantarum. This effect could not be mimicked by 
acidifying dry feed and therefore it was concluded that the LAB might play an 
intrinsic role in decreasing the susceptibility to Salmonella (116). These L. 
plantarum were not immunostimulating (150) and we hypothesized that immuno-
enhancing effect together with an acidifying effect of lactobacilli might even further 
enhance protection against S.E. In contrast, the immunological effect of lactobacilli 
on a Salmonella infection was mainly characterized by suppression of different 
responses. The systemic specific humoral IgM and systemic cellular specific 
responses were reduced. This was in contrast to the criteria for which these 
lactobacilli strains were selected (150, 152). As Salmonella is an intracellular 
bacterium the faster clearance was expected to be the result of a Th1-type 
response (73, 210, 298), and therefore an enhanced production of IFN-γ and its 
inducing factor IL-18 (188) was expected. 
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But upon feeding of lactobacilli in the gut the production was of mRNA for several 
Th1 skewing cytokines (IFN-γ, IL-2, IL-8 and IL-18) was reduced as compared to 
cytokines in the gut of chicks that received S.E. only. Though the systemic immune 
reactivity was weak, the containment of Salmonella in the gut suggested a local 
immune response or involvement of natural antibodies (IgA) that control commensal 
bacteria.  
 
The relatively weak immune response could be the result of the relatively low doses 
of Salmonella to which the system was exposed (103 cfu). In addition, the 
accelerated infection kinetics and clearance of the bacteria further reduced the 
systemic ‘antigenic load‘ which might have resulted in a reduced immune response 
in chicks fed with lactobacilli as compared to the chickens that received S.E. only. In 
addition, reduction of exposure to Salmonella by competitive exclusion using a 
Salmonella vaccine strain resulted in a considerable reduced antibody response 
after inoculation (187). Not only the dose of S.E. but also the route of infection that 
was used to infect the chickens influenced the quality of the antibody responses 
(13, 44). The moderate IgM and even weaker IgG response to the oral dose of 103 
cfu that we applied, equals the response observed by Chart (44) after infection with 
105 cfu by aerosol where part of the inoculation may enter via the lungs and another 
part orally. Therefore, the weaker IgG response we found is probably not low 
because of immunomodulation by the LAB but a result of the low infectious dose. 
This might also explain the relatively low IgM titer that we observed. In general with 
Salmonella infections both natural and experimental serum IgG titers were detected 
from one week after infection, that peaked between 2 and 3 weeks after infection 
and thereafter remained high for at least several months (14, 44, 45). In our 
experiment, the IgG response was still low at week 3 after infection. However, in all 
three groups that were infected with Salmonella about the same serum IgG 
response level was observed. 
 
Perdigon (220) described positive effect of lactobacilli on Salmonella infection in 
rodent models. In accordance with our findings, combinations of two Lactobacillus 
strains had a stronger effect than the single strains. In these experiments, the 
resistance to the Salmonellae based on protective immunity was mainly mediated 
by the mucosal tissues. The activation of immunocompetent cells in GALT by LAB 
slightly increased the local inflammatory events although similar as in our 
experiment no differences were observed in anti-Salmonella serum levels between 
the LAB treated and non-treated groups (212). However, we did not find an 
indication for increased inflammatory events in the gut. The inflammatory cytokines 
IL-6, IL-8 in the gut all were reduced. This difference might be host related mouse 
versus chicken but may also be the result of differences in intrinsic properties of the 
Lactobacillus strains and infectious agent that was involved (220). The morphology 
of the caecum and ileum was influenced by the Salmonella infection as well as by 
the lactobacilli. Salmonella infection induced shortening of the villi, as in our 
experiment in caecum and ileum. Similar observations were described by Isaacson 
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and Stephen et al. (127, 275). Probiotic L. reuteri can enhance villus length and 
crypt depth in ileum (74). Here L. paracasei and L. brevis diminished or even 
prevented reduction of the crypt/villus ratio’s in ileum and caecum that were the 
result of S.E. infection. Therefore it was concluded, that probiotic lactobacilli can 
reduce the damage in the gut caused by a Salmonella infection. This may result in a 
more rapid recover from a Salmonella infection as it is beneficial to the uptake of 
nutrients. In conclusion, in the present experiment the combination of Lactobacillus 
strains that we applied L. paracasei LW 122 and L. brevis LW 5 in the case of 
inoculation with Salmonella enterica Enteritidis phage type 4 in layer type chickens 
led to a mild infection that was reduced by the Lactobacillus strains. The dose and 
route of infection may have contributed to the relatively low immune response at the 
level of local interleukin expression in the gut and systemic humoral and cellular 
responses.  
 
Our data do not exclude that a combination of Lactobacillus strains in the case of an 
infection that does not result in a commensal host relationship could synergize 
support of different aspects of disease resistance, immune responses and may help 
reduce physiological damage in the gut.  
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When investigating if probiotics could be an alternative for some properties of 
antibiotics in chicken, several aspects should be addressed. Firstly, the host in 
which the probiotics are going to be applied. Chickens have developed in different 
ways, as in layer- and broiler-type chickens, and their immune system is also 
differently developed. Secondly, the probiotic strain should be selected for the 
application in the host. This selection concerns several aspects of the strain (dose, 
timing), the probiotic properties of this strain (immunomodulating), the host (age, 
health, environment, immune system) and the combination of the strain with the 
host. Because the research was focused on immunomodulating lactobacilli in 
chicken, we selected models (in vivo and in vitro) to investigate immunomodulating 
properties of lactobacilli in chicken. Eventually the most promising strains were 
investigated in an infection model.  
 
In the current chapter the results from the preceding chapters are discussed. This 
discussion is focused on immunomodulation by probiotic lactobacilli in chicken and 
followed by a summary of the main conclusions from the research described in this 
thesis. 
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 103 
Chicken immune system 
  
The opinion is that broiler type chickens are more vulnerable to pathogens than 
layer type chickens. Heavier broiler type chickens and turkeys showed lower 
immune responses than less heavy broiler types and turkeys (156, 163, 164). When 
this relation is broadened to layer and broiler type chickens, the difference in 
immune response to antigens might be more extreme. To investigate if broiler and 
layer type chickens respond differently to an antigen qualitatively and/or 
quantitatively, both types were compared under the same circumstances in chapter 
3. The kinetics of the specific IgM anti-TNP response upon TNP-KLH immunization 
was similar in layer- and broiler-type chickens. Broiler type chickens seemed to 
generate a good specific IgM response, but a poor specific IgG response. The layer 
type chickens generated a specific IgM response, which was a bit lower than the 
response of the broiler type chickens. On the other hand, these layer type chickens 
generated an IgG response that was higher and lasted longer than the response in 
broiler type chickens. From an evolutionary point of view, the primary IgM response 
might be more important for the shorter living broiler type chickens than the more 
sophisticated secondary response, and therefore has not been a major factor in 
genetic selection. The short life span of broiler type chickens could also be 
responsible for a faster development of the immune system in broilers, which could 
lead to a higher IgM response at the same age as layer type chickens. This 
hypothesis does not explain the low IgG response in broilers though. 
 
The in vitro T cell response (blood and spleen) by broiler type chickens was lower 
than in layer type chickens. A higher concentration of antigen or mitogen was 
needed in order to detect (re)stimulation in broiler type chickens (chapter 3, (148)) 
and the response occurred at a lower level. We conclude that the results of 
immunological studies can differ between the different chicken types. The poor IgG 
and cellular responses in broilers might be enhanced to increase disease resistance 
when removing antibiotics from the chicken feed.  
 
Replacement of antibiotics by probiotics 
 
Replacement of antibiotics by probiotics in feed, fulfilling the same functions, though 
initially expected, never was our purpose. We knew that an important feature of 
antibiotics, growth stimulation, was not detected in chickens. The type of 
Lactobacillus strain, the dose of lactobacilli, the duration of the application period 
and the host all modulate the properties of lactobacilli (62, 111, 152). 
 
Probiotics and gut flora 
 
Probiotic lactobacilli might be able to help develop and stabilize the microflora of 
newly hatched chickens. In chapter 5 we showed that lactobacilli did stabilize the 
gut flora in crop, jejunum and caecum. When lactobacilli were fed to chickens via 
Chapter 8 
 104
liquid fermented feed, the flora in the gut was stabilized sooner compared to dry 
feed (152). This stabilization was especially found in the reduced numbers of 
enterococci in the groups that received fermented feed compared to the dry feed 
group, together with 10-fold higher numbers of lactobacilli in crop, jejunum and 
caecum. By stabilizing the gut flora, these chickens should be less susceptible for 
pathogens that enter the body via the gut. This principle has been proven for 
Salmonella in broiler type chickens (118) and, according to the same principle, 
probably also holds for the susceptibility to other pathogens.  
 
Probiotics and immunomodulation 
 
Modulation of the immune response by probiotics has been described since a long 
time. Such effects were observed by several groups but were hard to reproduce 
when the bacteria strains and the host to which they were administered were not 
the same. The seemingly contradictory results that were found in different studies 
are lined up in review articles. In order to compare effects of probiotics, different 
aspects of the strain (type, dose, timing, growth phase, duration of application and 
the host (genetics, environment, health status and age) should be considered. We 
investigated the different aspects of the strain in chapters 2, 5 and 6, and the role of 
the host in chapters 6 and 7. 
 
Other investigators have performed experiments and human clinical trials, that were 
carried out with well-characterized strains (e.g. commercially available and patented 
or identified by ATCC number), which is an important progress. Another recent 
improvement is the setup of the experiments, where double blind groups are used. 
Although such experiments led to verification of immune modulation effects, it is still 
not known how immunomodulation is induced by probiotics. Currently, the 
hypotheses are focused on cell-mediated effector functions or DCs, which can be 
stimulated directly by probiotics. Research concerning which part of probiotic 
bacteria induces immunomodulation, focuses on cell wall structures as sugars and 
polymers.  
 
Probiotics may interfere with or enhance immune reactivity at various levels of the 
immune response process as antigen uptake, antigen processing and presentation 
in the intestinal mucosal immune system. Investigation of these stages of the 
immune response offers a grasp on how probiotics or fragments thereof might be 
delivered in to the systemic immune system and exerts health-stimulating activities. 
Nevertheless, other routes of entry or stimulation pathways cannot be ruled out. The 
mechanism(s) by which probiotics modulate immunity are not fully understood. Most 
published studies focused on in vitro or ex vivo immune responses, of which the 
results are difficult to translate to the in vivo situation in humans or animals. 
Although in vitro studies might be helpful to unravel the mechanism(s) by which 
probiotics modulate the immune response, in vivo models are more relevant to 
study the effects of probiotics on immunomodulation (62). 
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Evaluation of probiotic properties in in vivo models is time-consuming, labor-
intensive and requires large numbers of animals. Because of the complexity of the 
interactions of health stimulating probiotics with the host, evaluating probiotics in in 
vivo models is almost comparable to a black box. These interactions vary from 
surviving the stomach, interaction with the host gut epithelium, interaction with the 
host gut flora to interaction with the host immune system. Several in vitro assays 
have been set up to be able to evaluate single aspects of probiotics influencing the 
host health. These assays cover the areas of acid- and bile tolerance and adhesion 
to gut mucus or intestinal cell lines (Caco-2 and HT-29) (30, 193). Besides selection 
methods were described for probiotics that express antimicrobial activity (1, 29, 
181), growth inhibition of unwanted flora elements (132), competitive exclusion 
(288), and also an in vitro gut model (171, 291) has been described to evaluate gut 
microbial ecology. Not all assays are validated in the in vivo situation, but even if 
they are, it is important to realize that an in vitro assay in general is focusing on one 
single selected property important for probiotic health stimulation. The results in vivo 
so far may be less promising than the in vitro data since immunomodulation by 
probiotic bacteria is depending on many more factors besides the immune system. 
If enough probiotic bacteria survive the acid and bile and expand in the gut, the 
immunomodulating capacity of a strain can have its maximal effect. Besides survival 
and expansion the bacteria should come into close contact with epithelial cells 
(adhere to these cells). These aspects of conditions in which probiotic effects are 
observed are just few examples of all the conditions a strain has to stand or the 
properties it has to own. A combination of in vitro assays, each covering a different 
aspect of the functioning of probiotics, could be helpful to pre-select promising 
strains.  
 
In the in vitro assay for the selection of immunomodulating capacities of lactic acid 
bacteria that we developed, immunomodulation was assessed as the modulation of 
non-specific proliferation of splenocytes. The splenocytes were stimulated with a 
suboptimal concentration of ConA and the lactic acid bacteria were studied for their 
immunomodulating capacities of this suboptimal proliferation. The stimulation of 
proliferation of splenocytes correlated with enhancement of specific IgM responses 
in layer type chickens (chapter 5). In the in vitro assay the interaction of the LAB 
strain with T/B cells and APCs (macrophages) resulted in extra proliferation, 
induced by Lactobacillus strains on top of the suboptimal proliferation induced by 
ConA. ConA proliferation of T cells is dependent on the presence and activation of 
accessory cells. We hypothesized that those LAB that were able to enhance T cell 
proliferation in vitro either by activation of accessory cells or T cells may do the 
same in vivo, based on their enhancing effect on the secretion of IFN-γ, 
phagocytosis and expression of complement receptors on phagocytes. Sampling of 
LAB by DCs from the GI tract may differentially affect DC maturation (48) and 
stimulate the local T cells. Subsequently, the circulating pool of mucosa-homing T-
lymphocytes may exert an immune outcome at distant (mucosal) sites. Such an 
effect might be measured as immune stimulation or adjuvant activity since activated 
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T-helper cells could also move to the spleen and modulate the activity of T cell 
subsets involved in antibody production.  
 
Because of the direct interaction of the bacteria with the T and B cells and APCs 
cells, the in vitro assay can probably also be used to measure the effect of the 
bacteria on the induction of cytokine production by these cells. The cytokine profiles 
could help to unravel part of the mechanism of immunomodulation by probiotic 
bacteria, both enhanced proliferation and decreased proliferation. A similar 
approach is expected to be successful in other animals. 
 
Stimulation of cell-mediated immune effector functions 
 
Ingestion of probiotic bacteria or fermented milk products triggers spontaneous 
(108)and enhanced mitogen-induced (306, 307) production of interferon-γ by blood 
leukocytes. The cells responsible for the interferon production are likely to be NK 
cells and/or T cells (106, 107, 119). Ingestion of probiotic bacteria enhances the 
phagocytic capacity of blood polymorphonuclear leukocytes (5, 66, 251), triggers 
respiratory burst (66, 306) and increases their expression of receptors involved in 
phagocytosis, especially complement factor 3 (CR3) (111, 211). Blood monocytes 
are similarly affected, although to a lesser extent (211, 251). 
 
This stimulation of cell-mediated effector functions (IFN-γ production and enhanced 
phagocyte function) probably results from the production of immune stimulating 
cytokines and other mediators when probiotic bacteria interact with 
monocytes/macrophages in the Peyer’s patches, intestinal mucosa or other sites. 
Lactobacilli, as well as other Gram-positive bacteria, are efficient in inducing the 
production of IL-12 (119, 120). IL-12 is the major stimulator of cell-mediated 
immune effector functions. IL-12 stimulates IFN-γ production in T cells and NK cells 
and increases their cytotoxic potential (286). Many other cytokines and mediators 
will be triggered when probiotic bacteria interact with macrophages and other cells 
of the innate immune system, some of which may be involved in the enhancement 
of phagocytic function after intake of probiotics (308). In contrast to IL-12, the 
macrophage derived cytokine IL-10 (e.g. induced by L. rhamnosus) (120) 
downregulates IFN-γ production and thus opposes the effect of IL-12 on T cells and 
NK cells (56). Different bacterium strains can induce different cytokines, possibly 
leading to opposite effects on the immune system. 
 
The induction of cytokines could lead to improved macrophage activity in chicken. In 
chapter 6 we evaluated the effect of L. paracasei on the phagocytosis of Salmonella 
Enteritidis (S.E.) bacteria in gut cells and spleen. In healthy broiler type chickens the 
phagocytosis and bacterial activity of gut cells (caecum, ileum) was enhanced by L. 
paracasei. In the spleen this bacterial activity was lower. In layer type chickens the 
probiotics did not have an effect on phagocytic and bacterial activity of the ileum 
and spleen cells (152). Since we used the same Lactobacillus strain in both chicken 
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types, the differences on the phagocytic and bacterial activity might be explained by 
intrinsic differences in the quality of the innate immune system of layer- and broiler 
type chickens, which were discussed in chapter 4 (148). 
 
In layer type chickens with a S.E. infection, the clearance of S.E. from the liver and 
spleen was accelerated in the groups receiving L. paracasei or L. paracasei + L. 
brevis (chapter 6), probably by enhanced activity of macrophages. In chapter 6 we 
found that in spleen cells of healthy layer type chickens the macrophage activity 
was not enhanced by L. paracasei. In combination with a S.E. infection, the 
accelerated clearance by liver and spleen indicates that the macrophage activity 
was enhanced by the lactobacilli, as described by others (93, 216, 253). The 
phagocytosis in the two experiments was measured differently. In the healthy 
chickens (chapter 6) the phagocytosis was measured by the number of bacteria 
entered in spleen and gut cells. In the experiment with the Salmonella infected 
chickens (chapter 7) the number of bacteria per gram liver or per spleen was 
calculated at different times, resulting in infection kinetics in the liver and spleen. In 
a spleen in vivo, bacteria can be presented to activated T and B cells, which help 
clearing the infection (apart from macrophages), while in vitro the T cells were not 
activated by a S.E. infection. The combination of L. plantarum + L. paracasei had a 
stronger effect on the clearance than the L. paracasei only. This could either be a 
dose effect because of the administration of two strains, or the supplementary or 
cooperative effect of two different interactions. As Salmonella is an intracellular 
bacterium, the faster clearance was expected to be the result of a Th1-type 
response and therefore an enhanced production of IFN-γ and its inducing factor IL-
18 was expected. Upon feeding of lactobacilli the production of mRNA for several 
Th1 skewing cytokines (IFN-γ, IL-2, IL-8 and IL-18) in the gut was reduced as 
compared to mRNA of cytokines in the gut of chickens that received S.E. only. If IL-
10 could be measured and would be increased, this would indicate that T and NK 
cells in the gut were not activated and their cytotoxic potential was not increased as 
opposed to IL-12 inducing IFN-γ. If S.E. was becoming a commensal after infection 
(as discussed in chapter 7), no increased cytotoxic activity was expected.  
 
Dendritic cells and immunomodulation by lactobacilli. 
 
To clarify the mechanism(s) underlying the immunoregulatory effects of the gut 
microflora, including probiotic bacteria, recently more attention has been paid to 
their effect on DCs. DCs occur in most tissues and in particular at sites that 
interface with external environment, such as the mucosa of the GI-tract, where they 
reside in the Peyer’s patch, lamina propria and draining mesenteric lymph node 
(145). DCs are the gatekeepers of an immune response and are the principal 
stimulators of naive Th cells - a property that distinguish them from all other APCs 
(10). There is increasing evidence that the type/quality of initiated immune response 
relies on the highly polarized functioning of the DC and that this ultimately depends 
on DC type and state of activation. The DC function is greatly influenced by locally 
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present environmental factors (57, 144, 301). After stimulation by the surface of a 
probiotic bacterium or by degraded parts of this bacterium DCs present all kinds of 
markers on their surface. These markers affect innate and specific humoral and 
cellular immunity. Included are variable expression of both antigenic and co-
stimulatory signals as well as variations in expression of cytokines, such as IL-10 
and IL-12. Since it has been shown that DCs penetrate the epithelium without 
disrupting the barrier function and directly sample gut-associated bacteria (237), 
lactobacilli from the gut may differentially affect DC maturation as determined by 
cytokine and surface marker expression. DC may therefore play a central role in 
mediating the effects of probiotic bacteria. 
The capacity of lactobacilli to variably induce IL-12 and TNF-α, and, to a lesser 
extent, IL-6 and IL-10, indicates that different strains of Lactobacillus may 
differentially determine immune responses (57). Besides strain-differences, one 
strain can dose-dependently induce different cytokine profiles. L. casei was 
observed to induce IL-6, IL-12 and TNF-α when applied in low concentrations, while 
it also induced IL-10 when applied in high concentration in mice. The strain and the 
dose of the bacteria affect the interaction with local DCs and thus ultimately dictate 
whether a Th1, Th2 or Th3 response occurs (48, 57). 
 
IgA responses  
 
Probiotic bacteria induce a specific immune response to themselves, like any other 
microbes that are taken up from the intestinal lumen. In addition, microbes also 
stimulate the production of polyreactive antibodies that have other, unknown 
specificities (42, 229). The function of such non-specific antibodies is unknown, as 
are mechanism(s) of their induction. However, it is observed that ingestion of 
probiotics non-specifically stimulates enhanced production of secretory IgA on 
mucosal surfaces, or serum IgA in the circulation (308).  
 
Several studies have examined the antibody response to peroral (128, 165, 306) or 
systemic vaccination (151, 152, 306), or to natural infection (142, 143) after and 
during application of probiotic bacteria. Several strains were used and different 
results were reported, e.g. increased serum IgA antibody levels against Salmonella 
typhi or rotavirus infection (142, 165), as well as no enhancement of the IgA 
response was reported (266, 306). It is possible that a particular probiotic strain is 
more efficient than another in inducing IgA or that the duration of application is an 
important factor in IgA induction, inducing the differences in results reported. IgA 
production might be stimulated by IL-6 which is produced by epithelial cells after 
interaction with probiotic bacteria. From many LAB strains is reported that they 
enhance intestinal IgA responses and induce IL-6. IL-6 is mainly produced by APCs 
and promotes terminal differentiation of B cells into plasma cells producing IgA (84, 
189). 
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Adjuvant function  
 
Adjuvants are substances that enhance immune responses to antigens with which 
they are simultaneously administered. Adjuvants improve antigen presentation to T 
cells by enhancing the production of T cell stimulating cytokines and enhancing the 
expression of accessory molecules by APCs. Microbial antigens possess conserved 
structures that can activate monocytes, macrophages and DCs and therefore are 
good immunogens. Lactobacilli too possess these conserved structures. In 
combination with their harmless character Lactobacilli therefore could function as an 
attractive adjuvant by activating APCs and T cells. In several studies an adjuvant 
effect was observed after feeding probiotics (150, 165, 169, 219, 228), but this was 
not always confirmed in other research (99, 112, 179, 283, 308). In chapters 2, 5, 
and 6 the possible adjuvant effect of probiotic lactobacilli in chickens was evaluated. 
In our experiments, we found a few strains that had an adjuvant effect on the 
humoral response to an artificial antigen (TNP-KLH) in both layer and broiler type 
chickens. The effect was depending on the combination of the strain, host, dose of 
lactobacilli, and duration of application (150, 152).  
 
The non-specific humoral response was enhanced in broilers while feeding feed 
fermented with L. paracasei and L. paracasei + L. brevis. The IgM titers were 
enhanced after priming and booster immunization while the IgG titers were only 
enhanced after booster immunization while feeding the combination of the two 
Lactobacillus strains ((152); chapter 6). In experiments where the lactobacilli were 
only shortly administered (5 days prior to immunization) with a lower dose (109 cfu 
per day), the Lactobacillus strains did not have an adjuvant effect on the non-
specific humoral response in layer or broiler type chickens. 
 
Temporary feeding of L. paracasei preceding immunization had an adjuvant-like 
effect on the specific humoral responses in layer type strains ((149, 150); chapters 2 
and 5). Continuous feeding with feed fermented with the combination of L. 
paracasei + L. plantarum enhanced both specific IgM and IgG titers in broiler type 
chickens. 
  
The differences in enhancement of the immune response between the different 
experiments might be the result of differences in dose and feeding regime 
(temporarily or continuous), which could result in different kinetics of the 
immunomodulatory effects. The delay between the feeding of lactobacilli and the 
time point of measuring the humoral responses may influence the results. This 
delay was even larger for the IgG response, which generally is built up later than the 
IgM response. The effects on the IgG response were smaller than on the IgM 
response. The longer period between feeding of the probiotics and the switch to IgG 
could be too long to induce a significant positive effect. It might be that after feeding 
the probiotics for a longer period or in higher doses, an adjuvant effect on the IgG 
response does occur. The differences in stimulation of the IgG response between 
Chapter 8 
 110
broiler and layer type chickens might be related to the lower specific IgG anti TNP-
KLH response in broiler type chickens (148). 
 
The age of the chickens might also affect the possibility to modulate the immune 
response by probiotics, since in young animals the immune system is not as mature 
as in older animals. In the immature immune system the cells belonging to the 
immune system might be less susceptible to the effect of probiotics. The adjuvant 
effect on the specific anti-TNP response was absent in young broiler type chickens 
after temporary feeding of L. paracasei. The combination of the young age and the 
relatively lower dose of probiotics (in proportion to the body weight) that was 
administered in broiler type chickens might be responsible for the difference in 
immunomodulation between the two chicken types within the same experiment 
((152); chapter 6).  
 
The probiotic bacteria selected in in vitro and in vivo experiments did not have an 
adjuvant effect on the specific humoral immune response in chickens infected with 
S.E. These strains were selected because of their immunomodulating effect. The 
low dose of S.E. led to a mild infection that was reduced by the Lactobacillus 
strains. The response was not high and was even lower in animals that received the 
selected probiotic lactobacilli. This reduction in immune response could be the 
result of the faster clearance of Salmonella from the organs. The accelerated 
infection kinetics and the faster clearance of the bacteria give the immune system 
less time and opportunity to be in contact with the pathogen and build up an 
immune response, resulting in a decreased immune response at all parts of the 
immune response compared to the group with S.E. only. Our data do not exclude 
that a combination of Lactobacillus strains could, in the case of an infection that 
does not result in a commensal relationship with the host support disease 
resistance and immune responses. 
 
The adjuvant effect that we observed was never extremely strong and varied 
between the chickens within a group. We used eggs from a limited number of 
mother- and father animals in order to reduce the genetic variation between the 
animals. Within a group of chickens that received the same treatment both 
responders and non-responders were found. It might be that the relatively low 
antigen concentration we used for immunizations induced larger within-group 
variations. The combination of the within-group variation with the small adjuvant 
effects found made it hard to determine an adjuvant effect. This could also play a 
role in studies by others and lead to contradicting conclusions. 
 
In layer type chickens the non-specific proliferation of stimulated splenocytes was 
enhanced by probiotic bacteria when these were added directly to the cell culture. 
Oral administration of these probiotic bacteria did not have the same enhancing 
effect on the proliferation of spleen cells ex vivo as in the in vitro assay. In broiler 
type chickens the non-specific proliferation was not enhanced. The specific 
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response to (re)stimulation with antigen in vitro was not enhanced in layer type 
chickens, but was enhanced by L. paracasei in broiler type chickens following 
temporary administration prior to the application of the immune stimulus. This 
suggests that for specific antigens, such as e.g. vaccine antigens, immunoprobiotic 
lactobacilli might enhance disease resistance in this particular broiler type chicken. 
 
Strain specificity 
 
A returning aspect in this thesis about research in probiotics is bacterial strain 
specificity. In the in vitro assay, the differences in stimulation of cell proliferation 
between strains of the same species, but not the same type were clear. Bacterial 
strain specificity is hypothesized or described in many researches (e.g. 62, 111, 
112, 150, 152, 169, 221, 310). In several studies different Lactobacillus strains, or 
strains from the same species that might not be exactly the same sub-type were 
compared, leading to conflicting or irreproducible results, as even different strains 
that are closely related and have a part of their name in common such as L. brevis 
or L. reuteri strains do not have the same probiotic properties (150). 
 
Strain specificity could in part be determined by the cell wall of lactic acid bacteria. 
This cell wall is composed of e.g. peptidoglycans, teichoic acid and polysaccharides 
which slightly differ from strain to strain. Peptidoglycans may induce adjuvant 
activity at the mucosal surface (72). Muramyl dipeptide, a lower-molecular weight 
breakdown product of peptidoglycans may stimulate cytokine production by 
macrophages, monocytes and lymphocytes. Also teichoic acid may stimulate the 
production of certain cytokines by monocytes and lymphocytes (113).  
 
Lactic acid bacteria may increase secretory IgA activity in the gastrointestinal tract 
(114). One specific probiotic strain might induce expression of different surface 
markers on DCs, APCs and accessory cells than another probiotic strain will, 
because of the differences in the cell wall. These expressed surface markers can 
affect the extent of stimulation of T and B cells. Stimulated T cells could increase 
the T cell reaction or downregulate the existing T cell response. The B cells could 
be stimulated in production of antibodies (higher antibody titer) or in decreased 
production of antibodies by deactivation of these cells. 
 
Conclusions 
• Lactic acid bacteria can be selected on immunomodulating effect in vivo 
using the in vitro assay described in chapter 5.  
• Layer and broiler type chickens differ in immune response characteristics, 
therefore results obtained in one type cannot be interpreted to the other 
chicken type straight off. 
• Probiotic lactobacilli can support in development and stabilization of the gut 
flora in crop, jejunum and caecum of young chickens and therewith make 
them less susceptible for pathogens that enter the body via the gut. 
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• Probiotic lactobacilli can reduce or even prevent the reducing/damaging 
effect of a Salmonella infection on villus length. 
• Because of the broad variation between individual chickens, the strength of 
an immunomodulating effect as well as the proportion of positive by 
responding chickens are important to determine if a probiotic strain has a 
positive effect on the immune response. 
• Probiotic lactobacilli can increase macrophage activity and enhance 
clearance of systemic bacterial infection in liver and spleen.  
• Dependent on the strain and dose of the probiotic used, and dependent on 
the genetics and age of the host and the duration of the application, 
probiotic lactobacilli can modulate the humoral immune response in 
chickens. 
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Figure 2: Host-probiotics interface, adapted from (62).Host aspects that can be 
discriminated are: 1) microflora, 2) intestinal epithelium and 3) immune system. The 
arrows indicate the interactions or feasible interactions between probiotics and the 3 
host aspects or between the aspects themselves. The targets of probiotic activity 
(probiotic effects) are written in italics. Factors that play a possible role in the 
probiotic effect are underlined. The superscript numbers refer to corresponding 
chapters in which the host aspects, probiotic effects or effect related factors are 
discussed. 
 
In conclusion, probiotic lactobacilli are applicable in chickens for several purposes. 
These vary from developing and stabilizing the microflora, especially the starterflora 
of newly hatched animals, decrease or prevent physiological damage in the gut by 
pathogenic infections, to immunomodulation and enhancing disease resistance or 
helping to recover faster from an infection. 
 
Not all probiotic lactobacilli are suited for every purpose or all purposes together. 
The probiotic lactobacilli are no miracle medicine capable of all properties ascribed 
to them. A probiotic strain can have positive effects on the health, but the strain and 
the host have to be matched with each other. Improved health does not always 
imply better or more rapid growth. The combination of the host’s age and 
background genetics with the right bacterium strain and the right dosage and 
duration of application can have beneficial effects on the gut and the immune 
system. The observed effects are always limited and do not have the same effect in 
every single animal. However, when a flock is more resistant to pathogens, the 
individual animals will be better protected. When all variables important for 
functioning of probiotics are tuned well to each other, immunomodulation and 
increased disease resistance by probiotic lactobacilli are possible.  
 
At present it is complex to balance all factors appropriately, but when more 
knowledge about the mechanism(s) of immunomodulation by probiotic bacteria and 
the gut microflora and the interaction of these two with the immune system 
becomes available, it will become easier to select the right strains and their 
application. This will lead to a more stable chicken health, which is necessary when 
antibiotics will be removed from the feed and especially when they are held outside 
where they are exposed to many more pathogens than in the strictly hygienic, more 
industrial-like farms.  
 
Future research 
 
In order to further investigate the field of probiotic lactobacilli and 
immunomodulation, more knowledge of the interaction of probiotics with the host is 
needed. In addition, knowledge of the immunomodulatory mechanism(s) should be 
developed. With such knowledge probiotic lactobacilli could be rationally selected 
for different purposes. With help of in vitro assays both aspects can be further 
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investigated. Analysis of cytokine profiles induced by probiotic lactobacilli in NK 
cells and APCs like macrophages and DCs might help reveal parts of the 
immunomodulating mechanism(s).  
 
Modern techniques like micro-arrays using DNA-chips allow studies at the gene 
expression level. Information can be obtained on which genes are upregulated in 
cells of animals or humans that received a particular probiotic compared to cells of 
animals or humans which did not receive that particular probiotic treatment. The 
genes that are up- or down-regulated because of the probiotic might be involved in 
the immunomodulation observed. The information thus generated could provide 
more information about the interaction of probiotics with the host and the cell types 
involved. 
 
There might be a relation between certain glycoproteins and other surface 
molecules on probiotic bacteria and the direction (Th1, Th2, Th3) and proportion of 
immunomodulation induced by the strain. When such a relationship does exist, the 
effect of a probiotic strain could be predicted by the surface molecules present on 
the surface of the bacteria. These surface molecules could be relatively easy 
detected in in vitro assays.  
 
Probiotics that reduce inflammation could be used for treatment and/or prevention 
of e.g. inflammatory bowel disease and Crohn’s disease, whereas other probiotic 
strains that stimulate the immune system and stabilize the gut flora could be 
selected for treatment of viral diarrhea in young children. Probiotics that shift the 
Th1 –Th2 balance within the immune system in favor of Th1, might be appropriate 
for application in e.g. allergic responses.  
 
To evaluate the relevance of the immune stimulating lactobacilli that were selected 
in our TNP-KLH model, it is necessary to evaluate these strains in an infection 
model. This infection model should induce mild immune responses in order to be 
able to detect stimulation of the immune response and preferably be a relevant gut 
pathogen in chicken. The infection by the selected pathogen preferably is to be 
inhibited by the enhanced immune response in combination with competitive 
exclusion. Useful infection models should employ Campylobacter, Eimeria, 
Pseudomonas or Influenza. These pathogens naturally infect the chicken via the gut 
and cause infections that are relevant for chicken. TNP-KLH, the model-antigen we 
used in our experiments is a non-replicating antigen to which chicken mount an 
immune response, but which does not induce an infection. The Salmonella infection 
we used in our last experiment seemed to fulfill the conditions, but probably 
because this specific Salmonella bacterium did not induce illness and became a 
commensal of the chicken flora, the immune response likely is not representative for 
the immune response to a disease causing microorganism. 
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The assays to be used to detect the immune responses should be sensitive enough 
to differentiate between not only enormous differences in stimulation as by 
adjuvants, but also between subtle differences in immune responses. 
  
When stimulating the immune system, one of the first questions that arise is: is the 
immune system in healthy, well responding animals not going to be over-
stimulated? Such overstimulation might induce adverse effects. Over-stimulation by 
probiotics, however, has never been reported so far and no clinical evidence about 
this is available.  
Attention should be paid to the safety aspects of bacteria for oral application. 
Bacteria are capable of exchanging genes with other bacteria in the gut or other 
environment. For lactobacilli, however, this is not an issue, because of the GRAS-
status of the lactobacilli used in food applications. 
 
A continuously important issue in probiotic research is preciseness. The use of well-
defined strains and the identification of self-isolated strains are crucial for 
reproducible experiments. The strain name only is not informative enough, since 
there are often different strains with the same name, so a molecular biological 
verification of the strains should be available or be performed. In addition, all factors 
influencing the results of probiotic application must be well defined and the strain 
has to be tested in the animal species or in humans beforehand. 
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Samenvatting 
 
De darm heeft tegenstrijdige functies. Voedingsstoffen en water moeten de 
darmwand kunnen passeren, terwijl ziekteverwekkers als bacteriën, virussen, 
schimmels en parasieten dat juist niet zouden moeten kunnen. Om deze 
ziekteverwekkers buiten het lichaam te houden wordt de darm beschermd door een 
slijmlaag en het immuunsysteem. De bacteriën in de darm vormen met elkaar de 
darmflora. Deze darmflora bestaat uit honderden soorten bacteriën, in totaal vele 
miljarden bacteriën (geschat wordt 1014 in zoogdieren en kippen). Deze bacteriën 
hebben intensief contact met elkaar, met de gastheer en met het immuunsysteem 
rond de darm. De bacteriën leven in symbiose met elkaar en beïnvloeden elkaar 
door synergie, antagonisme en competitie. Daardoor is de darmflora een complex 
geheel waar veel verschillende soorten bacteriën in een delicate balans met elkaar 
en met de gastheer leven. Zij dragen bij aan de bescherming van de gastheer tegen 
ziekteverwekkers doordat de hechte gemeenschap van bacteriën die de flora 
vormen, indringers niet gemakkelijk toestaat. Maar deze delicate balans kan worden 
verstoord door drastische veranderingen in voeding, door virulente 
ziekteverwekkers, antibiotica en stress. 
 
Kippen komen steriel uit het ei; er zijn nog geen bacteriën in hun darm aanwezig. 
De kuikens krijgen hun darmflora door het contact met de ouderdieren (mest) en 
van de omgeving door het pikken op de grond. Echter, in de moderne 
kippenhouderij zijn de hygiënische maatregelen zeer streng en worden de 
verschillende generaties kippen strikt gescheiden gehouden. Hierdoor krijgen de 
jonge kuikens nauwelijks de kans om een evenwichtige, gezonde darmflora op te 
bouwen, terwijl in jonge dieren ook het immuunsysteem nog niet goed ontwikkeld is. 
De combinatie van de slecht ontwikkelde darmflora, het in ontwikkeling zijnde 
immuunsysteem, de stressvolle leefomstandigheden heeft tot gevolg dat kippen 
minder weerstand tegen ziektes hebben. 
 
De huidige kippen zijn in het verleden gefokt op ofwel snelle groei met zo min 
mogelijk voer (vleesproductie) ofwel de productie van eieren. Door zo te fokken zijn 
nu twee verschillende soorten kippen ontstaan, de vleeskippen en legkippen. Ze 
verschillen niet alleen in lichaamsgewicht en eiproductie, maar ook in 
leeftijdsverwachting en immuunsysteem. 
De meeste kippen worden gehouden in industrieachtige boerderijen onder extreem 
hygiënische omstandigheden, om de infectiedruk te verlagen. Onder minder 
hygiënische omstandigheden, zoals in biologische dierhouderijen waar de dieren 
ook naar buiten kunnen lopen, zijn relatief robuustere kippen nodig. Binnenkort 
wordt het verboden om antibiotica aan het voer toe te voegen. Deze antibiotica 
hebben een antimicrobieel en groeibevorderend effect. Wanneer geen antibiotica 
aan het voer worden toegevoegd en steeds meer kippen biologisch gehouden gaan 
worden, wordt een verbeterde weerstand tegen ziekten en een goed ontwikkeld 
immuunsysteem nog belangrijker.  
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De vraagstelling voor dit onderzoek was of immuunstimulerende probiotica als 
vervanging voor de antibiotica konden worden gebruikt. Probiotica worden meestal 
omschreven als ‘oraal toegediende levende micro-organismen die een 
gezondheidsbevorderend effect op de gastheer hebben’. Een aspect van antibiotica 
wat door probiotica niet kan worden vervangen is het groeibevorderende effect. Wij 
onderzochten of probiotica het antimicrobiële effect van antibiotica zou kunnen 
vervangen door stimulatie van het immuunsysteem, om zo de weerstand tegen 
ziekten te verbeteren.  
 
Melkzuurbacteriën, zoals lactobacillen en bifidobacteriën, zijn vaak geschikte 
kandidaten voor probiotica. Verschillende melkzuurbacteriestammen kunnen op 
allerlei manieren de gezondheid bevorderen. Bijvoorbeeld door het moduleren en 
stimuleren van het immuunsysteem en het versterken van de 
slijmvliesoppervlakten, zoals de darmwand, waar ziekteverwekkers het lichaam 
binnen kunnen treden. Een kort overzicht van probiotische effecten is beschreven in 
hoofdstuk 2 en 3.  
 
Veel onderzoek naar probiotica is gebaseerd op in vitro experimenten (niet in de 
levende gastheer, maar in de reageerbuis). Het werk beschreven in dit proefschrift 
richt zich op verschillende facetten van probiotica in vitro en in vivo (in de levende 
gastheer). De aanpak van het onderzoek beschreven in dit proefschrift was als 
volgt:  
• vergelijken van het immuunsysteem van leg- en vleeskippen  
• in vitro selectie van immuunmodulerende melkzuurbacteriën; hiertoe werd 
eerst een model opgezet 
• het immuunmodulerende vermogen van oraal toegediende lactobacillen, 
die in vitro geselecteerd waren, in een in vivo immunisatie met een model-
antigeen onderzoeken (valideren van gemaakte keuzes) 
• het immuunmodulerende effect van een stam (L. paracasei) in leg- en 
vleeskippen vergelijken. Omdat deze kippen een verschillend werkend 
immuunsysteem hebben zou dat invloed kunnen hebben op de werking van 
probiotica. Daarnaast kunnen ook de dosis van de probiotica, het 
toedieningsschema van de probiotica en de leeftijd van de gastheer een rol 
spelen in de immuunmodulatie 
• het effect van immuunmodulerende lactobacillus stammen op een 
veelvoorkomende Salmonella infectie in legkippen onderzoeken in plaats 
van het immunisatiemodel met een niet ziekteverwekkend antigeen dat in 
de andere proeven werd gebruikt. 
 
In hoofdstuk 4 wordt het vergelijken van de leg- en vleeskippen beschreven. Het 
resultaat was dat de vleeskippen een goede korte termijn immuunrespons met 
antistoffen (humorale respons, IgM) hebben, maar een verlaagde lange termijn 
humorale respons (IgG) en een verlaagde cellulaire immuunrespons. Legkippen 
hebben een hogere cellulaire immuunrespons en een hogere IgG respons dan 
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vleeskippen terwijl de IgM respons wat lager is dan die in de vleeskippen. Deze 
verschillen in immuunrespons zijn waarschijnlijk door het fokken van de twee 
verschillende soorten kippen meegeselecteerd en lijken in overeenstemming met de 
levensverwachting van de kippensoorten: de vleeskippen leven maximaal 6 weken 
en de legkippen leven enkele jaren. 
 
In hoofdstuk 5 wordt het opzetten van een in vitro model voor het selecteren van 
immuunmodulerende melkzuurbacteriën beschreven. Dit model wordt uitgevoerd op 
cellen van de milt van de kip. Wanneer deze cellen samen met een stimulerende 
stof (Concanavaline A) en een immuunmodulerende bacteriestam worden 
geϊncubeerd, gaat een deel van de cellen (de T-cellen) zich vermenigvuldigen. De 
groei van de cellen is een maat voor de immuunstimulatie door de bacteriestam. De 
bacteriestam stimuleert deze T-cellen tot vermenigvuldiging doordat er een 
interactie plaats vindt tussen macrofagen (‘grote eters’, cellen die ziekteverwekkers 
opnemen (opeten) en in stukjes aan het immuunsysteem presenteren), de 
lactobacillus en de T-cel. In de in vitro test werden de lactobacillus stam, de T-
cellen en de antigeen presenterende cellen samengevoegd. Wanneer een 
bacteriestam niet immuunstimulerend is, gaan de cellen zich niet vermenigvuldigen.  
Van één stam, L. paracasei werd in de eerste experimenten duidelijk dat deze 
significante immuunmodulerende capaciteiten heeft in vivo (verhoging specifieke 
IgM en IgG repons tegen TNP-KLH). De vermenigvuldiging van de cellen wordt 
steeds vergeleken met de vermenigvuldiging die door deze stam, die als referentie-
stam werd meegetest in ieder in vitro experiment. Het in vitro model werd 
gecontroleerd met twee in vivo experimenten en bleek inderdaad een voorspellende 
waarde te hebben voor de immuunstimulerende eigenschappen van 
melkzuurbacteriën. Van de meer dan honderd stammen die werden getest bleken 
slechts vijf een immuunstimulerend effect te hebben dat even groot of iets minder 
groot was dan dat van de referentie-stam. Op grond van deze experimenten blijkt 
dat selectie van stammen ook efficiënt in vitro plaats kan vinden en door het gebruik 
van dit model zijn minder proefdieren nodig voor de selectie van 
immuunstimulerende melkzuurbacteriën. 
 
In hoofdstuk 6 wordt beschreven hoe twee Lactobacillus stammen die in vitro 
geselecteerd waren op grond van immuunstimulerende eigenschappen in vivo 
worden geëvalueerd in leg- en vleeskippen. Omdat in hoofdstuk 4 bleek dat deze 
dieren immunologisch van elkaar verschillen, zou de werking van 
immuunstimulerende melkzuurbacteriën kunnen verschillen tussen deze soorten. 
Het immuunmodulerende effect op de antistofrespons (humorale immuunrespons) 
en de cellulaire immuunrespons werden bestudeerd in leg- en vleeskippen. In deze 
experimenten werd duidelijk dat Lactobacillus stammen verschillende effecten op 
het maagdarmkanaal en immuunsysteem hebben, afhankelijk van het soort kip, zijn 
genetische achtergrond en de leeftijd van de kip. Hoewel de effecten per dier niet 
spectaculair zijn, kan niet specifieke stimulatie van het immuunsysteem de 
gezondheid van een groep dieren op een goedkope manier ondersteunen. Zowel 
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de humorale als de cellulaire immuunrespons werden versterkt. Ook de invloed van 
de hoeveelheid lactobacillen per dag en de duur van de toediening van de 
lactobacillen werden bestudeerd en deze variabelen bleken de immuunstimulatie 
door de probiotica te beïnvloeden. Om het gewenste effect te verkrijgen moeten al 
deze variabelen verder onderzocht worden, geoptimaliseerd en gebalanceerd 
worden. 
 
In hoofdstuk 7 wordt beschreven hoe het effect van twee Lactobacillus stammen, 
die zowel in vitro als in vivo een sterk immuunstimulerend effect hebben, in een 
Salmonella infectie model in legkippen werd bestudeerd. De Salmonella infectie 
werd sneller uit de lever en de milt verwijderd in de groepen die de Lactobacillus 
stammen kregen toegediend dan in de groep zonder, maar bleef aanwezig in de 
darm alsof het een onderdeel van de natuurlijk aanwezige darmflora was (als 
commensaal). De immuunrespons tegen Salmonella zowel humoraal als cellulair) 
was verlaagd in de groepen met de probiotische stammen, waarschijnlijk door de 
kortere aanwezigheid van de Salmonella infectie in het lichaam (milt en lever). De 
probiotische bacteriën versnelden mogelijk de infectie, waardoor het 
immuunsysteem minder tijd had om een goede respons op te bouwen. De lage 
infectiedosis en de infectieroute hebben waarschijnlijk ook bijgedragen aan de lage 
immuunrespons. Dit betekent niet dat een combinatie van probiotische stammen bij 
een infectie, die niet uitmondt in een gastheer-commensaal relatie, geen positief 
effect kunnen hebben op verschillende aspecten van de weerstand, 
immuunresponsen en fysiologische schade in de darm. 
 
Probiotische lactobacillen kunnen, wanneer ze nauwkeurig geselecteerd worden, de 
immuunrespons in kippen versterken. Daardoor kunnen probiotica gebruikt worden 
als voederadditief in kippenvoer om ziekteresistentie te verhogen. Naast het 
immuunmodulerende effect, kunnen lactobacillen ook helpen bij het opbouwen en 
stabiliseren van de darmflora in jonge kippen. Vooral in jonge kippen zou deze 
combinatie een positief effect kunnen hebben.  
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van velen. Deze pagina’s wil ik gebruiken om een aantal mensen te bedanken die 
voor mij onmisbaar zijn (geweest). 
 
Allereerst mijn begeleiders, Wim en Suzan. Suzan, ik mis je, je onophoudelijke 
enthousiasme en doelgerichte aanpak. Ik ben blij dat je mijn begeleidster was. 
Jammer dat je de promotie zelf niet mee kan maken. Wim, bedankt voor je kritische 
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Mijn stagiaires, Mariska en Remy, dankzij jullie inzet is de in vitro assay een echte 
degelijke assay geworden. De biotechnici Wouter, Albert, Bernard, Peter, Arnold en 
Wilfred, jullie positieve en praktische instelling en ervaring maakten dat ik het 
dierendeel van de experimenten vol vertrouwen aan jullie kon overlaten. 
Ad voor alle hulp in de sectiezaal. Jij zorgde voor mooie stukjes orgaan om verder 
mee te werken, en gaf kundig commentaar op wat je kon opmaken van de 
binnenkant van de dieren. Ik heb veel van je geleerd. 
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Hans van Dam voor de leerzame overleggen. 
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kort kwam, of kwam even binnen lopen om te zien of je kon helpen. Ook voor 
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jullie dan? 
 
Mam, jouw oppasmaandagen in Lelystad waren voor mij, maar toch zeker ook voor 
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Analysis of the Lactobacillus strains frequently used in the research described in 
this thesis as performed by BCCM/LMS, Ghent, Belgium: 
 
Tests performed: 
Recovery and purity check 
Cultures were recovered and checked for purity on MRS agar (Oxoid CM361). After 
anaerobic incubation for 24-48h at 30°C or 37°C as indicated by the client, all 
cultures showed a homogeneous growth. 
 
Basic microbiological tests 
Following microbiological tests were performed: cell morphology, gram stain, 
oxidase and catalase reaction. 
 
Fatty acid analysis  
Cells were grown for 24 h at 28°C on MRS agar (Oxoid CM361); cells of L. casei 
LW 120 were grown for 48 h at 28°C. The cellular fatty acid composition was 
determined gaschromatographically. The extraction and the analysis were 
performed conform to the recommendations of the commercial identification system 
MIDI (Microbial Identification System Inc., Delaware USA). Profiles were compared 
with the MIDI identification database TSBA40 V.4.10. 
 
1D-protein gelelectrophoresis (SDS-PAGE) and cluster analysis 
Cultures were grown in anaerobic conditions on MRS agar (Oxoid CM 361) for 24h 
at 30°C or at 37°C as depending on the optimal growth temperature. The 
preparation of the cell extracts and the 1D-protein gelelectrophoresis (SDS-PAGE) 
were carried out conform with the protocol established by the Research Group of 
the Laboratory for Microbiology, University Ghent (Pot, B., P. Vandamme and K. 
Kerstens (1994). Analysis of electrophoretic whole-organism protein fingerprints. 
Chemical Methods in Prokaryotic Systematics, M. Goodfellow and A.G. O’Donnell 
(eds.), J. Wiley and sons, Chichester).The normalized and digitized protein patterns 
were numerically analyzed and clustered with the reference profiles (culture 
collection strains and recent industrial isolates) in the LAB database as currently 
available (GelComparTM 4.2 software, Applied Maths, Belgium). 
 
16S rDNA sequence analysis and phylogenetic study (L. brevis LW 5; L. 
reuteri LW 81; L. paracasei LW 122) 
Genomic DNA of the strains was prepared according to the protocol of Niemann et 
al. (Niemann S., A. Puehler, H.-V. Tichy, R. Simon and W. Selbitschka (1997). 
Evaluation of the resolving power of three different DNA fingerprinting methods to 
discriminate among isolates of a natural Rhizobium meliloti population, J Appl 
Microbiol 82: 477-484) or Pitcher et al. (Pitcher, D.G., N.A. Saunders and R.J. 
Owen (1989). Rapid extraction of bacterial genomic DNA with guanidinium 
thiocyanate, Lett Appl Microbiol 8: 151-156). 
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16S rRNA genes were amplified by PCR and purified using the QIAquick PCR 
Purification Kit (Qiagen GmbH), Hilden, Germany). 
Complete sequencing was performed using Applied Biosystems, Inc 377 DNA 
Sequencer and the protocols of the manufacturer (Perkin-Elmer Applied Biosystems 
Div., Foster City, CA, USA) using the ‘ABI PRISM TM BigDye TM Terminator Cycle 
Sequencing Ready Reaction Kit (with AmpliTaq® DNA Polymerase, Fs)’.The 
forward and reverse primers resulted in partial overlap of sequences, ensuring 
highly reliable assembled data. 
Sequence assembly was performed by using the program AutoAssemblerTM 
(Perkin-Elmer Applied Biosystems Div., Foster City, CA, USA). 
Phylogenetic analysis was performed using the software package BioNumerics 
(Applied Maths, Belgium) after including the consensus sequence in alignment of 
small ribosomal subunit sequences collected from the international nucleotide 
sequence library EMBL. This alignment was pairwise calculated using an open gap 
penalty of 100% and a unit gap penalty of 0%. A similarity matrix was created by 
homology calculation with a gap penalty of 0% and after discarding unknown bases. 
A resulting tree was constructed using the neighbor-joining method. 
 
Results 
All strains were positive in the gram staining and negative in the oxidase and 
catalase reactions. 
 
Strain Fatty acid analysis SDS-PAGE 16S rDNA seq. analysis 
L. brevis LW 5 Lactobacillus sp. L. coryniformis >97% sim. with L. brevis 
L. brevis LW 7 Lactobacillus sp. L. brevis  
L. brevis LW 40 Lactobacillus sp. L. brevis  
L. reuteri LW 46 Lactobacillus sp., possibly L. 
reuteri 
L. reuteri  
L. buchneri LW 50 Lactobacillus sp., possibly L. kefiri L. buchneri  
L. reuteri LW 81 Lactobacillus sp. L. reuteri >97% sim. with L. reuteri 
L. buchneri LW 83 Lactobacillus sp., possibly L. 
parabuchneri 
L. buchneri  
L. paracasei LW 120 Lactobacillus sp., possibly L. 
paracasei 
L. paracasei  
L. murinus-animalis  
LW 121 
Lactobacillus sp. L. murinus-
animalis 
 
L. paracasei LW 122 Lactobacillus sp., possibly L. 
paracasei 
L. paracasei > 97% sim. with L. 
paracasei 
L. plantarum LW 143 Lactobacillus sp., possibly L. 
parabuchneri 
L. plantarum-
group 
 
L. brevis LW 167 Lactobacillus sp., possibly L. 
parabuchneri 
L. plantarum-
group 
 
 

